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Lower motor neuron damage often results in accid paralysis in which the aected muscles
are unable to be stimulated articially via the supplying nerve. Such damage is common in pa-
tients who suer from spinal cord injury and Multiple Sclerosis. Current practice for articial
recovery of muscle function involves stimulating the muscles directly by means of Functional
Electrical Stimulation (FES), which requires 100-1000 times more current than that required
for nerve stimulation, thus presenting the risk of pain receptor activation. A potential al-
ternative exists in chemical stimulation by means of administration of the neurotransmitter,
Acetylcholine (ACh). This study investigates the potential of this possibility by examining
the response of two muscle types to extracellular administration of ACh. Peak forces and
times taken to reach peak forces were recorded for gastrocnemii (predominantly fast twitch)
and solei (predominantly slow twitch) for 2 ranges of concentrations (low 4µg/ml-550µg/ml
and high 1.6g/ml-6.3g/ml). Muscles were denervated for 4 dierent periods namely 7 days,
14 days, 50-55 days and 204-208 days. Novel application of Empirical Mode Decomposition
(EMD), Hilbert Spectral Analysis (HSA) and Marginal Hilbert Spectra (MHS) were applied
to stochastic force-time data and allowed for visual depictions of energy-frequency-time distri-
butions. Additional alternate chemical and electrical stimulation was used to determine the
eect of ACh in comparison to a known stimulus.
Post-denervation bre type changes occurred sooner in gastrocnemii than solei. In order of
decreasing sensitivity, and taking both slow contractures and contractions into account, muscles
were ranked as follows: denervated solei (DS), innervated solei (IS), denervated gastrocnemii
(DG) and innervated gastrocnemii (IG). In general, denervated muscles were more sensitive
to ACh and produced more measurable responses than their innervated contralaterals, except
for short term DG at high concentrations. This was attributed to receptor proliferation. The
suggestion of a lower concentration threshold to produce the same response for denervated
muscles than their innervated contralaterals is made. Moreover, this observation is rst visi-
ble in fast twitch muscles, reasoned by preferential phenotypical changes of fast twitch bres
post-denervation. It is further suggested that bre type changes (as opposed to receptor pro-
liferation) is the governing factor of long term denervated muscles. The largest dierence in
response between DS and IS was observed at 14 days post-denervation.
Long term DS were found to lose all potential for slow contracture for all tested concen-
trations of ACh. This was not the case for long term DG. Additionally, fast twitch responses
were still visible in long term DG. These observations were attributed to a decrease in sen-
sitivity of long term denervated slow twitch bres such that they are less sensitive to ACh
stimulation than both orginally slow twitch bres as well as slow twitch bres which appear
post-denervation in originally fast twitch muscles. Results are supportive of a threshold dener-
vation period for slow twitch muscles, beyond which an increase in concentration corresponds
to an increase in output force. In addition, times taken to contraction could be grouped ac-
cording to short and long term denervation periods, where the short term periods (7 and 14











similar observation was made for long term denervation periods (50-55 days and 204-208 days).
Concentration threshold dependencies were observed at dierent denervation periods such that
denervated slow twitch muscles reacted faster than their innervated contralaterals. IG dis-
played an increase in fast twitch bre sensitivity, attributed to increased activity necessitated
by denervation of the contralateral limb.
DG were slower to reach peak force than IG. The opposite was true for DS. DG contracted
sooner than IG at combinations of long term denervation periods (50-55 days and 204-208
days) and low concentrations (4-550µg/ml); as well as short term denervation periods (7 days
and 14 days) and high concentrations (1.6-6.3g/ml).
IS produced larger contractions than DS when stimulated chemically if rst primed by
electrical stimulation. Combined EMD, HSA and MHS analysis revealed high energy outputs
from bre bundles contracting within a wider frequency range for denervated muscles compared
to their innervated contralaterals. It was suggested that this be attributed to larger bre type
variation in denervated muscles than innervated muscles. Denervated muscles stimulated with
large concentrations of ACh post electrical stimulation, produced a reduced energy output
from the contracting bres and a shift in frequency of contraction. This was probably due to
either preferential bre type saturation and or fatigue of fast twitch bres. Fast twitch bre
fatigue was further noted by reduced energy output of muscle contraction whilst the frequency
of contraction remained unchanged. This was observed in IG subjected to alternate stimulation
(ACh-electrical-ACh). Low energy output from muscle bres contracting at low frequencies
when stimulated with high concentrations of ACh post electrical stimulation were considered to
be responses from slow twitch bres thus indicating slow bre predominance, potential fatigue
and block of fast twitch bre conduction ability.
Based on the results obtained, it was concluded that direct muscle stimulation by ACh in
the manner conducted in this study would be less eective than the current use of electrical
stimulation.
Recommendations for future studies include the use of larger testing groups to verify sta-
tistical signicance; in vivo testing of the investigated parameters by i.a. ACh administration;
set rate stimulation by ACh administration for a nite period (comparable to like FES test-
ing) and conduction of presented experiments for shorter denervation periods with the aim of
determining the optimal time period and concentrations required for denervated muscles to
behave as close as possible in functionality as innervated muscles. Additionally, application
of intra arterial (i.a.) or micro uidic administration of ACh could potentially benet from
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a posteriori Derived from empirical observation.
cholinergic Denoting nerve endings, that when stimulated, release acetylcholine as a
neurotransmitter, such as those of the parasympathetic system.
Releasing or activated by acetylcholine or a related compound.
concentration
lag
Initiation at a higher concentration of a pattern or trend similar to that of a
dierent muscle.
contracture A reversible and prolonged contraction, not characterised by short bursts of
propagated contractile activity along the muscle bre.
endoplasmic
reticulum
A network of membranous tubules within the cytoplasm of a cell, responsible for
the production of the protein and lipid components of most of the cell's organelles.
exocytosis The process of cellular secretion in which the secretory products are contained
within a membrane-enclosed vesicle. The vesicle fuses with the cell membrane so
that the lumen of the vesicle is open to the extracellular environment
brillation Fine, rapid twitching of individual muscle bers with little or no movement of the
muscle as a whole.
frequency
modulation
Modulation in which the instantaneous frequency of a sine wave carrier is caused
to depart from the center frequency by an amount proportional to the
instantaneous value of the modulating signal.
Gibbs
phenomenon
The Gibbs phenomenon is an overshoot (or "ringing") of Fourier series and
other eigenfunction series occurring at simple discontinuities.
isometric
contraction
Muscular contraction during which muscle bre length remains unchanged.
ligand A smaller molecule that binds chemically to a larger molecule, which is usually a
protein. Neurotransmitters can be the ligands for specic membrane proteins
(ACh is thus considered a ligand).
lower motor
neuron
A motor neuron that has its cell body in the grey matter of the spinal cord and













motor neuron An eerent neuron that conducts muscle action potentials away from the central
nervous system to eector organs (muscles and glands). It forms the ventral root
of spinal nerves.
motor unit A lower motor neuron and all the skeletal muscle bres stimulated by branches of
its axon. Larger motor units (more muscle bres per axon) produce more force
when the unit is activated, but smaller motor units aord a ner degree of neural
control over muscle contraction.
A set of muscle bres innervated by a motor neuron.
physostigmine A compound used for its anti-cholinergic activity.
sensitivity Skeletal muscle sensitivity to Acetylcholine. No attempt is made at quantifying
the this term, but it is rather used as a comparative measure of the muscle's
reaction to ACh. For instance, if one of two muscles tested at the same
concentration were to produce a larger contractile output than the other, it would
considered more sensitive than the other to ACh in terms of contractility. If one
were to contract sooner than the other, it would be considered more sensitive to
ACh in its' time to contraction response than the other.
somatic
motor neuron
A motor neuron in the spinal cord that innervates skeletal muscles. Somatic
motor neurons may be categorized as alpha and gamma motoneurons. Alpha
motoneurons stimulate extrafusal skeletal muscle bers and gamma motoneurons
stimulate intrafusal bers within the muscle spindle.
tetanus Denotes a smooth, sustained contraction of a muscle (as opposed to muscle
twitching), caused by rapidly repeated stimuli.
upper motor
neuron
Cell bodies of interneurons located in the precentral gyrus of the frontal lobe of

















AEC Animal ethics committee
ATP Adenosine triphosphate
ATPase Adenosine triphosphatase
CNS Central Nervous System
CSA Cross sectional area




EMD Empirical mode decomposition
EPSP Excitatory post-synaptic potential
F-t Force-time
FA Fourier analysis
FES Functional electrical stimulation

















IMFs Intrinsic mode functions
IS Innervated Soleus/Solei
LG Lateral gastrocnemius
LMN Lower motor neuron
MG Medial gastrocnemius
MS Multiple sclerosis
nAChr nicotinic Acetylcholine receptor
NCAM Neural cell adhesion molecule
NMJ Neuromuscular junction
Q Dose (of ACh administered)
SCh Succinylcholine
SCI Spinal Cord Injury
SD Standard deviation
SR Sarcoplasmic reticulum
STFT Short time fourier transform
T Rise time
UMN Upper motor neuron













Nervous system damage may result from spinal cord injury (SCI), stroke or neurological disorders
(such as multiple sclerosis (MS)) which may all have severe impacts on muscle tone and contraction.
In 2007, the number of Americans living with SCI was 255,702 on average; with a further 12,000
incidences occurring per year. Less than 1% of patients experience full neurological recovery at
the time of hospital discharge. 2,500,000 people worldwide suer from MS. MS is an autoimmune
disease in which myelin sheaths degenerate, causing an adverse eect on central nervous system
(CNS) functionality; particularly by interruption of nerve signals and impulses. If areas of the brain
or CNS which control movement are aected, this may result in movement impairment or complete
loss of movement. The worldwide estimated stroke prevalence in 2006 was 6,400,000. Depending on
the area and extent of brain injury and the type of stroke, motor activity may be aected. Motor
neuron damage may be classied into two primary groups, depending on the region of damage.
Upper motor neuron (UMN) lesions constitute damage to neurons from the frontal cortex or their
tracts. UMN lesions are characterised by spastic paralysis. Lower motor neuron (LMN) lesions
constitute damage to neurons or bres of the ventral horn. This often results in accid paralysis in
which the aected neurons are unable to relay signals to the muscle bres to initiate contraction.
Paralysis occurs due to an interruption in the conduction pathways from the brain to the
muscle bres. It is possible for the connection between the brain and motor neurons to be severed
whilst still maintaining the functional viability of the motor neurons. In such cases, the motor
neurons themselves are undamaged and it is possible to stimulate them electrically to cause muscular
contraction. Functional electrical stimulation (FES) has been used as a means of reestablishing basic
functionality by stimulating elementary motion, for example in patients suering from dropped foot
due to MS or stroke [Taylor, 2002, Burridge et al., 1997].
FES does not prevent degeneration of nerve tracts and may thus prove ineective when complete
degeneration occurs (which would constitute peripheral nerve damage). Peripheral nerve damage
(as may occur in the case of LMN lesions) presents a more complicated case. In this instance, the
motor neuron is no longer viable and can thus not be stimulated electrically. It is however possible
to elicit contractions by stimulating the denervated muscle directly, although this has proven to be
more challenging due to the functional anatomy of muscle bre innervation. Each motor neuron
has many axonal branches, one or more of which innervate a muscle bre [Feindel et al., 1952,
Hunt and Kuer, 1954]. Stimulation of an undamaged motor neuron to cause the contraction of
the associated muscle bres thus requires 100 to 1000 times less current [Sheer and Chae, 2007]
than that required for direct denervated muscle stimulation [Eken and Gundersen, 1988] due to the
volumetric dierence in stimulation sites. The higher stimulating current requirement for individual
muscle bre stimulation creates the potential risk of stimulating surrounding pain receptors whose











limitation of FES includes the inability to treat multiple muscles simultaneously due to restrictions
on the maximum stimulation current [Kern et al., 2002].
Physiologically, undamaged motor neurons communicate with muscle bres at the neuromus-
cular junction (NMJ) by means of a neurotransmitter, Acetylcholine (ACh). The post junctional
membranes on the surface of the muscle bres contain a number of specic receptors. Nicotinic
acetylcholine receptors (nAChR's) in skeletal muscle bres bind to release ACh molecules, allowing
for sodium/potassium channels to open and for depolarisation, and hence contraction, to occur. An
alternative means to electrical stimulation thus exists in the use of ACh as a chemical stimulant.
Hypersensitivity to ACh in chronically denervated skeletal muscle bres has been reported [Axels-
son and Thesle, 1959]. Chronically denervated frog skeletal muscles and cat gastrocnemius were
found to be 100 and 1000 times more excitable respectively when compared to their innervated
counterparts. Theoretically, it may then be possible to articially administer ACh to denervated
muscle bre membranes in an eort to stimulate muscular contraction. In order to substantiate the
viability of such an application, it is necessary to determine the dynamic response of denervated
skeletal muscle bres to controlled amounts of articially administered ACh. This could eectively
rule out the possibility of pain receptor stimulation and oer an alternative to electrical stimula-
tion in cases of LMN damage. Applications would include incorporation of ACh administration
into neural prostheses (for example, stimulation of the blink reex by micro-uidic application of
ACh in patients with facial paralysis).
1.1 Objectives of Study
To the best of my knowledge, no in-depth investigation has been reported in literature on the eects
of denervation periods on the contractile response of mammalian skeletal muscle to ACh. Hence,
the objectives of this study are three-fold. The primary objective is to investigate denervated
muscle contraction dynamics induced by in vitro extracellular ACh administration. This involves
determining times to peak force of contraction and maximum force of contraction on denervated
skeletal muscles for varying concentrations of ACh. Innervated muscles will be used as a control. A
further objective is to determine the eects of varying concentrations of ACh on two dierent muscle
types (fast and slow twitch). The inuence of the dierence in muscle denervation periods will be
investigated by examining three dierent time periods of denervation (short term, medium term
and long term denervation groups). In addition, further signal analysis methods will be applied to











2 Review of Relevant Literature
A literature search of the biomedical and engineering aspects of muscle denervation and experimen-
tation was conducted and the relevant information is presented in section 2. Section 2.1 provides
an overview of the physiology of both innervated and denervated skeletal muscle and section 2.2
comprises the engineering applications to the physiological theory.
2.1 Biomedical aspects
Extensive research has been conducted in the eld of muscle contraction and stimulation of den-
ervated muscles mainly due to the simplicity of the denervation model; the need to understand
the mechanisms governing muscular disorders and to further rehabilitation schemes for patients
suering from paralysis. Denervation models allow for analysis of the nervous system control of
peripheral tissues [Midrio, 2006]. Skeletal muscle morphology is identical in vertebrates, thus al-
lowing for animal models to be used to investigate muscle contraction dynamics and the potential
factors which inuence them. A thorough understanding of muscle bre physiology is also necessary,
considering their altered state in the face of denervation.
2.1.1 Excitation contraction coupling
The purpose of skeletal muscle is to generate sucient force to enable controlled movement of
associated extremities. In order to do so, the muscle bres are required to receive signals from the
pre-central gyrus and cerebellum via motor neurons directed by the CNS.
Motor units comprise a number of muscle bres which are innervated by a motor neuron. A
cell body (soma), an axon and dendrites constitute a motor neuron. Motor neurons may have
many dendrites but only one axon which in turn may branch into many axon terminals. Axon
terminals synapse with either the dendrites of an adjacent motor neuron or with the motor end
plates of muscle bres. The process of neural stimulation and consequent muscle contraction is
termed excitation contraction (EC) coupling. Each muscle bre is innervated by its own motor
neuron axon. An electrical impulse is conducted from the axon to the neuromuscular junction,
of which only one exists on each muscle bre. The NMJ (whose size has been demonstrated to
be directly proportional to muscle diameter [Gauthier and Dunn, 1973]), is the connection zone
between the axon terminus (or terminal bouton) and the sarcolemma. These are depicted in Figure
1.
The post-synaptic junction of the membrane is termed the motor endplate. Cell adhesion
molecules are proteins found in pre- and post-synaptic plasma membranes. They project from
both membranes into the synaptic cleft to bond to one another hence ensuring that the pre- and











Figure 1: Depiction of neuromuscular junction and propagation of action potential
to occur across the synaptic cleft.
Neurotransmitters are chemicals which initiate action potentials in post-synaptic cells. Loewi
[1921] was the rst to establish proof of neurotransmitter existence and action [Katz, 1966] in his
experiments conducted on cardiac muscle of the frog. In his experiments, the cardiac branch of the
vagus nerve was stimulated and a substance, initially termed Vagusto by Loewi, was shown to
inhibit the contractile ability of cardiac muscle. This substance was later identied as ACh. Dale
et al. [1936] showed that stimulation of motor nerves innervating skeletal muscle in vertebrates
results in the release of ACh.
The arrival of an electrical impulse at the terminal bouton stimulates the opening of the calcium
channels thus enabling calcium ions in the synaptic cleft to diuse into the axon terminal. This
increase in calcium ions activates regulatory proteins such as calmodulin. These regulatory proteins
activate protein kinase (an enzyme) which further phosphorylates other regulatory proteins. Docked
vesicles containing ACh are found on the pre-synaptic cleft. The eventual eect of the activation
chain of events is to encourage the existing synaptic vesicles in the presynaptic axon terminal to
fuse with the plasma membrane of the axon which hence allows for exocytosis to occur by formation
of a pore for the release of neurotransmitters such as ACh.
ACh is synthesized by choline acetyltransferase whereupon it is transported into synaptic vesicles
by means of vesicular ACh transporter (VAChT) for storage. The membrane of the synaptic vesicle











pH gradient to exist between the lumen and the cytoplasm. The VAChT exchanges ACh molecules
for protons from the synaptic vesicles. The number of vesicles and frequency of action potentials
determine the amount of neurotransmitter which is released into the synaptic cleft. After exocytosis
occurs, the vesicles are taken back up into the pre-synaptic axon terminal to be reused for the same
purpose. This entire process, from the diusion of Ca2+ into the pre-synaptic cell, to exocytosis,
takes less than 100µs.
The released ACh diuses across the synaptic cleft and binds to the nAChR's on the sarcolemma
of the muscle bre resulting in sodium/potassium channel opening. There are two types of channel
regulation, namely chemical or ligand regulated channels and voltage regulated channels. Neu-
rotransmitters are ligands which bind to receptor proteins on the post-synaptic membrane and
hence activate ligand regulated channels. Ligand regulated channels are primarily present in post-
synaptic membranes, whereas voltage regulated channels may be found in axons. ACh may be
used as an excitatory or inhibitory neurotransmitter depending on the type of innervation (somatic
or autonomic) and the end stimulus (muscles, organs or glands). Since, this study focuses on the
use of ACh at the NMJ, it is important to understand the receptor properties. There are two
types of cholinergic receptors (receptors which receive ACh) namely nAChR's and muscarinic ACh
receptors. nAChR's are found in the brain and in skeletal muscle bres whereas muscarinic ACh
receptors are found in smooth and cardiac muscles and glands. Only nAChR's are relevant to this
study which pertains to paralysed skeletal muscle stimulation.
nAChR's are pentameric molecules and in innervated muscle bres are found mainly in the
vicinity of the NMJ. Two of their extracellular binding sites allow for the attachment of one ACh
molecule each. Once two molecules of ACh are bound to the nAChR sites, a channel in the
receptor protein is opened thus allowing for Na+ to ow into the cell and K+ to ow out of the
cell simultaneously and through the same channel. The Na+ ows into the cell along a steeper
electrochemical gradient than the K+ leaving the cell, causing depolarisation or an excitatory post-
synaptic potential (EPSP). The polarity of the membrane remains the same when an EPSP is
created , due to the outward ow of potassium (this is not the case with action potentials, which
are associated with voltage regulated channels in which the potassium gates only open once the
sodium gates have closed). Figure 1 depicts the nAChR's and the ligand regulated channels opened
by ACh molecule binding.
This binding process causes the ligand gated ion channels to open and allows Na+ ions to enter
the cell resulting in depolarisation. Upon reaching the threshold value, voltage gated ion channels
open and depolarisation occurs whereupon a new action potential impulse is produced to propagate
along the sarcolemma. The sarcolemma is then repolarised when the K+ ion channels open (sub-
sequent to the closing of the Na+ ions channels) and the K+ ions leave the cell. Hyperpolarisation
occurs when more potassium ions leave the cell than is necessary resulting in a relative refractory















Individual muscle bre Endomysium
The impulse encounters invaginations of the sarcolemma known as T-tubules which are located at
each Z-disk. This prompts the release of Ca2+ ions from the terminal cisterns of the sarcoplasmic
reticulum (SR) where it is stored. The Ca2+ ions are released into the sarcoplasm surrounding
the myolaments and bind to the Troponin C molecules on the thin myolaments. This causes a
rearrangement of the Troponin (C, I and T) molecules on the thick myolaments such that the
binding site on the actin globule is uncovered to enable cross-bridge attachment.
Energy required for movement of the cross-bridge myosin head is released from the breakdown
of adenosine triphosphate (ATP) into adenosine diphosphate (ADP) and a phosphate ion (P).
The movement of the myosin head results in movement of the actin lament since they are
attached at the actin globule cross-bridge attachment site. The myosin head then detaches as a
new ATP molecule attaches to it. The ATP molecule undergoes hydrolysis again and the myosin
head returns to an upright position in anticipation of further stimuli. Once the stimulation halts,
Ca2+ ions are returned for storage to the SR by means of active transport. The troponin molecules
rearrange to their resting position such that Troponin-I covers the cross-bridge attachment site
thus preventing myosin head attachment and contraction. Cross-bridge cycling hence translates to
muscle force generation. The muscle is relaxed when Acetylcholinesterase (AChE) breaks down the
excess ACh at the NMJ to allow for the receptors to respond to another stimulus.
The sequence of events in the EC process is rapid prior to muscle bre contraction. Contraction
lags behind the initial stages of the EC process. Due to this lag, continuous stimulation will result in
contraction with increased force by a process of summation. Successive stimuli at high frequencies
thus result in stronger contractions since initial stimuli overcome intrinsic resistance from parallel
structures (such as tendons) Lieber [1992].
2.1.2 Skeletal muscle morphology and physiology
Skeletal muscle itself is composed of a number of subunits. Each subunit is covered with fascia
and sheaths of connective tissue. Table 1 describes the subunits of skeletal muscle composition and
their respective sheaths. Figure 2 depicts the units of which skeletal muscles are comprised.
Whole skeletal muscles are composed of muscle fascicles which are in turn composed of muscle











Figure 2: Subunits of skeletal muscle (Copyright © 2001 Benjamin Cummings, an imprint of
Addison Wesley Longman, Inc.)
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(in respective order of decreasing sized subunits). Skeletal muscle is most easily identied micro-
scopically by striations visible due to the arrangement of the myobrils. The sarcomeres form
the basic contractile units of muscles [Fulton and Isaacs, 1991]. Sarcomeres are composed of thin
actin and thick myosin protein molecules grouped in bands and framed by Z-lines. Isotropic bands
(I-bands) are formed by the actin laments which are positioned on either side of the Z-lines.
The thick myolaments are composed of a globular head (composing heavy meromyosin) and a
thin tail (composing light meromyosin). The globular heads are found on the ends of the sarcomere.
The purpose of the globular head is two fold. Firstly, it acts as a binding site for actin. Secondly,
it acts as an enzyme site for catalysis of ATP hydrolysis. This is necessary for the energy release
required for muscle contraction. Cross bridges are formed by the globular heads when actin laments
connect to their binding sites and are pulled towards the sarcomere centre. The cross bridges are
positioned spirally at 60o from one another, whilst remaining at 14-15nm apart (axial translation)
[Shimizu et al., 1985]. Each thick lament has 6 thin surrounding myolaments. The thin laments
are comprised of actin globules, tropomyosin and troponin. The actin globules are 5nm in diameter
and are linked in series. Each thin lament consists of two spiralled actin chains. Tropomyosin,
a long protein molecule, is found on the spiral formed grooves of the actin chains. Troponin is
found along the actin spirals at 38.5nm apart. There are three types of troponin namely Troponin
C, Troponin T and Troponin I. Troponin C acts as a site for Ca2+ binding, Troponin T contains
tropomyosin and Troponin I inhibits cross-bridge attachment when Ca2+ is not present.
Actin and myosin are involved in contraction and are hence termed contractile proteins, whereas
tropomyosin and troponin regulate force production by controlling cross-bridge attachment and are
hence termed regulatory proteins. Another protein essential to the functioning of skeletal muscle
is Titin. Titin is present in myobrils and is believed to maintain the position of the thick myosin
lament in the centre of the sarcomere between the Z-lines. This is necessary during long durations
of contraction and unequal force application to the thick lament [Wang et al., 1979, Kellermayer
et al., 1997].
Skeletal muscles are comprised of either slow or fast twitch bres, or a combination of both,
which dictates the force velocity relationship of the muscles. Slow twitch bres (also termed Type
I muscle bres) have an extensive blood supply due to their use of aerobic respiration. These
bres are red in colour and contract with low forces for long durations. Fast twitch bres (or Type
II muscle bres) on the other hand are considered white bres and use anaerobic respiration or
oxidative metabolism (subtype dependent) to contract with greater forces for shorter periods and
are known to fatigue rapidly. The amount of force produced per contraction is the same for both
slow and fast twitch bres. The distinction thus lies in the greater speed with which the fast twitch
bres are able to re [Fox, 2003]. Figure 9 shows an adenosine triphosphatase (ATPase) stain for
innervated fast and slow twitch skeletal muscle bres.











(a) Gastrocnemius (b) Soleus
Figure 3: Histological ATPase stains for (a) fast twitch bres in rat gastrocnemii (arrowheads Type
IIc) [Burnes et al., 2008] and (b) Type II bres (stained dark) in rat solei [Bye et al., 2008]
specic to muscle functionality, for instance rapid contraction of the gastrocnemius is necessary
for fast motion such as running; whereas the primary function of the soleus is to maintain balance
against gravitational eects by means of slow contraction [Shier et al., 1996].
Muscle contraction dynamics are dependent upon a number of factors which determine the time
constants of the system by means of neurotendinous sensory organ feedback. These factors include
bre composition, length (sensed by type II secondary spindle endings), shortening velocity and
tension history (sensed by type Ib golgi tendon organs). Type Ia primary spindle endings sense
length and strain rate.
Rats have three major plantar exors, namely soleus, gastrocnemius and plantaris. The soleus
and gastrocnemius will be used in this study. The soleus muscle is a monoarticular ankle extensor
mainly comprised (80%) of slow twitch bres, whereas the gastrocnemius is a biarticular ankle
extensor mainly comprised of fast twitch bres (percentage diers depending on the region of the
muscle) [Lieber, 1992]. Albuquerque and Thesle [1968] conducted a comparative investigation
into the membrane properties of fast and slow skeletal muscles of the rat when both innervated
and chronically denervated. It was found that in innervated muscle bres, the electrophysiological
properties did not dier signicantly. When considering ACh sensitivity however, a dierence
between the fast and slow twitch muscles (of the extensor and soleus muscles respectively) was
apparent. In the innervated extensor site, the ACh sensitivity site was found to be conned to the
endplate whereas in the innervated soleus muscle, ACh sensitivity regions were found to exist at
the endplate as well as along the muscle bre in close proximity to the tendon.
Prodanov et al. [2005] mapped the spatial distribution of the motor endplates of the gastroc-
nemius muscle of the rat. The maps were created from series of cross sections stained for AChE
activity. The lateral and medial gastrocnemii were considered as separate entities. The motor end-











Figure 4: Eect of motor unit summation on degree of contraction. Arrows are indicative of stimuli.
in 3 columnar regions. The motor endplates of the medial gastrocnemius (MG) were found to
be distributed in a pattern resembling a leaf, with its main constituents in the distal third of the
muscle. Such information is useful in determining the region of injection or application of neuro-
transmitter substances. Both the MG and the LG are supplied by four dierent branches (each)
of the sciatic nerve, each controlling a section of the muscle independently. Prodanov et al. [2005]
further observed that for the LG, only the lateral portion contained motor endplates on the surface
of the muscle. They noted that the MG displayed a larger deviation in data. The LG was used in
this study.
2.1.3 Characteristic behaviour of skeletal muscle
Motor unit sizes vary depending on the level of control and force. Small motor units are associated
with thin (and hence easily excitable) axons, few muscle bres and ne muscle control whereas
larger motor units innervate more muscle bres and are associated with thick (and hence less
excitable) axons and large forces. Stimulation of a motor unit results in the contraction of all the
bres associated with the respective motor unit.
Force summation occurs by means of motor unit summation and wave summation. Motor unit
summation involves the recruitment of motor units such that an increase in the number of recruited
motor units corresponds to an increase in the degree of contraction. Figure 4 displays this trend.
Wave summation occurs with an increase in stimulation frequency. The motor units are stimu-
lated continuously without being given a chance to completely relax. Some of the Ca2+ ions remain
in the sarcoplasm, resulting in a larger number of cross bridge formations. Stimulation whilst still
in a state of contraction thus results in force summation, marked as section '2' in Figure 5.
In the case where motor units are continuously stimulated at high frequency (with no chance for











Figure 5: Display of force summation and resulting unfused and fused tetanus.
indicated by the marker '3' in Figure 5. When the release rate ofCa2+ions exceeds the rate of
uptake, fused tetanus results, as shown at marker '4' in Figure 5. The smooth constant force is
indicative of tetanic contraction. The maximum contractile force eventually begins to decrease over
time as the muscle fatigues.
2.1.4 Muscle denervation
Denervated muscles provide good models for investigations of muscle dynamics under varying con-
ditions. They have been used as the focus of studies exploring methods of exercising and or
reinnervating denervated bres [Gutmann and Guttmann, 1944, Gardiner et al., 1984, Kern et al.,
1999].
Upon severing of a motor nerve, Wallerian degeneration occurs. This process is characterised
by predominantly distal axonal degeneration, although a portion of the proximal end of the axon
also degenerates. Additionally, Schwann cells concerned with the distal portion of the axon lose
their dierentiating properties and rapidly increase, destroying the remaining axon and myelin
segments by phagocytosis. Further physiological changes to the cell body also occur (for more
detailed descriptions please consult Nicholls [2001]).
Subsequent to severing of a motor nerve, denervated skeletal muscle bres pass through a
number of characteristic physiological changes including the occurrence of brillations [Brown,
1937, Langley and Kato, 1915], increased sensitivity to various chemical stimulants and muscle
atrophy. Fibrillations occur 2 to 5 days post-denervation in rabbits [Langley and Kato, 1915] and
rats (compared to 1 week + in humans) and are marked by allochronic and involuntary contractions
which are not due to ACh stimulation but rather caused from direct muscle membrane activity.
They do however, initiate from the original endplate region.
Changes in denervated muscle membrane sensitivity can be explained by changes which occur in











in pre- and post-developed muscles and in innervated and denervated muscle bres [Watson et al.,
1976]. Before muscle bres become innervated, nAChR's may be found spread out along the muscle
bres. A reduction in extrajunctional nAChR's occurs in developed adult skeletal muscle and may
be attributed to nAChR gene expression [Chahine and Goldman, 1992]. The nAChR's are found
clustered at the NMJ's in fully developed and innervated muscle bres (15000-20000 nAChR's/µm2
[Levitt-Gilmour and Salpeter, 1986]) and few extrajunctional nAChR's are present [Miledi, 1960b].
It has been shown that in sites of low sensitivity, the time course of ACh potentials is slower [Katz
and Miledi, 1964b]. This was attributed to low nAChR site density in insensitive regions thus
involving a larger area of stimulation. Potential change is aected by receptor topography and
density. An increase in stimulative means results in the saturation of the closest receptors with
later activation of remote receptors due to increased diusion time.
Receptor gradients from endplate to non endplate regions in adult skeletal muscle occur at a
steeper gradient than newly innervated skeletal muscle. In their study on receptor site distribution
in innervated muscles (sartorius of the Rana temporaria and Rana esculenta, rectus abdominus of
the Rana temporaria and diaphragm and rectus abdominus of the rat), Katz and Miledi [1964b]
measured the amplitude of depolarisation as an indicative parameter due to its ease of measurement
and the accuracy with which it could be done. They reported low extrajunctional sensitivity of the
innervated skeletal muscle bres and ensured the validity of their results by implementing measures
such as muscle cleaning and varying pipette pressure on the muscle. This eliminated any potential
barrier eects of connective tissue or tendon layers at the muscle insertion to the tendon.
Subsequent to denervation however, extrajunctional ACh receptors proliferate. The proliferated
receptors are not initially evenly distributed along the muscle bre but rather are spread down a
concentration gradient from the junctional folds to the tendons. Levitt-Gilmour and Salpeter
[1986] investigated denervation eects on the sternomastoid muscles of the mouse and found the
site density 500µm from the endplate to be 4 times higher than non-endplate regions which was
dened as 2mm from the endplate. Further, they observed that 4 days post-denervation the density
of the receptors in endplate regions were 4 times more than that of non endplate regions and no
indication of new receptors possessing a slow degradation rate was found. Such a gradient is not
unlike that observed after developing muscles have been innervated. Levitt-Gilmour and Salpeter
[1986] suggested the existence of a mechanism which presupposed a maximum number of nAChR's
at the NMJ, even whilst in stages of altered synthesis and atrophy.
ACh sensitivity in innervated slow twitch and fast twitch bres dier in so far as the slow
twitch bres have a low ACh sensitivity along the whole bre whereas the fast twitch bres exhibit
no extrajunctional ACh sensitivity [Hartzell and Fambrough, 1972]. The sites of ACh sensitivity
in denervated muscle bres however, are similar in both slow and fast twitch bres and are not
regionally specic but rather apply to the entire muscle bre [Albuquerque and Thesle, 1968,











to exhibit an increased sensitivity to ACh [Watson et al., 1976, Katz and Miledi, 1964b]. Increased
membrane sensitivity to a number of chemicals signies lower stimulant concentrations required
to initiate contractions. Reduction factors of up to 1000 have been reported [Brown, 1937], as
in the case of ACh stimulation, where ACh is administered intra arterially (i.a.) or within the
denervated muscle bathing medium. Hartzell and Fambrough [1972] conducted an investigation into
the distribution and sensitivity of nAChR's of the rat diaphragm post-denervation1. The innervated
adult rat diaphragm is comprised of predominantly slow twitch bres [Kilarski and Sjostrom, 1990].
Extrajunctional nAChR's were seen to increase from 2 to 3 days post-denervation, as too was
observed by Levitt-Gilmour and Salpeter [1986]. Levitt-Gilmour and Salpeter [1986] reported that
by 8 days post-denervation, extrajunctional receptors proliferated over the entire muscle surface
at a site density of between 200-400 binding sites/µm2; and that the number of receptors at the
junctional folds remained constant for a number of weeks before exhibiting a decrease. At 14 days
post-denervation Hartzell and Fambrough [1972] stated that the extrajunctional receptors had
reached 1695 nAChR's/µm2 but by 45 days had reduced 3-fold to 529 nAChR's/µm2 (although
still resulting in an overall increase in extrajunctional nAChR's). The decrease in ACh sensitivity
between 14 and 45 days is akin to the sensitivity of a 5 day post-denervation bre. This was
hypothesized to be due to a decrease in the number and density of extrajunctional receptors and
or a decrease in surface area due to muscle atrophy. Hartzell and Fambrough [1972] established a
logarithmic relationship between the density of the nAChR's and ACh sensitivity such that nAChR
density was 0.53 times the log of the ACh sensitivity (where the sensitivity was determined by means
of iontophoretic application of ACh). The receptors displayed a 19-fold increase after a period of
14 days post-denervation if counted by specic binding methods [Hartzell and Fambrough, 1972].
Three theories exist as to the nature of the increase in extrajunctional receptors post-denervation.
These include
1. redistribution of existing receptors
2. latent receptor activation
3. generation of new extrajunctional nAChR's
(1) would result in a marked decrease in the number of junctional receptors. Hartzell and Fam-
brough [1972] did not observe such a decrease and noted that this was not a general trend in
the literature hence concluding that if redistribution were to occur, it would do so in insignicant
amounts and would thus not be the sole cause of the increase in extrajunctional receptors. The
literature is more supportive of (2) [Katz and Miledi, 1964a] and (3), although a combination of all
three possibilities has neither been ruled out nor veried [Hartzell and Fambrough, 1972].











Gauthier and Dunn [1973] investigated the semitendinosis muscle (composed of red, intermedi-
ate and white bres) of the rat at a 14 day denervation period. It was observed that at this period,
the bres were altered to a more homogeneous state resembling that of red or intermediate bres
but that these diered from normal bres in their ultrastructural properties. The increase in red
and intermediate bres was attributed to a preferential modication of white bres, conrmed by
a myobrillar ATPase staining technique to distinguish between bre types before and after den-
ervation. This alteration was considered as either a conversion (from white to red or intermediate)
or as a deterioration of bre type.
The discrimination in bre type alteration may be due to either inherent muscle bre properties
or their respective motor neurons (with specic motor neurons, diering cytochemically, supplying
dierent muscle types). Type I (red) bres are considered more independent of the nerve supply,
substantiated by muscle proteins which subsist independently of the nerve supply. Gauthier and
Dunn [1973] contested such complete independence, alluding to changes in ultrastructural proper-
ties. Further observations at this denervation period included an increase in free ribosomes and
rough surfaced endoplasmic reticulum. The increase was considered unbiased towards bre type
and attributed to the elimination of the nerve supply as a universal response. The observation was
however, more evident in red and intermediate bres (noted to possess more extensive supercial
sarcoplasms). The increase in ACh sensitivity along the muscle bre was attributed to the observed
increase in physiological apparatus of protein synthesis.
Gauthier and Dunn [1973] stated that post-denervation transformations should not be attributed
to discontinued use of the muscle, but rather to some trophic control by the respective nerve. It
was suggested that the observed increase in the number of ribosomes corresponds to the increased
production of a protein receptor. Gauthier and Dunn [1973] further asserted that the change in
ACh sensitivity to incorporate the entire bre post-denervation is curtailed by compounds which
inhibit protein synthesis. This increase in sensitivity, apparent after 2-3 days [Levitt-Gilmour and
Salpeter, 1986, Lømo and Rosenthal, 1972] is consistent in time with the appearance of additional
ribosomes, suggesting that increased ribosome appearance is either adjunct to or precedent to the
inception of whole muscle ACh sensitivity. Moreover, Gauthier and Dunn [1973] supported their
proposition of increased ribosome-ACh sensitivity correlation, with their further observations of
whole skeletal muscle ACh sensitivity at birth (in the rat) corresponding to a wealth of ribosomes
in said bres. They additionally noted that prevention of protein synthesis in undierentiated bres
(sensitive to ACh in their entirety) in vitro inhibits the progression to muscle bre supersensitivity
to ACh. Such ndings are consistent with receptor proliferation.
Denervation alters muscle dynamics dierently to what immobility or unloading would [Lieber,
1992]. Muscle atrophy (a decrease in total muscle mass) is the rst noticeable change subsequent
to denervation and occurs in both slow and fast twitch muscle bres. As a result of this atrophy,











occurs practically immediately post-denervation [Shier et al., 1996]. Muscle bre degeneration
ensues approximately 2 months post-denervation. If no reinnervation occurs (for reinnervation, see
section 2.1.5), muscle bres reach the nal stage of atrophy which involves replacement of bres
with brous, fatty tissue. Remaining bres comprise a cell membrane and cell nuclei, but a limited
ability to contract. This results in almost no capacity for myobril regeneration.
Post-denervation, muscle bres transform from slow to fast twitch bres and thus increase
the contractile speed, albeit at a lower force than their innervated counterparts [Lieber, 1992].
Albuquerque and Thesle [1968] observed a three-fold increase in the electrical time constant in both
fast and slow twitch muscle bres post-denervation in experiments involving rat skeletal muscle.
Denervation has been shown to cause an increase in the transverse resistance of the membranes in
both slow and fast twitch bres. Further notable changes post-denervation include an increase in
the threshold required to generate an action potential and a reduction in the amplitude and rate of
rise of spike, both of which are more pronounced in slow twitch bres [Albuquerque and Thesle,
1968].
2.1.5 Denervated muscle bre functional electrical stimulation and reinnervation
It is possible for denervated muscle bres to become reinnervated, provided the nerve supply to
the muscle bres redevelops rapidly. Damaged nerves which have not completely degenerated, may
regenerate at various rates depending on the nerve. If reinnervation occurs within 3 months, the
muscle bres are likely to reacquire full functionality. As post-denervation time wears on however,
regaining of full functionality becomes less probable and after 1 to 2 years, unlikely [Shier et al.,
1996]. Eberstein and Eberstein [1996] proclaimed that once a muscle has been denervated for
over a period of one year, the muscle could not be restored to its' full contractile functionality.
It was accepted that if the damaged nerve regeneration rate was so slow as to exceed this time
frame, the respective muscles would not respond to reinnervation. FES has thus been used to
maintain denervated muscle viability until reinnervation occurs [Eberstein and Eberstein, 1996].
The one year time period for muscle reinnervation was generally accepted in clinical rehabilitation
applications. Kern et al. [2002] however, disproved this by successfully stimulating and training
denervated, degenerated muscles 15-20 years post-denervation over a period of 3-4 years, albeit
obtaining high variations in contraction forces and fatigue resistance during initial years.
Muscle bre reinnervation has been shown to result in a decrease in the number of extrajunc-
tional nAChR's. Chahine and Goldman [1992] have ascribed this phenomenon to the suppression
of nAChR gene expression. Neural cell adhesion molecules (NCAM's) have also been shown to play
a signicant role in muscle bre reinnervation. Denervated muscle bres make use of NCAM's to
instigate the process of reinnervation. It has however been demonstrated [Lieber, 1992] that electri-
cal stimulation of denervated muscle suppresses the expression of NCAM's and hence discourages











Figure 6: Eect of acetylcholine concentration on contractures developed in crustacean gastric mill
muscles [Marder and Paupardin-Tritsch, 1980]
cases of complete destruction of the muscle bre such that only the basal lamina is left intact, along
with damaged muscle bre constituents. NCAM's thus aect reinnervation but are not the sole
cause thereof.
2.1.6 Response of innervated and denervated skeletal muscle to ACh administration
Application of ACh to explanted, innervated, whole skeletal muscles placed in a tissue bath, has
been shown to cause the muscle to produce a slow contracture2. The muscles' ability to react to
this form of stimulation may last for a number of hours [Quilliam, 1955]. Marder and Paupardin-
Tritsch [1980] investigated the eect of ACh (amongst other ligands) on contractures developed
in (striated) gastric mill muscles of crustaceans. Figure 6 illustrates their ndings (adapted from
Marder and Paupardin-Tritsch [1980]).
Fast and slow twitch muscles dier in their response to activation. Short bursts of propagated
contractile activity are characteristic of fast twitch bres whereas slow twitch and multiply inner-
vated bres display a gradual increase in tension, dependent on the degree to which the membrane
is depolarised [Sanghvi and Smith, 1969].











Sanghvi and Smith [1969] investigated the eects of a number of cholinomimetics and neuro-
muscular blocking agents, including ACh and succinylcholine (SCh) respectively, on the extraocular
muscles of the cat. ACh was found to induce a contraction which was maintained under both in
vitro as well as in vivo conditions. Small doses resulted in recurring motor unit activation in fast
twitch bres (measured by means of electromyography). Large doses resulted in the cessation of
the recurring motor unit activation.
Application of ACh to extraocular muscles has been shown [Sanghvi and Smith, 1969] to result
in slow contracture. ACh was also shown to evoke a prolonged contraction of the isolated superior
oblique muscles of the cat. Physostigmine (refer to Glossary of Terms on page xx) was used to
increase the eect of ACh. Gasser [1930] described a contracture as a reversible and prolonged
contraction, not characterised by short bursts of propagated contractile activity along the muscle
bre. Contractures are commonly known to result in shortening and hardening of muscle.
Sanghvi and Smith [1969] presented two reports on the eects of ACh on slow twitch bres. One
reviewed study [Hess and Pilar, 1963] supported that ACh causes only slow contractures in slow
twitch bres whereas another reviewed study [Bach-y Rita and Ito, 1966] added that invocation of
contraction by electrical stimulation prior to ACh stimulation resulted in short bursts of propagated
contractile activity as well as slow contractures as described by Gasser [1930].
Dierent doses of SCh were found to result in dierent stages of contraction. Low doses resulted
in a combination of asynchronous tetanus (refer to marker `3' in Figure 5 in section 2.1.3) and
slow contracture. Large doses caused slow twitch bres to produce contractures with some motor
activity conned to individual muscle bres and a reduction in maximal twitch force. Since SCh
is a paralytic agent, the twitch depression eect caused by large doses is expected and was further
substantiated by a potential inability of the muscle to contract further if already in a contracted
state. Sanghvi and Smith [1969] likened the response of extraocular muscles to cholinomimetics
and neuromuscular blocking agents to that of amphibian and avian skeletal muscles, all of which
exhibit slow contractures upon stimulation with some fast twitch contractions. The type of response
elicited was found to be dependent upon the dose (and hence concentration) of the agent.
A dierence in cholinomimetic eects under varying conditions was also reported [Sanghvi and
Smith, 1969]. Parameters said to aect stimulation included temperature (tests were conducted
both in vivo  at body temperature and in vitro  at room temperature) and exposure time to
the stimulating agent (short exposure times occurred with i.a. administration for in vivo tests and
longer exposure times for in vitro exposure times).
Brown [1937] experimented with the stimulation of denervated mammalian (cat) and amphibian
(frog Rana esculenta) gastrocnemii muscles by means of i.a. injection of ACh. Mammalian mus-
cles were denervated for periods between 4 and 27 days whilst amphibian muscles were denervated
for 3 weeks. The development of isometric tension (refer to section 2.2.1) was recorded amongst











quick contraction and a slow contracture, which was a previously noted phenomenon in literature
but which had never been thoroughly examined. The double peak phenomenon implied a partial
similarity between innervated and denervated muscle contractile response thus warranting further
investigation [Brown, 1937]. Mammalian muscles denervated for a period of 1 week were tested
with various doses of ACh. Larger ACh doses were administered to innervated muscle. The results
were comparable in terms of the quick response and the subsequent relaxation periods, in which the
denervated muscle exhibited a longer time period of relaxation after the quick response than that
of the innervated muscle. Small doses caused a quick contractile response, quick relaxation, and
the recommencement of brillations thereafter. The quick contractile response was noted to occur
in conjunction with an increase in action potential discharge, where an extended action potential
discharge period was evident in denervated mammalian muscle after stimulation by ACh admin-
istration, compared to shorter discharge periods in innervated mammalian muscle. An increase
in the dose (and hence concentration) of ACh caused the initial quick contraction time to display
an increase in tension and the relaxation to be reduced. At such increased doses however, the
relaxation phase was inhibited by a gradual increase in isometric tension. Further increases in the
administered dose resulted in increased peak tension of the slow contraction phase, whereupon the
slow contracture exhibited a greater peak tension than the initial quick response until eventually
the quick response was no longer discernable at maximal dose and the increase in action poten-
tial discharge shown to accompany the quick response was inhibited. Large contractures further
resulted in an increase in the ACh threshold and a reduction in the tension of contractions elicited
by maximum dose administration of ACh. Moreover, brillations did not recommence quickly af-
ter high doses of ACh, taking up to 10 minutes to do so. This eect was found to be in direct
proportion to the duration of the period of slow contracture. A third contraction phase was noted
in tests conducted with doses of ACh low enough to stimulate a slow contracture with a maximal
tension less than or equal to half that of the quick contraction. This third phase of contractile
activity was thought to be due to remaining ACh in the interstitial uid, the eect of which had
been temporarily suppressed by the slow contracture phase.
In 3 week denervated frog muscles, no spontaneous brillations were noted. In fact, the only
signicant dierence between the innervated and denervated frog muscles worth mentioning here is
the lower threshold (dose) required required to stimulate the denervated muscle in comparison to
the innervated muscle. The dose of ACh required to elicit a response in denervated muscle equal
in tension to that of innervated muscle, is a factor of 10 less than the dose required for the latter.
It should be noted here that the discussion of innervated frog skeletal muscle is relevant in that
their contractile response to ACh has been shown to be comparable to that of denervated mam-
malian muscle insofar as the eects on quick response, suppression of brillation and suppression
of contractile response to direct electrical stimulation [Brown, 1937].











vated and denervated mammalian muscle, three important dierences have been noted [Brown,
1937]. These include the requirement of a lower dose of ACh to elicit a response in denervated
muscle (compared to innervated), the extended period of the mechanical response elicited and the
lengthened duration of the action potentials occurring alongside the aforementioned mechanical
response. The increased sensitivity of denervated muscles has partly been attributed to the lack
of AChE associated with nerve endings. The lengthened periods of activity noted in denervated
muscle can thus be explained by a combination of the low threshold dose required and indepen-
dence from the requirement of rapid application (as needed in innervated muscle to overcome the
eects of AChE). The slow contracture phase of the response is not associated with repititive ac-
tion potentials. In fact, the physiological mechanism involved with the propagation of contractile
activity is inhibited by the slow contracture phase. Further, the slow contracture has been reported
to involve all the muscle bres in denervated mammalian and amphibian muscles. Although no
rigorous investigation into the contractile response of denervated muscles at varying time periods
has been conducted, Brown [1937] hypothesised that an increase in the gradual slow contracture
and an increase in membrane sensitivity (characteristic of denervation) occurred simultaneously.
This was determined by considering mammalian muscles denervated for periods of 4 and 6 days
where at 4 days, (threshold dose)4day denervation ≥
1
2 (threshold dose)0day denervation, with a barely
visible slow contracture; and at 6 days post-denervation, the muscle was considered highly sensitive
and the slow contracture was distinct.
The contractile eects on skeletal muscle due to ACh administration can thus be related to
the response of the junctional and extrajunctional nAChR's. As discussed in section 2.1.4, the
nAChR's of rat skeletal muscle are distributed down a density gradient with the maximum density
occurring at the endplate. Sensitivity thus decreases with increasing distance from the reactive
area. Frog skeletal muscles dier slightly in that intermittent regions of higher sensitivity exist
along the bre. Miledi [1960a] asserted that regional sensitivity to ACh aects the time course
of ACh potentials. Regions of low sensitivity exhibit slow rise time (T3) due to the delay in the
recruitment of surrounding r ceptors in an attempt to elicit a depolarising response (mV) of the
membrane. Feltz et al. [1971] investigated the eect of ACh on junctional and extrajunctional
nAChR's in terms of distribution and rise time of synaptic responses (depolarisation) in innervated
frog skeletal muscle. The resultant responses diered greatly between junctional and extrajunc-
tional nAChR's. Junctional receptors exhibited highly sensitive behaviour (sensitivity expressed in
mV/nC) to ACh administration with rise times below 10ms, independent of ACh dose (Q) increase.
Extrajunctional receptors on the other hand exhibited low sensitivity to ACh administration with
slow rise times which correlated linearly with a Q
2
3 dose of ACh [Feltz et al., 1971]. The rise time of







, where Q is the dose of ACh administered, D is the constant




















response at the extrajunctional regions increased with an increase in the amplitude of depolarisa-
tion. The dierence in response between junctional and extrajunctional nAChR's was attributed to
the dierence in area covered by the receptors. Extrajunctional nAChR's cover a larger area with
a more uniform distribution whereas junctional receptors are densely packed into a smaller region
which the administered doses cannot saturate hence resulting in rise time independence from Q.
The amplitude of depolarisation is dependent upon the concentration of the ACh being adminis-
tered. Miledi [1960a] and Katz and Thesle [1957] asserted that the speed of desensitisation (by
repetitive application) of a receptor site increases signicantly with an increase in concentration of
the chemical depolarising stimulant.
In experiments on innervated frog muscle in which ACh was administered i.a., Brown [1937]
reported a rapid whole muscle contraction whose tension, at high enough doses, was able to exceed
maximal twitch tension.
An important consideration, very pertinent to this study involves the eect of ACh on the
contractile response of skeletal muscle to direct electrical stimulation (refer to section 3.3.2). Brown
[1937] reported that when doses of ACh were large enough to produce a slow contracture, any
subsequent attempt at direct electrical stimulation was futile (no visible contractions occurred).
The occurrence of such suppression of a response to direct electrical stimulation was taken as an
indication of the presence of a slow contracture. Moreover, additional chemical stimulation was still
able to produce a contractile response, despite the muscles' unresponsive result to direct electrical
stimulation but this response was merely an extension of the slow contracture. Note that the initial
generation of a slow contracture is imperative - if only a quick response is elicited, the response
to electrical stimulation is not depressed. The occurrence of a slow contracture thus aects the
quick contraction response, brillation activity and direct electrical stimulation reactions; but has
no inuence on slow contracture by further ACh stimulation. These eects may persist long after
the tension developed in the muscle during the slow contracture phase has subsided.
2.2 Engineering aspects
A study of muscle contraction dynamics requires a means of analysing the obtained contractile
response. In this study, explanted skeletal muscles (solei and gastrocnemii) were stimulated and
their contractile responses (i.e. generated force) recorded. The signal analysis applied to the
recorded contractile responses included Empirical Mode Decomposition in conjunction with Hilbert
spectra. This section describes these principles as well as the application of other engineering and












Explanted muscles stimulated to produce contractile forces may be tested under one of two condi-
tions, isotonic contraction or isometric contraction. Isotonic contraction requires that a constant
tension be applied to the muscle and its change in length recorded. Isometric contraction on the
other hand requires that the muscle be maintained at constant length whilst the contractile force
is recorded upon stimulation. Isometric contraction is applied in this study, as demonstrated in
Figure 7 (adapted from Ethier and Simmons [2007]).
2.2.2 Signal characteristics
The output signals obtained in this study were considered to be non-stationary (transient) and
non-linear. A stationary signal is one in which the statistical properties (such as the mean or
variance) of the signal do not vary over time. Mathematically, a time series X(t) is said to possess
weak stationarity if [Huang et al., 1998]
E
(
| X (t)2 |
)
<∞
E (X (t)) = m
C (X (t1) , X (t2)) = C (X (t1 + τ) , X (t2 + τ)) = C (t1 − t2)
where
E (.) is the expected value average, and
C (.) is the covariance function;
and strict stationarity [Huang et al., 1998] if, for all t and τ ,
[X (t1) , X (t2) , ..., X (tn)]
and
[X (t1 + τ) , X (t2 + τ) , ..., X (tn + τ)]
are the same.
Systems are considered non-linear when the amplitudes of their variations become nite. Most
natural occurring physical systems are intrinsically non-linear. Even the data obtained from linear
systems may be deemed as non-linear in their nal state due to limitations and imperfections of
probes or applied numerical methods [Huang et al., 1998].
There are a select number of methods which allow for the analysis of non-linear and non-























Fourier analysis (FA) involves the decomposition of a signal into trigonometric components of
dierent frequencies, essentially transforming the signal from a time-based to a frequency-based
domain. As will be demonstrated shortly, this method is not ideal for the analysis of non-linear
and non-stationary signals. It does however, form the basis of the underlying principles of other
techniques which will be discussed here, hence forming the foundation of a broader explanation to
follow.
The downfall of taking the Fourier transform (FT) of a signal is that it only provides the
frequency components contained within the signal but provides no indication as to when in the
time domain these frequencies occur. FA is thus only useful for stationary signals, or in instances
when the user has no interest in the time domain information. The short time Fourier transform
(STFT) was thus developed as an attempt at tackling the shortcomings of the FT by using a
windowing technique to analyse only select portions of data at a time. STFTs segment a signal
and assume stationarity over each segment thus providing a xed resolution at all times (once a
time window is selected, its size is the same for all frequencies). This nite window decreases the
frequency resolution and provides limited precision based on the size of the window.
It follows then that a more adaptive approach is necessary if one wants to achieve better precision
and accuracy in the time and frequency domains.
2.2.4 Wavelet analysis
Wavelet analysis (WA) provides just such an adaptive approach. WA is in eect a variable window
Fourier spectral analysis (FSA) and is dened mathematically as















is the basic wavelet function
a is the dilation factor ( 1a is indicative of the frequency scale)
b is the translation of the origin (indicative of the time location of an event)
Equation 2.1 represents the energy of X for scale a at t = b [Huang et al., 1998].
The basic wavelet function (as dened above) is selected according to the type of signal being
analysed and is applied before the analysis is undertaken. WA is capable of providing time and
frequency information of a signal simultaneously and overcomes the resolution problems of the
STFT by means of its variability. The technique involves decomposing the signal (to a pre-dened











to each component. The resulting frequency bands are displayed over time intervals4. Variable
resolutions may be obtained such that higher frequencies are better resolved in time and lower
frequencies are better resolved in frequency (the signal may be analysed at dierent frequencies with
dierent resolutions). The width of the window is variable and hence changes for every spectral
component. Negative frequencies are not computed. WA has been applied to time-frequency
distributions of data in time series [Huang et al., 1998, Farge, 1992, Long et al., 1993].
Pitfalls of this method include the time frequency resolution trade o (localised changes require
one to analyse the high frequency range thus making it dicult, if not impossible to to determine
local changes in the low frequency range), the restriction to the basic wavelet function selected
(this presupposes that the user knows the shape of the useful components of the signal) and the
assumption of linearity of the signal (since the technique is based on FA as described in section
2.2.3). Despite these shortcomings, WA is still a highly regarded technique in the analysis of
non-stationary data.
2.2.5 Empirical mode decomposition and Hilbert spectral analysis
Empirical mode decomposition (EMD) is a digital signal processing technique which allows for the
analysis of stochastic signals (generally non-linear and non-stationary) [de Lima et al., 2006] whilst
still maintaining information relative to the time domain.
The EMD technique is based on a number of assumptions as dened by Huang et al. [1998],
namely
1. a minimum of two extrema (a maximum and a minimum) occur in the signal to be analysed
2. if extrema are non-existent in the data set and only inection points exist, dierentiation will
be repeatedly applied to the data until the extrema are identied and the ultimate results
achieved by integrating the components
3. the time scale is determined by the time period occurring between said extrema
EMD produces intrinsic mode functions (IMFs) which are complete and locally orthogonal bases
of the original signal [Huang et al., 1998] (so-called due to their representation of the oscillatory
components xed in the data). Time varying frequencies within the signal are thus maintained in
the IMFs. Huang et al. [1998] dened IMFs as functions which satisfy the following two conditions
1. the number of extrema is equal to the number of zero crossings or dier by a maximum value
of one over the whole data set
2. the mean value of the envelope dened by the local maxima, as well as that dened by the
local minima, must be zero at any point
4Note here the applicability of the Heisenberg Uncertainty Principle which states that the simultaneous momentum











These criteria for dening IMFs allow for both frequency as well as amplitude modulation.
The owchart in Figure 8 outlines the EMD process and hence the means of obtaining the IMFs
of an input signal.
The IMFs may be representative of physical occurrences since they represent dierent frequency
and time scale components of the signal [de Lima et al., 2006, Huang et al., 1998, Mendez et al.,
2010, Peng et al., 2005, Sharpley and Vatchev, 2006] and have been used in seismic and biological
signal analysis [Battista et al., 2007, de Lima et al., 2006] as well as EMG [Andrade et al., 2006],
ECG [Balocchi et al., 2004, Mendez et al., 2010, Salisbury and Sun, 2004] and EEG [ur Rehman
and Mandic, 2010, Sweeney-Reed et al., 2004] signal analysis. The raw signal is sifted through
the process charted in Figure 8 and the outcome is a set of IMFs with the last output component
representing the residual data which were not classied into any of the IMF components. During the
spline tting process errors occur which accrue during sifting and may result in slight inaccuracies
of the nal amplitude and frequency values. In spite of these small errors, the method is successful
in extracting most of the dynamic features from the signals examined [Huang et al., 1998]. The
sifting process serves to eradicate the presence of riding waves as well as to improve the symmetry
of the wave proles by smoothing irregularities in the amplitudes [Huang et al., 1998]. The eect
of the latter is controlled by applying a limit to the standard deviation (SD) between consecutive
siftings in order to avoid the extreme case of obtaining a xed amplitude signal. The SD is typically












The physical signicance of each IMF is to be interpreted by the user and thus supposes prior
knowledge of the signal, although methods have been developed which aim to select IMFs relevant
to the physical signicance of the signal. Some such methods are discussed by Peng et al. [2005],
Adu-Gyam et al. [2010] and Boutana et al. [2010]. IMF selection is essentially equivalent to
applying a bandpass lter to the signal, but is superior to bandpass ltering in FA in that signal
stationarity is not a limitation [Huang et al., 1998]. It is however, common practice for researchers
to make use of all the IMFs [Mendez et al., 2010] (besides the nal, representing the signal residuals.
The residual may be included if evidence for physical signicance exists).
EMD analysis is often used in conjunction with the Hilbert-Huang transform (HHT) and plotted
on a Hilbert spectrum (HS) (amplitude squared will represent energy density). The HS allows for
the energy contained in the IMFs to be visualised, and events localised (signicant for locally
inhomogeneous signals), as functions of time and frequency. This method is unique in that it
allows for quantitative analysis of frequency variation. The IMFs provide a group of local functional
components for which the instantaneous frequency is identied everywhere. The combined EMD






















1998, Peng et al., 2005, de Lima et al., 2006].
FSA is only capable of achieving a global characterisation of uniform harmonic elements in
the signal. Since non-stationary data is non-uniform globally, additional harmonic elements are
mathematically required to simulate the data. Further, FSA is based on the linear superposition of
trigonometric functions. Extra harmonic elements (which credit no physical signicance) are thus
added to deformed (non-linear, non-stationary) signals when implementing this technique. These
features of FSA result in the signals' energy being spread over a broad range of frequencies, which
detracts from the grounds of physical interpretation. The HS employs the instantaneous frequency
and energy as opposed to those globally dened which does not require the introduction of spurious
harmonic components. WA, as mentioned in section 2.2.4, is applicable to non-stationary (but not
non-linear) systems; is restricted in time and frequency resolutions depending on the frequency
range (high or low) and further constrained by having to select a basic wavelet before analysis
can take place. According to Huang et al. [1998], the HS determines the intrawave frequency
modulation whereas WA demonstrates an energy spread, lacking in precision, over the primary
energy component in the wave. Demonstration of frequency variation within a period of oscillation is
unique to the EMD-HS technique. The WA technique often results in energy `leakage' into adjacent
modes. Whilst some frequency variation does occur in the HS due to the Gibbs phenomenon5 at
abrupt frequency changes and due to the end eects introduced by the nite data length, these are
insignicant in comparison to the leakage exhibited by WA.
Accuracy in determining the occurrence of events in the time domain is crucial for non-stationary
signals. This dictates that the employed method allows for adaptivity and for both frequency
and energy (amplitude) to be functions of time [Huang et al., 1998]. Adaptivity allows for the
method to detect local variations in the data thus emphasising the physical signicance of a signal
without merely blindly conforming to mathematical constraints (such conformist activity occurs
when FA is applied to non-linear signals, resulting in the generation of spurious harmonics). Such
an adaptive basis is achievable through a posteriori development. In EMD analysis, the resulting
IMFs constitute the adaptive basis as they are derived from the data.
The Hilbert transform (HT) of an arbitrary time series is given by







P is the Cauchy principle value
X (t) and Y (t) form a complex conjugate pair
An analytic signal Z (t) (which represents an IMF after the application of the HT) can then be
represented by















X2 (t) + Y 2 (t)
]1/2





The instantaneous frequency (ω) denition which best ts these conditions [Huang et al., 1998]





Based on the stationary phase assumption (see Huang et al. [1998] and Schwartz et al. [1995]
for further details), equation 2.2 is applicable locally and hence does not require a full period of
oscillation to identify a frequency. The frequency can thus be dened locally at all points. Any
changes in frequency may then be considered as frequency modulation, with each frequency being
designated to a dierent IMF component.
For a measure of cumulative amplitude or energy at every frequency component for the complete




H (ω, t) dt
In the context of the complete time span of the data, the energy representation provided by the
marginal HS is indicative of the probability of the respective component frequency waves to appear
locally.




H2 (ω, t) dω












This study investigates the eects of various concentrations of ACh on denervated skeletal muscle
bres. The number of subjects is limited to 45 Long Evans strain of rats which were divided into 4
test groups with denervation periods of 7, 14, 50-55 and 204-208 days. The experimental protocol
will be described in four stages. The rst stage involves the denervation procedure, the second
stage details the explantation procedure, stage three describes the chemical stimulation protocol
of the explanted muscles and the fourth stage details the histological bre staining process for
determination of fast twitch bres. All procedures adhered to protocols approved by the Animal
Ethics Committee (AEC).
3.1 Denervation procedure
The denervation procedure involved severing of the sciatic nerve in the right hind limb of each rat.
The procedure was performed on each rat under sterile conditions.
Rats were weighed in order to determine the amount of analgesia, Meloxicam, to be admin-
istered. Meloxicam (10mg/kg) was administered 1 hour pre-operatively. An extraction fan was
turned on to evacuate the area of halothane vapour. Halothane was added to the halothane va-
poriser (Blease) in readiness for administration to the rat. A temperature control heating pad was
turned on and used to keep the rat warm. Oxygen, at a ow rate of 5L/min, was mixed with
halothane in a chamber. Once the chamber was ooded with the halothane/oxygen mixture, (4%),
the rat was placed into the halothane chamber.
Once the rat was unconscious, it was removed from the chamber and a nose-cone, through which
halothane and oxygen were administered, was placed over its' face. The halothane ow rate was
then readjusted to 2L/min and the vaporiser adjusted to 1.5%. The rat was placed on the heating
pad (maintained at 37oC) which was covered with tissue paper to keep the heating pad clean and
provide a layer of thermal protection between the heating pad and the rats' body. Care was taken
to position the rat and nose-cone such that the rats' airway was not obstructed.
Fur was then removed from the right hind limb using a pair of scissors. The remaining hair
was shaved with a blade and cleaned with a betadine and alcohol solution using gauze swabs. The
shaved hind limb was positioned such that the posterior aspect was exposed. Betadine and alcohol
solution was reapplied to the shaved hind limb once it was securely positioned. The operators'
gloved hands were sterilised with alcohol and sterile instruments used henceforth.
An incision was made in the posterior aspect of the right hind limb from the hip to the knee.
Two pairs of toothed forceps were utilized to hold the tissue apart whilst a pair of ne scissors was
used to cut through the surrounding fascia and fat. The exposed muscle bellies were separated and
the sciatic nerve located (this stage of the procedure is illustrated in Figure 9).











Figure 9: Right hind limb during denervation procedure. Stage of procedure: Location of the sciatic











cation. The sciatic nerve was exposed as far as possible and traced back as proximally as possible
using a pair of curved microforceps. A 6-0 silk suture was used to ligate the sciatic nerve in the
most proximal position. Ligation prevents regeneration of the sciatic nerve once severed. A section
of the nerve was then removed6 (approximately 1cm). This was done such that the nerve was cut
as close to the ligature as possible as well as as distally along the nerve as possible.
Lentrax was injected into the open wound (amounts were not specic as the Lentrax was injected
into a cavity and not intramuscularly). The incision was sutured using a 6-0 silk suture. The wound
was cleaned again using betadine and alcohol. Lentrax (0.1ml/kg) was then injected intramuscularly
into the left hind limb. Ears were clipped as a means of tagging the rat for identication. The
clipped ear was cleaned with betadine and alcohol and Lentrax was applied topically. Oxygen
was turned o at the mains and the vaporiser was turned o. The nose-cone was removed from
the rats face and the rat was kept under observation until it regained consciousness. During this
waiting period it remained on the heating pad to maintain regular body temperature. Once the rat
regained consciousness and started to move about, it was placed back into the cage and returned
to the animal unit.
Rats were monitored daily and Meloxicam (10mg/kg) administered intra-muscularly in the left
hind limb every 24 hours for 3 days (starting on the day of the denervation procedure).
3.2 Muscle explantation procedure
Subsequent to the denervation procedure, rats were left for various time periods of denervation
before the denervated muscles were removed. Specically, for four groups of rats, these denervation
time periods were 7 days, 14 days, 50-55 days and 204-208 days. At the termination point of these
periods, rats were decapitated using a small animal guillotine. The use of decapitation in place
of commonly used euthenising agents ensured that no paralytic eect was induced on the muscle
bres.
The muscle explantation procedure for each rat can be described as follows:
Immediately after decapitation the body was placed on an ice pack for the duration of the
explantation procedure. The soleus and gastrocnemius muscles from the right (denervated) hind
limb were removed rst and then the soleus and gastrocnemius muscles from the left (innervated)
hind limb were removed to be used as controls for subsequent experimental procedures. In order
to remove these muscles, a skin-deep incision was made around the base of the ankle and from
the ankle to above the knee. This allowed for the skin to be pulled proximally from the ankle to
above the knee hence exposing the underlying muscles. A pair of ne scissors was used to separate
the achilles tendon from the bone at the base of the hind limb. The separated part of the achilles
tendon was clamped with a pair of forceps and the distal portion of the tendon was then severed
6The distal portion of the nerve which remains after severing has been demonstrated to play a pivotal role in the











using a pair of ne scissors. The clamped achilles tendon was lifted away from the bone and a sharp
scalpel blade used to further separate the muscles proximal to this region (from the underling bone,
surrounding muscles, tissue, fascia and fat).
The denervated soleus (DS) muscle of the right hind limb was identied and removed rst,
followed by the denervated gastrocnemius (DG). Care was taken to remove muscles whilst still
preserving slips of tendon on each end of the muscle (this later allowed for loops to be tied to the
tendon slips and attached to the testing rig, as described in Section 3.3). The innervated soleus
(IS) and innervated gastrocnemius (IG) were subsequently removed from the left hind limb in much
the same way. Innervated soleus and gastrocnemius muscles were used as controls for their specic
denervated counterparts of the same rat.
All four excised muscles were placed in a Krebs-Ringer buer solution and kept on ice. Upon
completion of the explantation procedure, the muscles were stored in Kreb's Ringer buer solution
at -15oC until tested.
Muscle bre samples from the innervated and denervated solei and gastrocnemii were obtained
from one rat in each denervation group and frozen using liquid nitrogen, to be used later for
histological staining. Frozen samples were stored in a freezer at -80oC.
3.3 Chemical stimulation experimental setup and protocol
Chemical stimulation of the explanted muscles involved the delivery of Acetylcholine chloride
(AChCl) to the muscles. AChCl (Sigma-Aldrich) was obtained in powder form and two stock
solutions of 1mM and 0.56M were prepared every two weeks due to chemical stability of the solu-
tion in this form. Highly hygroscopic properties of the powder form dictated that preparation of
the stock solution be performed in a glovebox containing an inert gas (for which nitrogen was used).
The stock solution as well as the powder form of AChCl was stored out of sunlight. Additionally,
the powder form was stored with nitrogen sealed in the container and the stock solution was stored
between 4-8oC between tests.
The concentration of the stock solution of AChCl was dictated by the concentrations required
for stimulation. Six concentrations of ACh were used to stimulate muscular contraction. These con-
centrations and hence the corresponding volumes to be used from the stock solution were calculated
by means of the dilution principle, given by
(Cstart) (Vstart) = (Cfinal) (Vfinal) (3.1)
where
Cstart is the AChCl concentration at the start of injection
Vstart is the volume if the injected quantity











Table 2: Volumes of AChCl stock solution required for corresponding AChCl concentrations
Stock solution AChCl Concentration [mass/volume] AChCl stock solution volume [µl]
1mM 4 [µg/ml] 1.39
96 [µg/ml] 33.3
550 [µg/ml] 190.6
0.56M 1.6 [g/ml] 100
3.2 [g/ml] 200
6.3 [g/ml] 400
Vfinal is the volume of the solution in the tissue bath plus that of the injected quantity
A detailed explanation of the use of equation 3.1 can be found in Appendix C. The results,
indicating the doses of stock solution required to obtain the desired concentrations are indicated in
Table 2.
Since these experiments were conducted in vitro, every attempt was made to simulate in vivo
skeletal muscle in as near a physiological condition as possible. Table 3 provides a list of the
apparatus used during the chemical stimulation procedure and a brief description of the uses of
each item. A brief description of the horizontal tissue bath design is provided in section 3.3.1.
Detailed design drawings can be found in Appendix B.
The experimental set-up involving the equipment listed in Table 3 is displayed in Figure 10.
3.3.1 Tissue bath design
The horizontal tissue bath was designed to allow for mimicry of the natural physiological muscle
environment. The bath was fashioned from a half-pipe of acrylic. The material was practical as
it could be easily shaped on a lathe, as opposed to the frequently used glass, and also possesses
better insulation properties than glass. Walls of the bath were 8mm thick, allowing for further heat
insulation. Heating of the bath solution was achieved by circulation of preheated water through two
glass pipes which spanned the length of the bath. The pipes were positioned in parallel to each other
in a horizontal plane at 12mm apart. Hot water (the temperature of which was controlled by the
heating circulator) circulated through them, which in turn heated the bath solution by convection
and ensured that the muscle, which was placed between the heating pipes, was maintained at a
constant temperature of 37oC. A 2mm diameter hole was positioned at the base of one wall of the
tissue bath and served as an entry point for bubbling of carbogen gas into the bath solution to
ensure pH control. O-rings ensured that no leakage between the endcaps and the piped body of











Table 3: Description of apparatus used for chemical stimulation procedure
Apparatus symbol Name of Apparatus Purpose of apparatus
A Force transducer Detection of muscular contractions






Collectively enables data acquisition, amplied
by B
D Computer Allowed for visual display of livetime recording;
Stored collected data
E Horizontal tissue bath Chamber used to simulate in vivo conditions of
rat skeletal muscle
F Heating circulator Heated and circulated water through water
channels built into the tissue bath. Maintained
water temperature such that tissue bath
temperature remained at 37oC
G Automated pipette (x3) Delivered large doses of Acetylcholine chloride to
muscle at constant rate
H Suction pump Used for ushing bath solution between tests
I Carbogen tank Bubbled carbogen into tissue bath to simulate
eects of cellular respiration
J Kreb's Ringer buer
solution (Sigma-Aldrich)
Medium containing salts to simulate in vivo
physiological conditions of the muscle
K Fan and temperature
probe
Measured temperature in region of bath and
maintained at 37oC by means of feedback
mechanism and adjustable temperature settings.
This assured that the signal did not drift out of
range and that any drift introduced was not due
to temperature change aecting the sensitive
strain gauges.
























The chemical stimulation procedure performed on each muscle in turn involved the following steps:
The horizontal tissue bath (E) was lled with Kreb's Ringer buer solution (J). The heating
circulator (F) was turned on and allowed to preheat the tissue bath and subsequently maintain a
temperature of 37oC (akin to that of a rats' natural body temperature). The temperature probe
was placed next to the tissue bath and the temperature controlled fan (K) was turned on. The
muscle was removed from the fridge and placed in a dish containing Kreb's Ringer buer solution
at room temperature.
A 6-0 silk suture was used to tie a loop on either end of the muscle. The sutures were attached
to the slips of tendon which had been kept intact during the explantation procedure. Carbogen (I)
(95% oxygen, 5% carbon dioxide) was bubbled through the tissue bath to aid in preserving muscle
viability and maintaining pH of the Kreb's Ringer buer solution.
The muscle was placed in the horizontal tissue bath (E) by attaching one loop to a hook xed in
the tissue bath and the other loop to the force transducer (A) and allowed to thaw further at 37oC
for 10 minutes. The force transducer consisted of strain gauges which allowed for the mechanical
force to be expressed in terms of a voltage change. Changes in force were thus pre-calibrated to
changes in voltage which allowed for the muscle to be tensioned to a pre-determined force of 1g.
The muscle was pretensioned by means of a slide and lock mechanism attached to the base of the
force transducer (refer to L in Figure 10).
A low pass lter with a cut o frequency of 25Hz was applied. Once the muscle was pre-
tensioned, recording of voltage changes (akin to changes in contraction force) commenced for 3
minutes without any chemical stimulation to serve as a baseline of noise contribution for each test.
AChCl was aspirated into an automated pipette.7 After 3 minutes, AChCl was delivered to
the muscle by means of an automated pipette, set at the maximum delivery rate. Pipette tips
were placed directly above the mu cle (submerged in Kreb's Ringer bath solution). During initial
test stages, a small circulator was used to circulate the Kreb's Ringer buer solution within the
bath. Later, the circulator was removed just before AChCl administration to prevent the AChCl
from circulating away from the muscle before reaching the endplates. Each test was allowed to run
for 19 minutes (following the 3 minute baseline noise contribution recording). Muscles from the
short term groups (7 days and 14 days) were directly stimulated electrically subsequent to AChCl
administration. This provided a means of determining (and checking for) slow contracture phases,
as described in section 2.1.6 and implemented by Brown [1937]. The chemical-electrical stimulation
cycle was repeated if deemed necessary, depending on the results obtained. The horizontal tissue
bath (E) was ushed 3 times with double distilled water after each stimulation test to prevent any
7The amount of AChCl stock solution aspirated into the automated pipette (and hence the quantity administered
to the muscle) was determined by the dilution principle and dependent upon the desired concentration for each test,











Table 4: Incubating solution compositions for myobrillar ATP staining
Veronal Buer (pH 9.4) ATP solution (pH 9.4)
0.1M Sodium Barbitone 0.1M Sodium Barbitone
0.18M Calcium Chloride 0.18M Calcium Chloride
Distilled Water Distilled Water
pH adjusted with 0.1M NaOH ATP (disodium salt)
pH adjusted with 0.1M HCl pH adjusted with NaOH
AChCl from remaining in the bath and aecting subsequent tests.
3.4 Histological bre staining
Muscle samples from each denervation group were frozen in liquid nitrogen and stored at -80°C for
later myobrillar ATPase staining. Only fast twitch bres were stained for from each denervation
group to determine bre composition during denervation stages and comparisons made by staining
of control innervated muscle bres.
The ATP staining procedure (similar to that used by Gauthier and Dunn [1973]) involved a
pre-incubation stage and a substrate (ATP) incubating stage. A Veronal pre-incubation buer (pH
9.4) was used to accentuate fast twitch (Type II) muscle bres. Table 4 provides the composition
of the pre-incubation buer as well as that of the substrate incubating solution.
The staining procedure is outlined in the Table 5. .
APTES slides were used for mounting cryosectioned muscle samples which were transverse
sectioned to a thickness of 10µm. The inside temperature of the cryostat machine was set to -21oC.
Muscle samples were removed from storage at -80oC and positioned on the chuck, stabilised by use
of Tissue tech (one muscle sample per chuck). The muscles were placed at the desired orientation
to allow for transverse sections to be cut. Muscle samples were left in the cryostat machine with the
glass lid closed for a few minutes in order to acclimatise. Samples were then cryosectioned to 10µm
thicknesses (the rst few samples were discarded to ensure the correct thickness was obtained).
Slides contained between 6 and 12 samples each, depending on the cross-sectional diameter of the
muscle sample (for instance, denervated muscle samples had atrophied considerably over the various
time periods and the smaller the diameter of the muscle sample, the more sections a slide was able to
accommodate). Once samples were sectioned, the sections were lifted o the metal bevel (inside the
cryostat machine) by means of the APTES slides and immediately labelled according to order and
orientation. Care was taken in noting if any of the sections had been transposed during sectioning











Table 5: Staining procedure for fast twitch muscle bres
Duration Staining procedure for fast twitch bre sections Notes
Use 10µm sections of tissue on APTES slides
15 mins Place in Veronal Buer
4 mins Place in incubation buer (pH 9.4)
10 mins Place in ATP solution
Few seconds Wash in CaCl2
4 mins Incubate in CoCl2 (2%)
As needed Wash well in 0.01M Sodium Barbitone
As needed Rinse in distilled water
Few seconds Develop colour in dilute ammonium sulphide (1%) Use under fume
hood
1 min Rinse in tap water
As needed Dehydrate through alcohol solutions
As needed Clear in xylol
As needed Mount with Entellan
Slides containing sections were stored at -20oC until the staining procedure was performed8.
Stained sections were stored in a refrigerator at -4oC until photographed under a light microscope
by use of a digital camera. Storage in this manner did not exceed 2 hours.











4 Results and Discussion
This section details the results obtained from stimulation by ACh of the explanted muscles. Fur-
ther results include explanted muscle dimensions and mass. Results from the histological ATPase
staining are also presented. Wherever possible, ANOVA (single factor) was used to attest to sta-
tistical viability. However, given the that the sample sizes were limited by ethical constraints, full
statistical analysis could not be conducted for data from all groups. This is a noted limitation
and potential trends are thus discussed as noted, and veried by literature where possible; hence
use of the words 'trend(s)' and 'pattern(s)' do not necessarily imply statistical signicance. Later
recommendations of larger sample sizes are made in section 7. An in depth discussion of the data
is provided as the results are presented.
4.1 Muscle mass and dimensions
Muscle dimensions and mass were recorded in order to normalise the recorded contractile force as
described in section 4.2.2. This was necessary as whole muscles were used as opposed to single
muscle bres. Further comparisons were drawn between change in mass and dimension as per
length of denervation period.
Table 6 provides the explanted muscle mass for both solei and gastrocnemii at the dierent
denervation periods as well as the percentage mass loss (plotted in Figure 11) and signicance
thereof, for denervated solei and gastrocnemii at all denervation periods investigated.
Table 6 shows that on average, the muscle masses decreased after denervation (seen when
comparing DS to IS and DG to IG at all denervation periods). This is an expected outcome, often
noted in literature and is due to muscle atrophy which occurs post-denervation.
Both the DS and DG demonstrate an increase in percentage mass loss with an increase in
denervation period. The DS exhibited a higher percentage mass loss over time than the DG. At 7
days post-denervation, the smallest loss occurred in comparison to the dierence between muscle
types at all later denervation periods. It is noted that at 7 days post-denervation the gastrocnemii
displayed a high sensitivity to chemical stimulation. This will be discussed in greater detail with
other quantitative data (force response to chemical stimulation, time to peak force, response to
electrical stimulation etc. in later section 4.2. Another observation which can be made from the
information presented in Figure 11, is the far greater percentage mass loss of the 14 day DS in
comparison to the 14 day DG. This time period is considered by literary sources [Axelsson and
Thesle, 1959, Hartzell and Fambrough, 1972, Fambrough, 1974] to be the most sensitive post-
denervation period of slow twitch muscles and is supported by the results obtained from this
investigation, as will be demonstration later in the discussion. It is thus relevant to note that the
graph 'extremes' (or most noticeable dierences) appear at the highest periods of sensitivity for











Table 6: Mass of explanted solei and gastrocnemii muscles and percentage mass loss of denervated
muscles at various stages of denervation.
































7 0.218 0.174 18.85 p=0.024,
n=10,
df=19
1.805 1.542 14.48 p=0.0078,
n=10,
df=19
14 0.214 0.101 50.42 p=0.0000368,
n=8,
df=159
1.683 1.236 22.73 p=0.025,
n=8, df=15
50-55 0.337 0.137 59.06 p=0.00002,
n=9, df=17
1.555 0.745 45.11 p=0.0089,
n=9, df=17
204-208 0.352 0.104 70.72 p=0.00004,
n=6, df=11
2.243 0.825 60.06 p=0.00024,
n=6, df=11
solei and gastrocnemii from 7 to 14 days denervation w s noted, followed by a decrease in the like
from 14 days onwards. All percentage mass losses were signicant, with all p-values < 0.05.
4.2 Chemical stimulation
The raw data obtained from the experimental muscle contraction recordings was output to LabChart
7 software. The parameters of the output were voltage (mV) and time (sec). Datasets were
exported as MATLAB extension les. All data was processed in MATLAB R2010a and Microsoft
Oce Excel 2007. A database of all tests and pertinent information was generated in Microsoft
Oce Excel 2007 using Visual Basic (VBA) to code algorithms which standardised dataset names
allowing for data lters to be applied according to dened parameters (such as AChCl concentration,
denervation period and muscle type) and imported gures generated in MATLAB R2010a. In order
to standardise these gures, an algorithm was written in MATLAB R2010a to downsample, shift,
convolve, mark and plot all datasets on the same scales for easier comparison. Algorithm details
are presented in Appendix D.
Variables investigated included maximum contraction force and time taken to reach maximum
contraction.
The parameters dening the basis for comparison between datasets included concentration of











Figure 11: Percentage mass loss of denervated solei and gastrocnemii muscles in comparison to
their innervated contralaterals for all investigated periods of denervation (5% error bar).
muscles.
The methods of analysis included direct force readings from the trace after normalisation and
further in depth analysis with implementation of EMD, HSA and MHS, the results of which will
each be explained in turn in the subsections to follow.
4.2.1 Change in force-time relationship with increasing concentration for denervated
and innervated muscles at short and long term denervation periods
This section presents the F-t traces for denervated muscles and their controls for increasing concen-
trations and for all denervation periods investigated. Only 'pattern' changes will be noted in this
section since values are required to be normalised for a direct comparison (as is conducted in section
4.2.2). Any values displayed on the gures are absolute values which have not been normalised.
Red lines on the F-t graphs represent the time of injection of ACh.
7 days post-denervation, DG showed gradual increases in force for all concentrations except at
the lowest concentration of 4µg/ml which appears to be too weak a concentration to cause any force
variation or slow contracture post ACh administration for DG muscles. The IG however, displayed
a small gradual increase in force at this low concentration in comparison to the DG, although
not much force variation was noted. The IG displayed a clear increase in force variation with an
increase in concentration but only exhibited large visible slow contracture eects at the highest
administered concentration of 6.3g/ml, (Figure 14f) which shows a steep gradient of change in force











the DG and IG responses could be attributed to the bre type changes which have been reported to
occur post-denervation and which have also been observed in this study (see section 4.3), such that
DG display an increase in the percentage of slow to fast twitch bres, hence the observed increase
in slow contracture development post-denervation. At 14 days post-denervation, the DG are more
sensitive to low concentrations than at 7 days, displaying a gradual increase in force from the lowest
administered concentration of 4µg/ml, probably due to further receptor proliferation. Further, an
increase in concentration results in the same response from the 14 day DG in comparison to the
7 day DG, but larger concentrations have less of an eect on the slow contracture appearance in
the 14 day denervated muscles, as is consistent with literature [David and Pitman, 1982]. David
and Pitman [1982] reported rapid desensitisation and depression of muscle response to increased
concentrations (doses) of ACh. Larger doses are more likely to saturate all the receptors in the
muscle and, in the case of gastrocnemii, result in repetitive fast twitch contraction of bre bundles
(recall that gastrocnemii are predominantly composed of fast twitch bres) which predominates
any slow contracture response from the fewer slow twitch bres present. The IG muscles from
this denervation period reacted in much the same way as those of the 7 day denervation period,
although an increase in force variation for all concentrations at 14 days post-denervation was noted.
This could be due to an increased sensitivity of IG as a result of increased IG use as a means of
physiological compensation after the denervation of the muscles in the contralateral limb. 50-55
day and 204-208 day DG both showed very little force variation post-denervation and no gradual
increase in force except for a small rise noted in DG, denervated for 204-208 days and stimulated at
4µg/ml (Figure 18a). IG for these periods also displayed very little force variation in response to
ACh administration, although a higher occurrence of slow contractures was noted. This is expected
since the traces were obtained from whole muscles, hence excluding the eects of muscle atrophy
from the direct F-t traces (note that these eects are taken into account for all later quantitative
analysis presented). These slow contractures were observed at 4µg/ml for IG from the 50-55 day
denervation period and for all concentrations administered to IG from the 204-208 day denervation
group. In general, a reduced response, both in force variation as well as slow contracture, were
noted for longer term denervation periods (50-55 days and 204-208 days) in comparison to the short
term denervation periods of 7 and 14 days.
At 7 days post-denervation, the IS displayed gradual increases in force and small amounts of
force variation in comparison to their denervated contralaterals which displayed large force variation
and only produced slow contractures at higher concentrations. In fact, the DS response was similar
to that of IG from the 7 day denervation period, perhaps further illustrating the shift in bre
type composition. Moreover, the large force variation could be attributed to an increase in the
number of fast twitch bres which appear in solei post-denervation [Bakou et al., 1996]. At 14 days
post-denervation, gradual increases in force were noted to occur at lower concentrations than those










wnFigure 12: F-t record of IG noise run
proliferation of nAChRs. Whilst larger concentrations at 14 days post-denervation still resulted in
slow contracture response, the force increase was more gradual than that noted at 7 days. This may
be due to the bre type changes, namely an increase in the ratio of type II bres to type I bres
known to occur post-denervation and supported by the histological ATPase staining in section 4.3.
IS from the 14 days post-denervation group displayed more gradual increases in force than those
from the 7 day post-denervation group. Rosenthal [1977] observed an increase in the number of
type II bres of an IS upon denervation of its ipsilateral limb muscles. This was likely due to a
physiological attempt at maintaining mobility and functionality as close to normalcy as possible.
It is thus not beyond consideration that such change may occur in the contralateral IS, and would
explain the more gradual increase in force for an IS from 14 day denervation period compared to
that of a 7 day denervation period, although further investigation would be required to conrm
this. No gradual increases in force were noted for solei denervated for periods of 50-55 days and
204-208 days. IS from the 50-55 day denervation period displayed gradual increase in force, as did
those from the 204-208 day denervation period (at greater rates than the former), as illustrated in
Figures 23 and 24.
In order to determine clear evidence of muscular contraction linked to the delivery of AChCl,
longer noise runs were conducted on a muscle from each muscle group for each denervation period.
Figure 12 displays one such noise run (in which no chemical or electrical stimulation was applied)
involving an IG, the force of which was measured over a period of 1200sec. Whilst some uctuation
is seen to occur, it does so around a mean value. Any uctuation seen in the 3 minute interval
before stimulation is thus considered to behave in much the same manner. Noise runs for other
muscles produced much the same results, hence indicating that the recordings of muscles stimulated










wn(a) DG 4µg/ml 7 day denervation (b) IG 4µg/ml 7 day denervation
(c) DG 96µg/ml 7 day denervation (d) IG 96µg/ml 7 day denervation
(e) DG 550µg/ml 7 day denervation (f) IG 550µg/ml 7 day denervation
Figure 13: Force-time traces of denervated and innervated gastrocnemii at a 7 day denervation
period for (13a) DG stimulated with 4µg/ml of ACh (13b) IG stimulated with 4µg/ml of ACh
(13c) DG stimulated with 96µg/ml of ACh (13d) IG stimulated with 96µg/ml (13e) DG stimulated










wn(a) DG 1.6g/ml 7 day denervation (b) IG 1.6g/ml 7 day denervation
(c) DG 3.2g/ml 7 day denervation (d) IG 3.2g/ml 7 day denervation
(e) DG 6.3g/ml 7 day denervation (f) IG 6.3g/ml 7 day denervation
Figure 14: Force-time traces of denervated and innervated gastrocnemii at a 7 day denervation
period for (14a) DG stimulated with 1.6g/ml of ACh (14b) IG stimulated with 1.6g/ml of ACh
(14c) DG stimulated with 3.2g/ml of ACh (14d) IG stimulated with 3.2g/ml of ACh (14e) DG










wn(a) DG 4µg/ml 14 day denervation (b) IG 4µg/ml 14 day denervation
(c) DG 96µg/ml 14 day denervation (d) IG 96µg/ml 14 day denervation
(e) DG 550µg/ml 14 day denervation (f) IG 550µg/ml 14 day denervation
Figure 15: Force-time traces of denervated and innervated gastrocnemii at a 14 day denervation
period for (15a) DG stimulated with 4µg/ml of ACh (15b) IG stimulated with 4µg/ml of ACh (15c)
DG stimulated with 96µg/ml of ACh (15d) IG stimulated with 96µg/ml (15e) DG stimulated with










wn(a) DG 1.6g/ml 14 day denervation (b) IG 1.6g/ml 14 day denervation
(c) DG 3.2g/ml 14 day denervation (d) IG 3.2g/ml 14 day denervation
(e) DG 6.3g/ml 14 day denervation (f) IG 6.3g/ml 14 day denervation
Figure 16: Force-time traces of denervated and innervated gastrocnemii at a 14 day denervation
period for (16a) DG stimulated with 1.6g/ml of ACh (16b) IG stimulated with 1.6g/ml of ACh
(16c) DG stimulated with 3.2g/ml of ACh (16d) IG stimulated with 3.2g/ml of ACh (16e) DG










wn(a) DG 4µg/ml 50-55 day denervation (b) IG 4µg/ml 50-55 day denervation
(c) DG 96µg/ml 50-55 day denervation (d) IG 96µg/ml 50-55 day denervation
(e) DG 550µg/ml 50-55 day denervation (f) IG 550µg/ml 50-55 day denervation
Figure 17: Force-time traces of denervated and innervated gastrocnemii at a 50-55 day denervation
period for (17a) DG stimulated with 4µg/ml of ACh (17b) IG stimulated with 4µg/ml of ACh (17c)
DG stimulated with 96µg/ml of ACh (17d) IG stimulated with 96µg/ml (17e) DG stimulated with










wn(a) DG 4µg/ml 204-208 day denervation (b) IG 4µg/ml 204-208 day denervation
(c) DG 96µg/ml 204-208 day denervation (d) IG 96µg/ml 204-208 day denervation
(e) DG 550µg/ml 204-208 day denervation (f) IG 550µg/ml 204-208 day denervation
Figure 18: Force-time traces of denervated and innervated gastrocnemii at a 204-208 day denerva-
tion period for (18a) DG stimulated with 4µg/ml of ACh (18b) IG stimulated with 4µg/ml of ACh
(18c) DG stimulated with 96µg/ml of ACh (18d) IG stimulated with 96µg/ml (18e) DG stimulated










wn(a) DS 4µg/ml 7 day denervation (b) IS 4µg/ml 7 day denervation
(c) DS 96µg/ml 7 day denervation (d) IS 96µg/ml 7 day denervation
(e) DS 550µg/ml 7 day denervation (f) IS 550µg/ml 7 day denervation
Figure 19: Force-time traces of denervated and innervated solei at a 7 day denervation period
for (19a) DS stimulated with 4µg/ml of ACh (19b) IS stimulated with 4µg/ml of ACh (19c) DS
stimulated with 96µg/ml of ACh (19d) IS stimulated with 96µg/ml (19e) DS stimulated with










wn(a) DS 1.6g/ml 7 day denervation (b) IS 1.6g/ml 7 day denervation
(c) DS 3.2g/ml 7 day denervation (d) IS 3.2g/ml 7 day denervation
(e) DS 6.3g/ml 7 day denervation (f) IS 6.3g/ml 7 day denervation
Figure 20: Force-time traces of denervated and innervated solei at a 7 day denervation period
for (20a) DS stimulated with 1.6g/ml of ACh (20b) IS stimulated with 1.6g/ml of ACh (20c) DS
stimulated with 3.2g/ml of ACh (20d) IS stimulated with 3.2g/ml of ACh (20e) DS stimulated with










wn(a) DS 4µg/ml 14 day denervation (b) IS 4µg/ml 14 day denervation
(c) DS 96µg/ml 14 day denervation (d) IS 96µg/ml 14 day denervation
(e) DS 550µg/ml 14 day denervation (f) IS 550µg/ml 14 day denervation
Figure 21: Force-time traces of denervated and innervated solei at a 14 day denervation period
for (21a) DS stimulated with 4µg/ml of ACh (21b) IS stimulated with 4µg/ml of ACh (21c) DS
stimulated with 96µg/ml of ACh (21d) IS stimulated with 96µg/ml (21e) DS stimulated with










wn(a) DS 1.6g/ml 14 day denervation (b) IS 1.6g/ml 14 day denervation
(c) DS 3.2g/ml 14 day denervation (d) IS 3.2g/ml 14 day denervation
(e) DS 6.3g/ml 14 day denervation (f) IS 6.3g/ml 14 day denervation
Figure 22: Force-time traces of denervated and innervated solei at a 14 day denervation period
for (22a) DS stimulated with 1.6g/ml of ACh (22b) IS stimulated with 1.6g/ml of ACh (22c) DS
stimulated with 3.2g/ml of ACh (22d) IS stimulated with 3.2g/ml of ACh (22e) DS stimulated with










wn(a) DS 4µg/ml 50-55 day denervation (b) IS 4µg/ml 50-55 day denervation
(c) DS 96µg/ml 50-55 day denervation (d) IS 96µg/ml 50-55 day denervation
(e) DS 550µg/ml 50-55 day denervation (f) IS 550µg/ml 50-55 day denervation
Figure 23: Force-time traces of denervated and innervated solei at a 50-55 day denervation period
for (23a) DS stimulated with 4µg/ml of ACh (23b) IS stimulated with 4µg/ml of ACh (23c) DS
stimulated with 96µg/ml of ACh (23d) IS stimulated with 96µg/ml (23e) DS stimulated with










wn(a) DS 4µg/ml 204-208 day denervation (b) IS 4µg/ml 204-208 day denervation
(c) DS 96µg/ml 204-208 day denervation (d) IS 96µg/ml 204-208 day denervation
(e) DS 550µg/ml 204-208 day denervation (f) IS 550µg/ml 204-208 day denervation
Figure 24: Force-time traces of denervated and innervated solei at a 204-208 day denervation period
for (24a) DS stimulated with 4µg/ml of ACh (24b) IS stimulated with 4µg/ml of ACh (24c) DS
stimulated with 96µg/ml of ACh (24d) IS stimulated with 96µg/ml (24e) DS stimulated with











4.2.2 Maximum force of contraction generated by denervated muscles and their con-
tralateral controls
This subsection presents the maximum forces of contraction obtained from the experimental results
and discusses them as functions of the four periods of denervation as well as the range of adminis-
tered ACh concentrations. Maximum forces of contraction as determined directly from the recorded
traces, were normalised by cross sectional area (CSA) as described by Brooks and Faulkner [1988].
This was deemed necessary for comparative purposes since experiments were conducted on whole
muscles with signicant mass and dimension dierences. Briey, the muscle CSA was determined






m [g] is the whole muscle mass
L [cm] is the length of the muscle
ρ = 1.06g/cm3 is the density of mammalian skeletal muscle [Mendez and Keys, 1960, Brooks
and Faulkner, 1988, Martin et al., 2009]
The recorded muscle force was then divided by the CSA to obtain the normalised force Fcsa.
The maximum generated Fcsa will be discussed as functions of each stipulated parameter em-
ployed in this study (denervation period and concentration) for each muscle (DS, IS, DG and IG).
Maximum Fcsa generated by each muscle type as a function of denervation period,
presented for each concentration of ACh
Figure 25 displays the results of the maximum Fcsa for all four muscle types (DS, IS, DG
and IG) across all denervation periods and concentrations. Doses falling into the low concentra-
tion range (4µg/ml, 96µg/ml and 550µg/ml) were administered to muscles from the longer term
denervation periods of 50-55 days and 204-208 days and doses from both low as well as high con-
centration (1.6g/ml, 3.2g/ml and 6.3g/ml) ranges were administered to muscles from the shorter
term denervation periods of 7 days and 14 days9.
From Figure 25, it is evident that the denervated muscles (DS and DG) exhibit a higher sensitiv-
ity10 than their respective innervated contralaterals (IS and IG) for most denervation periods and
concentrations. Exceptions occurred only for the gastrocnemii muscles at the extremes of the two
highest concentrations of 3.2g/ml and 6.3g/ml, for the two lowest denervation periods, 7 days and
14 days. As previously noted, large doses of ACh have been shown to depress the muscle response.
9Only the short term 7 and 14 day denervation period groups were administered high ACh concentration doses.
This was due to time and ethics constraints such that a limited number of animals was able to be procured and
denervated beyond periods of 14 days.











(a) 4µg/ml (b) 96µg/ml (c) 550µg/ml
(d) 1.6g/ml (e) 3.2gml (f) 6.3g/ml
Figure 25: Maximum forces [g] (ordinate) normalised by CSA presented for concentrations of (a)











The depressed response noted in this study for muscles at the strongest administered concentra-
tions, is supportive of denervated muscles pre-empting the innervated muscle response. In other
words, the depressed response is hypothesized to occur at lower concentrations for denervated than
for innervated muscles. Larger denervation periods should be investigated at these concentrations
to determine the extent of receptor proliferation and bre typing. This response was only seen in
the DG, indicating that bre type is an important factor in the underlying physiological rationale
responsible for this phenomenon. The dierence is more pronounced for the 7 day denervation pe-
riod than for the 14 day denervation period, complying with literature which cites high sensitivity
of gastrocnemii to ACh for this denervation period. In order of decreasing sensitivity, the muscles
were ranked as follows: DS, IS, DG, IG. As discussed in section 2.1.4, the IS is known to consist
primarily of slow twitch (red, type I) bres, with the remaining approximate 10-20% being fast
twitch (white, type II) bres and the IG is known to consist mainly of fast twitch bres. Gauthier
and Dunn [1973] reported the preferential alteration of white bres post-denervation and a resultant
increase in the ratio of red and intermediate to white bres in the mixed semitendinosis muscle of
the rat. The slow twitch soleus muscle has been reported to exhibit an increase in the number of
fast twitch bres post-denervation [Bakou et al., 1996]. From this information and a consideration
of the results presented here, it can be deduced that the DS still contained the highest ratio of slow
to fast twitch bres, with the ratio decreasing with decreasing sensitivity (or Fcsa). Since the DS
consistently produced the highest forces for all denervation periods, it is hypothesized that a cut o
point exists in bre type changes, such that muscles do not soley consist of one bre type even after
the longest denervation period. This is supported by the histological ATPase bre type staining
results presented in section 4.3. In terms of slow contractures, Hess and Pilar [1963] and Bach-y
Rita and Ito [1966] were in agreement that these occurred in slow twitch bres. Brown [1937]
had earlier considered the slow contracture eects to occur in all muscle bres, but noted a pari
passu relationship between the increase in membrane sensitivity and that of the slow contracture in
denervated muscles. Thus the order of force sensitivity observed in this study indicates that slow
twitch bres produce stronger contractures than fast twitch bres.
In the low concentration range of 4-550µg/ml, the 14 day denervation period was consistently the
highest period of sensitivity for all solei. This is evident in the red histogram bars in Figures 25(a)-
(c). The high sensitivity of the denervated muscles after 14 days of denervation is consistent with
literature [Gauthier and Dunn, 1973]. Recall from section 2.1.4 that Hartzell and Fambrough [1972],
in their study on the denervated rat diaphragm, observed the occurrence of the highest number of
nAChR's at 14 days post-denervation. This supports and explains the increased force output of the
denervated muscle as observed in this study at 14 days post-denervation. The number of nAChR's
for dierent denervation periods as reported by Hartzell and Fambrough [1972] is plotted in Figure
26.











Figure 26: Number of nAChR's/µm2 in denervated rat diaphragm presented for three denervation
periods as reported by Hartzell and Fambrough [1972].
high concentration range of 1.6-6.3g/ml. It was however noted, that the DS and IS from the 7 day
denervation period group produced the highest forces at the strongest concentration of 6.3g/ml. The
short denervation period suggests predominance in slow twitch bre types and increased receptor
proliferation (not yet peaked, since the largest numbers only occur 14 days post-denervation). Thus
a large number of slow twitch bres with increased ACh sensitivity due to receptor proliferation
reacts favourably to large concentrations by producing large forces, supporting the hypothesis that
large concentrations under combined conditions of fewer slow twitch bres and nAChR's result in
a depressed response to ACh. A pertinent question is thus presented in which factor (bre type or
receptor number) plays the biggest role in ACh response.
The percentage dierence in the maximum Fcsa between innervated and denervated solei at
each denervation period for all concentrations is depicted in Figure 27. The highest percentage
dierence in force was seen to occur at a 14 day denervation period (indicated by the red series in
Figure 27) except at the two highest concentrations of 3.2g/ml and 6.3g/ml. The highest maximum
Fcsa percentage dierence at 14 days post-denervation was followed by denervation periods of 204-
208 days, 50-55 days and 7 days in order of decreasing percentage dierence. This again supports
the occurrence of major physiological change at 14 days post-denervation, after which the largest
dierences were seen to follow a trend of an increase in percentage maximum Fcsa dierence with
an increase in denervation periods.











Figure 27: Percentage dierence in maximum forces of contraction between innervated and dener-
vated solei over full concentration range and all denervation periods.
tion is accompanied by a decrease in percentage dierence. An exception occurs at the 50-55 day
denervation period in which a low percentage dierence is recorded at a concentration of 4µg/ml,
followed by an increase in this dierence at the concentration of 96µg/ml. Upon considering the
forces generated for this denervation period at all tested concentrations, small forces were observed
to accompany small percentage dierences in maximum Fcsa and similarly, large percentage dier-
ences in maximum Fcsa were accompanied by comparatively large generated forces. To illustrate
specically, the maximum Fcsa generated at 4µg/ml were 0.26g (DS) and 0.21g (IS). At 96µg/ml,
the forces were larger at 0.75g (DS) and 0.32g (IS), as was the percentage dierence. At 550µg/ml,
the forces decreased (from those at 96µg/ml) to 0.23g (DS) and 0.13g (IS) along with a decrease in
percentage dierence in Fcsa. The demonstration of large forces being produced by low concentra-
tions begs the question of comparitive nAChR sensitivity: do either old or new receptors exhibit
higher sensitivity than the other, or perhaps even a higher binding anity to ACh?
Within the high concentration range, an increase in administered ACh concentration was ac-
companied by an increase in the maximum Fcsa percentage dierence. This is in contrast to the
opposite trend observed in the low concentration range (with the exception of the 50-55 day dener-
vation period trend). As mentioned in the discussion on sensitivity, the two highest concentrations
administered (3.2g/ml and 6.3g/ml) rendered a higher percentage dierence between the 7 day DS
and their innervated counterparts than the 14 day DS and their innervated contralaterals. This
suggests that a concentration threshold was reached in which all the receptors of the 7 day DS were











Figure 28: Percentage dierence in maximum forces of contraction between innervated and dener-
vated gastrocnemii over full concentration range and all denervation periods.
Thus, in the low concentration range, large percentage dierences are accompanied by compar-
atively large forces and greater numbers of nAChR's/µm2; and in the high concentration range,
large percentage dierences are accompanied by large forces, but the high concentrations presum-
ably saturate the receptors and become the maximum Fcsa deciding factor along with bre type.
The percentage dierence in the maximum Fcsa between IG and DG at each denervation period
for all concentrations is depicted in Figure 28. These plotted series did not display trends as clear
as those observed for the slow twitch solei (depicted in Figure 27).
A consideration of the low concentration range exhibits a decrease in the percentage dierence
with an accompanying increase in concentration for 7 and 14 day DG, with a higher percentage
dierence between the 7 day DG and their innervated contralaterals than the same 14 day compar-
ison. This may be indicati e of the timeline of a number of physiological changes. Either, nAChR
proliferation occurs sooner in fast twitch muscles such as the gastrocnemius or the change in ratio of
bre types (type I to type II bres) plays a signicant role in the contractile ability of the muscle, or
both. To the best knowledge of the author, no studies between fast and slow twitch muscles which
directly compare the times of receptor proliferation and the resulting numbers of nAChR's/µm2
at dierent stages of denervation have been conducted. Separate studies however, have considered
various muscles (and hence dierent bre types) at dierent stages of denervation [Gauthier and
Dunn, 1973, Brown, 1937, Cornachione et al., 2011, Kilarski and Sjostrom, 1990]. Brown [1937]
conducted experiments on mammalian gastrocnemii denervated for periods between 4 and 27 days.











post-denervation which supports the observations made in this study. No mention was made of fur-
ther increase in sensitivity. Rosenthal [1977] and Gauthier and Dunn [1973] reported a preferential
alteration of fast twitch bres, supporting the author's suggestion of sooner changes in gastrocnemii
relating to bre typing aecting the muscles' contractile response post-denervation.
In tests conducted on DS muscles for periods of 3, 14 and 28 days, muscles were noted to display
signicant physiological changes 14 and 28 days post-denervation [Hyatt et al., 2006], which again
supports the observations made in this study in which 14 day DS have shown superior sensitivity to
other denervation periods. The results of the experiments conducted by Hartzell and Fambrough
[1972] as depicted in Figure 26, on the mixed bre type composition of rat diaphragm muscle, enable
a comparison based on muscle bre type composition, bre type changes and receptor proliferation
to be made. The innervated rat diaphragm is composed of 59.8% fast twitch bres [Jeckel-Neto
et al., 1993], the soleus is composed of 10-20% fast twitch bres [Hyatt et al., 2006] and the
gastrocnemius is composed of 80% fast twitch bres [Cornachione et al., 2011]. High sensitivities
at 14 day denervation periods are evident in both solei as well as diaphragmatic muscle, which
have a signicantly higher slow to fast twitch bre ratio than the gastrocnemii. 7 days post-
denervation, the fast twitch bres had not yet undergone full physiological changes (hence fast
twitch bres, known to be more dependent on the nerve supply [Bajusz, 1964], are still present at 7
days post-denervation) but by 14 days, Gauthier and Dunn [1973] reported that fast twitch bres
resembled slow twitch (red, type I) bres, although with signicantly less mitochondria. In their
experiments on fast twitch bres of the EDL muscles of Long Evans rats (the same strain used
in this study), Ørtenblad and Stephenson [2003] demonstrated that an inhibition of mitochondrial
ability to produce ATP resulted in a reduction in the excitability of the bres. This may provide
a further explanation for the lower sensitivity of gastrocnemii muscles at 14 days post-denervation
compared to 7 days post-denervation.
Despite these dierences in sensitivity between the 7 and 14 day denervation periods of the
gastrocnemii, the percentage dierences in Fcsa still remain fairly close in contrasting comparison
to the solei under the same conditions in the low concentration range. Here the solei showed a
substantial dierence between the 7 and 14 day denervation periods, with the 14 day denervation
period consistently exhibiting a higher percentage dierence than the 7 day denervation period, as
well as being higher than the 14 day DG percentage dierence.
For the 50-55 day denervation period, the percentage dierence in maximum Fcsa for the gas-
trocnemii follows the same trend as that of the solei in the low (4-550µg/ml) concentration range.
This is evident in the green traces in Figures 27 and 28. Similar observations to those made with the
solei with regard to the size of Fcsa generated in relation to the percentage dierence in maximum
Fcsa can be made with the gastrocnemii. That is, low percentage dierences were accompanied
by low forces and the high percentage dierence at 96µg/ml was accompanied by relatively large











dierence of maximum Fcsa as a function of concentration produced a dierent pattern to that
observed for the solei under the same conditions (refer to the purple traces in Figures 27 and 28
for visual clarity).
A consideration of the high concentration range for percentage dierences in Fcsa for gastrocne-
mii, illustrates a similarity in the 7 and 14 day series as they follow the same trend (refer to the red
and blue series in Figure 28). Whilst the solei displayed a clear increase in percentage dierence
in force as a function of increasing concentration, no such trend was apparent for the gastrocnemii.
The biggest discrepancy between the 7 and 14 day denervation periods occurred at the highest
concentration of 6.3g/ml, where the 7 day denervation period displayed a higher percentage force
dierence than that of the 14 day denervation period (not the case with the other two concentra-
tions in the high concentration range). In this concentration range, small percentage dierences in
force between the DG and IG were again accompanied by small forces (Fcsa).
Maximum Fcsa generated by each muscle type as a function of concentration of ACh,
presented for each denervation period
Figures 29 and 30 illustrate the eects of an increase in concentration on the maximum Fcsa
produced for each muscle at dierent stages of denervation.
A consideration of the 7 day denervation period indicates that the DS, IS and IG (Figures 29a
and 29b respectively) all exhibited an increase in contractile force with an increase in the full range
of (low and high) concentrations (4µg/ml - 6.3g/ml) and thus all displayed a peak force at the
highest concentration of 6.3g/ml. The graphs display the same trends between the innervated and
denervated muscles as well as between solei and gastrocnemii with change in concentration for this
denervation period.
For a denervation period of 14 days, the DS peak force occurred at the lowest concentration
of 4µg/ml (see Figure 29c). Within the low concentration range the DS displayed a decrease in
peak force with an increase in concentration. Within the high concentration range (1.6-6.3g/ml)
however, the forces generated by the DS increased with an increase in concentration, but the
maximum force in this range was noted to be less than half that of the maximum generated in the
low concentration range. The stable trend of the forces generated by the IS in the low concentration
range demonstrated a very slight decrease with an increase in concentration in comparison to the
dramatic decrease displayed by the DS in this concentration range. In the high concentration range,
the IS exhibited a steeper decreasing trend with an increase in concentration, in contrast to the DS
increase in force with an increase in concentration.
For a denervation period of 50-55 days, the peak force which the DS generated across the low
concentration range occurred at 96µg/ml. The IS followed the same force trend as the DS (see
Figure 30a) over this concentration range, but the forces generated were lower than those of the













Figure 29: Maximum forces [g] of contraction (ordinate) for denervated and innervated solei and
gastrocnemii as a function of concentration for short term denervation periods. (29a) IS, DS at 7
day denervation (29b) IG, DG at 7 day denervation (29c) IS, DS at 14 day denervation (29d) IG,













Figure 30: Maximum forces [g] of contraction (ordinate) for denervated and innervated solei and
gastrocnemii as a function of concentration for long term denervation periods. (30a) IS, DS at 50-55
days denervation (30b) IG, DG at 50-55 day denervation (30c) IS, DS at 204-208 day denervation











low, peaked at 96µg/ml and was followed by a steady decrease with an increase in concentration
thereafter. The same holds true for the DS, but the gradient of decrease in force with increase
in concentration was steeper than that of the IS. The peaks at lower concentrations suggest that
dierent ideal concentrations for dierent periods of denervation may exist which will generate
maximum forces.
For a denervation period of 204-208 days, the DS peak force occurred at the lowest concentration
of 4µg/ml. The forces generated under these conditions were shown to decrease with an increase
in concentration, as was the case with the 14 day denervation period (see the blue series in Figures
30c and 29c respectively). However, the forces generated at 204-208 days were smaller than those
generated at 14 days and exhibited smaller decreases with increasing concentrations. The forces
generated by the IS 204-208 days post-denervation in the low concentration range displayed an
increase in force with a corresponding increase in concentration, as was observed with the 7 day
denervation period.
For a denervation period of 7 days the IG followed the same force generation trend as the IS
at this period of denervation (see Figures 29a and 29b), both of which displayed an increase in
concentration across all ranges. The forces generated by the IG were however, lower than those
generated by the IS. The IG peak force occurred at the highest concentration of 6.3g/ml. The
DG did not follow the same force generation trend as either the DS or the IG at this denervation
period. Instead, the DG peaked at 96µg/ml, its low concentration range trend following the same
pattern of force generation as the DS denervated for a 50-55 day period (refer to Figure 30a).
The DG produced a second (lower) force peak at the lowest concentration of 1.6g/ml in the high
concentration range (Figure 29b).
For a denervation period of 14 days, the DG generated a peak force at 4µg/ml within the 4-
550µg/ml concentration range, similar to the case of the DS under the same conditions. This is
evident in the blue series in Figures 29c and 29d. Furthermore, it can be seen from these gures that
the DG decreased in much the same manner as the DS denervated for this period and within the low
concentration range. Still within the 14 day denervation period, an increase in the force generated
with an increase in the concentration (within the 4-550µg/ml range) was observed with the IG.
This trend is comparable to that of the IS at a denervation period of 204-208 days, illustrated in
Figure 30c. The IG was further noted to generate a higher force than the DG at 550µg/ml at 14
days post-denervation. The DG generated a second peak in the high concentration range at the
lowest concentration of 1.6g/ml. This 'two peak' observation was similarly made for the DG at a
denervation period of 7 days (Figure 29b), although the second peak in this 14 day instance was
considerably higher and similar to the rst peak, whereas the second force peak noted at 7 days
was signicantly lower than the rst. The rst 7 day denervation peak and both peaks noted in
the 14 day denervation period were all within the same range (just below 0.35g). The IG and DG











generated larger forces than those generated by the DG.
For a denervation period of 50-55 days, the DG peak force was generated at 96µg/ml. The DG
followed the same trend as the DS under the same conditions (compare the blue series in Figures
30a and 30b). Both force trends peaked at a concentration of 96µg/ml. The IG and DG followed
the same force generation trend for this denervation period, with the IG generating lower forces
than the DG, as was the case with the DS and IS at this denervation period.
For a denervation period of 204-208 days, the DG followed the same trend as the DS under
the same conditions (refer to Figures 30c and 30d). Both the DG and DS in this case peaked at
lowest concentrations of 4µg/ml. Similarly, the IG under these conditions followed the same force
generation trend as the IS (compare the red series in Figures 30c and 30d), although the force
generated by the IG when 550µg/ml was administered, was higher than that generated by the DG
for the same concentration. This same occurrence was observed between the IG and DG for the
same concentration at 14 days post-denervation (refer to Figure 29d). Upon consideration of the
high concentration range, it may be noted that the IG, unlike the IS (in comparison to its denervated
contralateral) generated higher maximum Fcsa than than the DG (204-208 day denervation period).
This was also true for 550µg/ml (the highest concentration in the low concentration range) for
denervation periods of 14 and 204-208 days.
Brown [1950] reported that large concentrations of ACh at the NMJ were demonstrated to
cause a neuromuscular block such that local continuous depolarisations were able to cause local
contractions, but blocked the conduction along the muscle bres. This eect appears to be more
apparent in solei denervated for periods beyond 7 days and for all periods of denervation for the
gastrocnemii (further supporting that changes occur more quickly in fast twitch muscle and that
denervation has more of an eect on fast twitch bres than slow twitch bres) within the low
concentration range. DS display an increase in force output with an increase in concentration
in the high concentration range, again pointing to the suggestion that a threshold concentration
exists such that the conduction blocking eect of large doses of ACh may be overcome, thus enabling
the development of slow contracture. This is evident in short term denervation periods of 7 and
14 days, but would benet from trend conrmation by further testing with longer denervation
periods. Denervated gastrocnemii do not display any trends with increase in concentration for the
7 day denervation period, but appeared to follow the eects reported by Brown [1950] in the low
concentration range for all other periods of denervation (as with the DS).
4.2.3 Relationship between concentration, denervation period and time to maximum
force of contraction
It is necessary to note at this point that time courses of contraction in this study were observed
to be longer than those reported in literature. This may be due to a dierence in a number of











in literature. For example, whilst Hess and Pilar [1963] conducted ex vivo experiments on skeletal
muscles suspended in an oxygenated Krebs solution contained within a tissue bath, their experi-
ments also diered from the present study in a number of ways. The animals which were used (cats)
were anaesthetised with sodium pentobarbital (proven to have an acute and direct eect on skeletal
muscle contractility [Taylor et al., 1984]), where the eect is more pronounced in slow twitch bre
reactions (slow twitch bres were tested by Hess and Pilar [1963]). Additionally, a larger tissue bath
was used in the present study. Whilst care was taken to ensure that ACh was always administered
at the same distance away from the muscle of each test for consistency, use of a larger tissue bath
may have resulted in a longer diusing time for ACh to reach the nAChR's. It is postulated that
one or more of these dierences may have impacted the time course of contraction.
As expected, the solei and gastrocnemii produced their maximum forces at dierent times post
ACh administration. The (predominantly fast twitch) innervated gastrocnemii reached maximum
contractile forces faster than the (predominantly slow twitch) solei. Figure 31 depicts the dier-
ences between time to maximum force of contraction for denervated muscles and their innervated
contralaterals for all concentrations used (plotted on a log scale on the horizontal axis) as well as
for the various denervation periods.
Figure 31a illustrates that gastrocnemii from every denervation period implemented in this
study (dotted series) took longer to reach maximum forces of contraction than their innervated
contralaterals. Further, gastrocnemii from the 7 and 14 day denervation periods followed the same
trends with increasing concentrations, which both follow the same trend as the IG from the 7 day
denervation period group, albeit at slower times. The IG from the 14 day denervation period group
diers from this same trend only slightly (in its response to the low concentration of 96µg/ml).
The IG from the 50-55 day and 204-208 day denervation period groups follow the same trend
of decreasing time to maximum output force with increasing concentration. Their denervated
counterparts too, together are similar in their response, but dier from the innervated muscles of
these periods, as shown in Figure 31a. Inection points are observed at 96µg/ml for both these
muscles, as seen for the IG from the 7 day denervation period. Thus, all the denervated muscle
responses appear to be mimicking the response trend of the IG from the 7 day denervation period
group, although at a lag.
In terms of maximum contraction force, the response of DS in comparison to IS followed the
opposite trend to that of the gastrocnemii. That is, the DS muscles from every denervation period
produced their maximum contractile output faster than all their innervated contralaterals. Simi-
larities in grouping were also noted. This involved the 7 and 14 day DS muscles following the same
trend (similar to that of the IS). Recall the same grouping from the gastrocnemii observations, al-
though displaying dierent trends to the solei. Moreover, the long term denervation periods (50-55
days and 204-208 days), again followed the same patterns of time to maximum contraction with













Figure 31: Time to maximum contraction force (ordinate [s]) versus concentration (abscissa











denervation group (with similar response grouping noted from gastrocnemii muscles). Inection
points were again noted at a concentration of 96µg/ml. In general, the muscle and trend producing
the fastest time to contraction was the DS, at a 7 day denervation period. The slowest was the
204-208 day IS.
Figures 31a and 31b illustrate that the responses of the slow twitch solei and that of the fast
twitch gastrocnemii and their denervated counterparts, at varying stages of denervation, appear to
produce mirror image reactions of one another.
Figures 32 and 33 provide a direct visual correlation of time to maximum contraction with
maximum forces of contraction for various time periods. Each image is presented for denervated
muscles and their innervated contralaterals for a dierent concentration.
Figure 32a illustrates the maximum force-time-denervation period relation for a concentration
of 4µg/ml. As previously demonstrated, the DS produced higher forces than the IS. Additional
information from this gure shows that denervation periods of 7, 14 and 204-208 days exhibit shorter
times to contraction than the IS. At 50-55 days the time to maximum contraction of the DS showed
no signicant dierence to that of the IS. The largest generated force at this concentration for these
muscles was produced by the DS at 14 days of denervation, which also displayed the longest time to
maximum contraction. An increase in concentration to 96µg/ml further demonstrated this eect.
Moreover, the maximum contraction time of the DS at 14 days of denervation was even closer to
that of its respective IS, but again the former produced a higher force. The times to maximum
contraction of the remaining denervation periods (7, 50-55 and 204-208 days) for the DS were less
than the IS for this increased concentration. For stimulation by 550µg/ml, the times to peak force
for the DS showed no signicant dierence to that of the IS, despite contracting at larger forces.
The times were slightly greater at 14 days post-denervation for the DS than the IS (1272s and 1172s
respectively) and slightly less at 7 days post-denervation for the DS compared to the IS (1082s and
1322s respectively).
Figure 33 illustrates the time to peak force for increasing concentration within the high concen-
tration range (1.6g/ml-6.3g/ml). The DS times to contraction were consistently shorter than those
of the IS except at the highest concentration of 6.3g/ml at 14 days of denervation (the highest
sensitivity period of the DS) where the DS took a longer time to reach its' peak force than the IS.
The DS forces were again consistently higher than the forces produced by the IS muscles (as was
observed in the low concentration range). Increasing time to peak force occurred simultaneously
with decreasing peak force of contraction for the DS.
Thus in general, an increase in concentration within the low concentration range resulted in
the DS contracting at times closer to those of the IS. The denervation periods themselves however,
showed no clear correlation with time. Only the 7 day and 204-208 day DS displayed an increase
in time to contraction with an increase in concentration (see Figure 31b, series 7 DS and 204-208














Figure 32: Correlation between time to contraction, maximum force of contraction and denervation
periods for (32a) DS and IS at a concentration of 4µg/ml (32b) IG and DG at a concentration of
4µg/ml (32c) DS and IS at a concentration of 96µg/ml (32d) DG and IG at a concentration of











(a) Solei, 1.6g/ml (b) Gastrocnemii, 1.6g/ml
(c) Solei, 3.2g/ml (d) Gastrocnemii, 3.2g/ml
(e) Solei, 6.3g/ml (f) Gastrocnemii, 6.3g/ml
Figure 33: Correlation between time to contraction, maximum force of contraction and denervation
periods for (33a) DS and IS at a concentration of 1.6g/ml (33b) IG and DG at a concentration
of 1.6g/ml (33c) DS and IS at a concentration of 3.2g/ml (33d) DG and IG at a concentration of














Figure 34: Dierence in time to contraction (s) between (34a) DS and IS and (34b) DG and IG at











Figure 34 provides the dierence in time to peak force between denervated and innervated
muscles for all concentrations and all denervation periods. The positive region of the graph indicates
that the time to peak force of the innervated muscles was greater than those of the denervated
muscles and the negative region of the graph indicates that the time to peak force of the denervated
muscles was greater than that of the innervated muscles. For solei at 7 days post-denervation the
dierence in time to peak force decreases with increasing concentration within the low concentration
range and the IS demonstrated longer times to contraction. Within the high concentration range
the opposite is true (green series Figure 34a), i.e. an increase in dierence in times to contraction
between DS and IS occurred with an increase in concentration, although the IS still exhibited longer
times than the DS. At 14 days post-denervation, the lowest concentration of 4µg/ml produces
longer times to the peak force for the IS than the DS, but an increase in concentration within
the low range resulted in the DS taking longer times to reach peak forces than their innervated
contralaterals, additionally displaying an increase in the time dierence between them. Within
the high concentration range, still considering the 14 day post-denervation period, the dierences
in times to peak tension between DS and IS muscles were noted to be higher than for the low
concentration range. Longer times were noted for IS for the higher 1.6g/ml and 3.2g/ml whereas
the highest concentration of 6.3g/ml results in a shorter time to contraction for the IS (indicated
by the negative range). The low concentration of 4µg/ml in the 50-55 day denervation period
displayed a shorter time to contraction for the IS than the DS. Larger concentrations of 96µg/ml
and 550µg/ml resulted in shorter times to peak tension in the DS compared to the IS. The dierence
decreased with an increase in concentration from 96µg/ml to 550µg/ml. The longest denervation
period of 204-208 days displayed an increase in dierence in time to peak tension between DS
and IS muscles with an increase in concentration. Administration of the low concentrations of
4µg/ml and 96µg/ml resulted in longer times to contraction for the IS than the DS. The highest
concentration of 550µg/ml resulted in a signicantly smaller dierence in times to peak tension,
as well as causing a shorter time to peak tension for the IS than the DS. These results all indicate
that dierent concentration thresholds exist at which the DS will be more likely to respond faster
than the IS for dierent time periods of denervation. The DS reached peak tension faster for all
concentrations in the 7 day denervation period. The 14 day denervation period showed higher
dependency on concentration in terms of contraction times, size and DS-IS bias. The 50-55 day
denervation periods demonstrated the smallest dependency on concentration increase, with little
dierence between times to contraction for DS and IS muscles and the lowest concentration causing
the fastest DS reaction time. The 204-208 days denervation period produced a shorter contraction
time for the DS at the highest concentration (used for this denervation period) of 550µg/ml.
Figure 32b illustrates the time to peak tension of DG and IG muscles at a concentration of
4µg/ml. Whilst the DG consistently displayed higher forces than the IG for all denervation periods











periods of 50-55 days and 204-208 days. An increase in concentration to 96µg/ml resulted in the
DG taking longer times to reach peak tension for all denervation periods. In order of increasing
dierence between DG and IG, the denervation periods rank as 7 days, 204-208 days, 14 days
and 50-55 days. Further increase in concentration still resulted in the DG taking longer to reach
peak tension than the IG, but a reduction in the time dierence (between DG and IG) was noted.
Administration of higher concentrations continued to result in longer times to peak tension for
the DG in comparison to the IG. The times eventually reach a point of coincidence at the second
highest concentration used (3.2g/ml) (Figure 33d). At the lower concentration of 1.6g/ml, the times
to peak tension and peak forces increased with time periods of denervation (Figure 33b) whereas
at the higher concentrations (3.2g/ml and 6.3g/ml) the opposite was true as these parameters
displayed a decrease with an increase in denervation period (Figure 33d and 33f). These two higher
concentrations also displayed higher forces for the IG than for the DG.
By way of reference to Figure 34, a number of dierences can be clearly noted between the DS
and DG responses. The DG were much less responsive to the administration of high concentrations
of ACh than the DS, both in the relative dierence in time to peak tension between innervated
and denervated muscles, as well as in the magnitude of these dierences. Further, the DG mostly
displayed longer times to contraction than their innervated counterparts (note the negative region
of Figure 34b), which is in contrast to the DS and IS observation. The 7 day denervation period
displayed the biggest dierence in time to peak tension with the lowest administered concentration of
ACh, 4µg/ml. All the times to peak tension were shorter for the IG than the DG for this denervation
period, except at the highest concentration of 6.3g/ml. The high concentration range displayed a
decrease in dierence in times to peak tension between DG and IG for this period of denervation.
The same observation in pattern can be made for these muscles at 14 days post-denervation, except
that the largest dierence in time to peak tension occurred at a higher concentration of 96µg/ml
(compared to 4µg/ml from the 7 day denervation period group) and longer times to peak tension
occurred for the IG than the DG at 3.2g/ml. The long term denervation groups (50-55 days and
204-208 days) displayed similar trends to each other. That is, the lowest concentration of 4µg/ml
resulted in longer times to contraction for the the IG and the larger concentrations of 96µg/ml
and 550µg/ml resulted in longer times to contraction for the DG muscles. The largest dierences
in time to peak tension between DG and IG occurred at the concentration of 96µg/ml for both
denervation periods, which was also noted for the 14 day denervation period.
4.2.4 Eect of ACh administration, as determined by electrical stimulation checks
Electrical stimulation was used after chemical (ACh) stimulation in order to determine the eects
of various concentrations of ACh on the contractile properties of the various muscles (and hence
bre types). The procedure involved an initial chemical stimulation by ACh (recorded for 19











steel electrodes. If large contractions were observed as a result of electrical stimulation, a large
dose of ACh was administered to the muscle and its' response recorded. A repeat electrical test
was then conducted. The frequency of response of the muscles to ACh occurred in a low frequency
range; hence for comparative purposes only the low frequency components of the electrical signal
are investigated here (note however that higher frequency components may exist in the muscles'
response to electrical stimulation, but are beyond the scope of this thesis). The results of the
combined chemical and electrical stimulation protocol are presented in this section for denervation
periods of 7 and 14 days in terms of varying concentrations of ACh applied to muscles and their
eects as illustrated by F-t traces, HS, WA and MHS. The reader is referred to sections 2.2.4 and
2.2.5 for the underlying theory of these data analysis methods.
Spectral plots of ACh-stimulated muscles are plotted for the rst half of the full test run as
the length of that portion of the signal was sucient for visualisation of spectral components.
Muscles stimulated by ACh were noted to produce slow contractures, which occur gradually over
time as bres are recruited. For this reason, longer time periods than spectra of electrical plots are
necessary (electrical stimulation causes rapid whole muscle contractions). Longer time periods used
for the spectral plots may result in some loss of resolution; therefore gure 35 has been included as
an example demonstrating the immediate eects of ACh stimulation at various time periods.
The HS of a noise run, that is, an isometric recording of the Force-time (F-t) output of a muscle
(in this case a 14 day DS) which has been neither chemically nor electrically stimulated, is presented
in Figure 36. From this gure it is evident that two frequencies exist within the signal at 4Hz and
4.5Hz (potentially due to brillation of various bres comprising the muscle), as well as some low
frequency components which are inherent in the signal. Denervated rat solei are known to brillate
post denervation for up to 3 weeks [Robinson et al., 1991]. Once stimulated by ACh, the bres will
react by contracting in bundles at dierent frequencies, thus in a sense 'overriding' the brillation
eects depending on the degree of reaction to stimulation. Only the noise run thus contains these
components.
Alternate chemical and electrical stimulation of muscles denervated for a 7 day period
This section primarily presents and discusses muscles denervated for a 7 day period, rst comparing
denervated muscle responses to their innervated contralaterals, followed by the eect of increasing
concentration on muscle response.
Refer to Figure 37. Stimulation of the DG with 4µg/ml ACh, displayed an increase in force
variation (peak-to-peak uctuation) with time post ACh administration (the point of administration
is indicated by a red line at 180s in the F-t trace Figure 37a). The MHS (Figure 37e) illustrates
that the signals' largest energy contribution lies within the 0.31-0.44Hz frequency range (peak at
+-0.37Hz). Electrical stimulation post-denervation (Figure 37b) resulted in a small contractile











Figure 35: Hilbert spectra of a 7 day IG stimulated at 96ug/ml. Top left: 700sec interval; Top













Figure 36: (36a) F-t record of DS noise run(36b) HS and (36c) MHS of a noise run conducted on











in frequency, energy and time in the HS (Figure 37d). The lower gure in (b) is indicative of the
onset of 5 successive electrical stimuli and the top gure in (b) demonstrates the muscle reaction to
the electrical stimuli. The MHS of the electrical stimulation check illustrated a signicant energy
component in the 0.44-0.5Hz range (Figure 37f), as well as the low frequency ranges (0.13-0.18Hz
and 0.18-0.25Hz), possibly indicating slow bre recruitment (at the low end of frequency spectrum)
and fast contraction (at the high end of frequency spectrum).
Refer to Figure 38. Post injection the DS displayed the same increase in force variation with
time as the DG stimulated at 4µg/ml (compare Figures 37a and 38a), but a greater variation in
force than that of DG was observed. High energy contributions of both signals exist between 0.31-
0.44Hz (peak at +-0.37Hz), but the DG exhibited slightly more energy than the DS (illustrated
in Figures 37e and 38e). Electrical stimulation post ACh administration showed high frequency-
time-energy locality within the spectrum, correspondimg to the MHS (Figure 38f) which indicated
a large energy contribution from 0.44-0.5Hz range. This appears to be indicative of a contractile
reaction of the muscle to electrical stimulation, as demonstrated by the wavelet cluster analysis in
Figure 37b.
Refer to Figure 39 in which the results of an IS, stimulated with 4µg/ml of ACh, is depicted.
The F-t record (Figure 39a) displays an increase in force variation (peak-to-peak uctuation) as
well as a small gradual or slow rise in force over time. The MHS (Figure 39e) of this chemical
stimulation, indicates a large amount of energy within 0.37-0.5Hz range (peak at 0.44Hz). Clear
locality was visible in the HS of the electrical stimulation test post ACh administration. The MHS
of the muscles' electrical response illustrates a large energy, low frequency contribution as well as
notable contribution of energy in the frequency range of 0.37-0.44Hz (Note that there is no energy
contribution from the 0.44-0.5Hz frequency range).
The DS displayed a higher degree of force variation than the IS when both stimulated at 4µg/ml.
The DS produced contractions of smaller force upon chemical stimulation in comparison to the IS
(compare Figures 38a and 39a). This is indicative of a larger response of the DS to ACh. The HS
corresponding to the DS showed a more localised response to electrical stimulation than that of
the IS. A comparison of the MHS of the chemical stimulation tests (Figures 38e and 39e), indicates
that the DS exerted more energy in a lower and wider frequency range in relation to the IS, but the
absolute energy of the IS was slightly larger. This is likely due to the larger number of bres within
the IS. Both muscles displayed large energy low frequency contributions, but the DS exhibited more
energy in the higher frequency range of 0.44-0.5Hz in its respective electrical stimulation MHS.
Figure 40 displays the response of a DG to 96µg/ml of ACh. Post injection, an increase in peak-
to-peak force variation as well as gradual increase in force over time (indicative of a slow contracture)
was noted. The MHS of the muscles' response to chemical stimulation (Figure 40e) indicates a
large energy contribution between 0.25-0.37Hz (peak at 0.31Hz). Electrical stimulation post ACh











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 37: Results of 7 day DG stimulated at 4µg/ml. (37a) F-t record of 4µg/ml ACh stimula-
tion (37b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (37c) HS of 4µg/ml ACh stimulation (37d) HS of electrical
stimulation post ACh administration (37e) MHS of 4µg/ml ACh stimulation (37f) MHS of electrical











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 38: Results of 7 day DS stimulated at 4µg/ml. (38a) F-t record of 4µg/ml ACh stimula-
tion (38b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (38c) HS of 4µg/ml ACh stimulation (38d) HS of electrical
stimulation post ACh administration (38e) MHS of 4µg/ml ACh stimulation (38f) MHS of electrical











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 39: Results of IS from 7 day denervation group, stimulated at 4µg/ml. (39a) F-t record
of 4µg/ml ACh stimulation (39b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (39c) HS of 4µg/ml ACh stimulation
(39d) HS of electrical stimulation post ACh administration (39e) MHS of 4µg/ml ACh stimulation











contribution within 0.44-0.5Hz range (shown in the MHS, Figure 40f). Clear contractions occurred
upon electrical stimulation, as may be seen in Figure 40b.
The response of a DS to 96µg/ml of ACh is depicted in Figure 41. The DS again displayed an
increase in peak-to-peak force variation post injection. No gradual increase in force was evident
(indicative of little or no slow contracture). The MHS displays the largest energy contribution in
the 0.18-0.31Hz range (peak at 0.25Hz). Clear locality was seen in the HS of the post-ACh electrical
stimulation. A large energy contribution in the frequency range between 0.37-0.44Hz was noted
from the MHS of the muscles' response to electrical stimulation (Figure 41f). This was noted to
be similar to that observed for the IS at a low concentration stimulation of 4µg/ml for the same
denervation period).
The reaction of an IS to 96µg/ml was such that a small amount of force variation occurred post
ACh administration in comparison to the pre injection range. A later, gradual increase in force from
about 400s on the F-t graph (Figure 42a) (220s post injection) was observed. The MHS (Figure
42e) shows an energy contribution within a 0.25-0.37Hz frequency range. This contribution was
small in comparison to the low frequency contribution already present within the signal. Electrical
stimulation displayed no locality in the HS, supported by the weak signal illustrated by the F-t trace
in Figure 42b, whilst the MHS illustrates an increased energy contribution between 0.44-0.5Hz.
The DS displayed a higher force variation post injection than the IS (see the F-t traces, Figures
41a and 42a). More energy was 'scattered' throughout the frequency range over time in the IS than
in the DS (see HS in Figures 41c and 42c). This seems to be the trend in tests which exhibited
slow contractures (increased force over time) and small frequency variations in comparison to the
pre injection range. The energy observed from the IS was concentrated within a higher frequency
range than that of DS at the same concentration of 96µg/ml (compare the MHS in Figures 41e
and 42e). The DS energy contribution in the lower frequency range was more comparable to that
of the IS stimulated at a low concentration of 4µg/ml). Again, greater locality was demonstrated
in the HS of the DS than that of the IS.
A DG stimulated at 550µg/ml displayed an increase in force variation post injection (see Figure
43a). The MHS shows very large and signicant energy contribution from 0.31-0.44Hz (peak at
0.37Hz). (This was noted for the DG and DS muscles stimulated at a concentration of 4µg/ml
as well). The HS of the muscles' reaction to electrical stimulation showed some locality in its
energy-frequency-time distribution corresponding to the stimulation time. The MHS displayed a
small energy contribution from 0.44-0.5Hz, with most of the energy contribution being from the
low frequency range.
The response of the IG to ACh at a concentration of 550µg/ml was similar to that of the DG
for the same concentration, that is an increased force variation post injection. No gradual rise in
force was noted. A relatively large energy contribution was noted between 0.13-0.25Hz (peak at











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 40: Results of 7 day DG stimulated at 96µg/ml. (40a) F-t record of 96µg/ml ACh stimu-
lation (40b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (40c) HS of 96µg/ml ACh stimulation (40d) HS of electri-
cal stimulation post ACh administration (40e) MHS of 96µg/ml ACh stimulation (40f) MHS of











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 41: Results of 7 day DS stimulated at 96µg/ml. (41a) F-t record of 96µg/ml ACh stimu-
lation (41b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (41c) HS of 96µg/ml ACh stimulation (41d) HS of electri-
cal stimulation post ACh administration (41e) MHS of 96µg/ml ACh stimulation (41f) MHS of











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 42: Results of IS from 7 day denervation group, stimulated at 96µg/ml. (42b) F-t record
of 96µg/ml ACh stimulation (42b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (42c) HS of 96µg/ml ACh stimulation
(42d) HS of electrical stimulation post ACh administration (42e) MHS of 96µg/ml ACh stimulation











from this range was greater than that of the low frequency energy contribution. The electrical
stimulation reaction showed no locality in the signal (similar to that of the DG). The MHS of the
electrical response illustrated a large, low frequency energy contribution and a slight contribution
from 0.44-0.5Hz, similar to the DG. The overall absolute energy was small, in the range of 10−5.
A DS stimulated at 550µg/ml exhibited increased force variation as well as gradual increase in
force over time (see F-t graph in Figure 45a) post injection. High energy contributions were all
within the low frequency range, with no additional frequency range contribution. Note however,
that the low frequency energy contribution to the signal was comparatively large, in the range of
10−3, suggesting the additional energy contribution due to ACh administration occurred within the
same low frequency range already inherent in the signal. Some locality was visible in the HS of the
muscles' response to electrical stimulation. A slight increase in energy distribution was observed in
the 0.37-0.44Hz range (see MHS in Figure 45f).
The IS reaction to 550µg/ml ACh was a gradual increase in force post injection, as well as
increased force uctuation. This is similar to the trend observed in the F-t trace of the DS, but the
IS force increases at a steeper gradient (i.e. the force developed more quickly and reaches higher
values) than the DS. Very large forces were reached by the IS but no tetanus of any mode was
evident in the F-t signal. All the signicant energy contribution occurred in the 0.06-0.13Hz range,
again, noting a substantial absolute energy in the range of 10−3, thus additional energy due to
ACh administration fell in the same range as the inherent system energy (within the low frequency
range). This is again the same as that observed in the DS. The HS of the muscles' response to
electrical stimulation also demonstrated high locality in energy, frequency and time (see Figure 46d),
as in the DS. The spectrum is indicative of potential slow bre recruitment (in the low frequency
range), with the highest energy component occurring between 12-15sec, coinciding with stimulation
time. The MHS of the muscles' response to electrical stimulation (Figure 46f), shows a very large
energy contribution in the 0.37-0.5Hz range (the large energy contribution is expected; special note
is taken of the increased range from 0.37Hz rather than the more often observed 0.44Hz).
An IS stimulated by 1.6g/ml of ACh displayed an increased force variation post injection. A
slight gradual increase in force was only observed after 700s (visible on the F-t recording, Figure
47a). The MHS illustrates a large energy contribution occurring in a 0.37-0.5Hz range (peak at
0.44Hz). This energy contribution is much higher than low the frequency energy contribution (see
Figure 47e). Electrical stimulation of the muscle showed a small amount of visible locality in the
HS. The MHS shows a slight increase in energy contribution in the 0.44-0.5Hz range.
An IS stimulated at a high concentration of 3.2g/ml demonstrated an increase in force variation,
as well as a gradual increase in force until unfused tetanus was reached at a low force, uctuating
around 5g. The MHS displayed an energy contribution of 0.25-0.37Hz which was lower than the
low frequency contribution, but still considered substantial (in the range of 10−4). The HS of











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 43: Results of 7 day DG stimulated at 550µg/ml. (43a) F-t record of 550µg/ml ACh
stimulation (43b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for
electrical stimulation post ACh administration (43c) HS of 550µg/ml ACh stimulation (43d) HS
of electrical stimulation post ACh administration (43e) MHS of 550µg/ml ACh stimulation (43f)











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 44: Results of IG from 7 day denervation group, stimulated at 550µg/ml. (44a) F-t record
of 550µg/ml ACh stimulation (44b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (44c) HS of 550µg/ml ACh stimulation
(44d) HS of electrical stimulation post ACh administration (44e) MHS of 550µg/ml ACh stimulation











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 45: Results of 7 day DS stimulated at 550µg/ml. (45a) F-t record of 550µg/ml ACh
stimulation (45b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for
electrical stimulation post ACh administration (45c) HS of 550µg/ml ACh stimulation (45d) HS
of electrical stimulation post ACh administration (45e) MHS of 550µg/ml ACh stimulation (45f)











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 46: Results of IS from 7 day denervation group, stimulated at 550µg/ml. (46a) F-t record
of 550µg/ml ACh stimulation (46b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (46c) HS of 550µg/ml ACh stimulation
(46d) HS of electrical stimulation post ACh administration (46e) MHS of 550µg/ml ACh stimulation











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 47: Results of IS from 7 day denervation group, stimulated at 1.6g/ml. (47a) F-t record
of 1.6g/ml ACh stimulation (47b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (47c) HS of 1.6g/ml ACh stimulation
(47d) HS of electrical stimulation post ACh administration (47e) MHS of 1.6g/ml ACh stimulation











and in the high frequency component between 7-12sec. The MHS supports this with high energy
low frequency component contribution. An increased energy contribution is further noted to span
0.31-0.44Hz (see Figure 48e).
A DS stimulated with the same concentration of 3.2g/ml displayed an increased force variation
but diered from the IS in that no notable gradual F-t increase was observed, nor was any tetanus
observed. The MHS depicted a large energy contribution between 0.31-0.44Hz (but not as large as
the low frequency energy contribution), which is a higher frequency range than the IS high energy
contribution. The HS generated from the electrical stimulation test demonstrated some locality
and a slight energy contribution was noted in the 0.44-0.5Hz range. The results of the stimulation
of the DS muscle are depicted in Figure 49.
Figure 50 illustrates the response of an IG to 3.2g/ml of ACh. An eventual gradual increase in
force from about 700s onwards in F-t trace was observed (see Figure 50a). The force was seen to
drop o after a peak was reached. The MHS displays the large energy contribution in a 0.31-0.44Hz
frequency range (with a peak at 0.37Hz). This energy contribution was larger than that of the lower
frequency range. Electrical stimulation resulted in a display of high locality in the HS, showing two
stimulation regions in Figure 50d (corresponding to time locations of stimulation). The MHS of the
muscles' response to electrical reaction illustrates a very large low frequency energy contribution
(relative to itself; since the absolute energy is small, in the range of 10−5). An increased energy
contribution was noted in the 0.44-0.5Hz range.
A DG stimulated with the highest ACh concentration of 6.3g/ml (see Figure 51), displayed a
gradual increase in force over time and appeared to reach unfused tetanus, uctuating around 10g.
The MHS displayed the majority of energy contribution as being from within the low frequency
range of 0.06-0.13Hz but the absolute energy was observed to be high (10−3 range). Electrical
stimulation showed no clear locality, although clear components were noted throughout the signal,
presumably a continuation of the eects of previous ACh administration. The MHS showed a large,
low frequency, energy contribution (relatively, but the absolute energy was only in the 10−5 range).
No energy contributions from higher frequency ranges were observed, although small contractions
in the electrical F-t trace were visible.
A DS, tested at the highest used concentration of 6.3g/ml ACh showed a gradual increase in
force with time. A large amount of scatter visible in the HS plot, indicated that the energy was
not conned to small frequency bands. The MHS showed a large energy contribution from the low
frequency range. A further increased contribution was observed between 0.25-0.37Hz. The MHS
from the electrical stimulation test showed a very small energy contribution (relative to the low
frequency contribution) from a higher 0.37-0.5Hz frequency range. The results are illustrated in
Figure 52.
An IS stimulated at 6.3g/ml (Figure 53) demonstrated an initial increase in force variation,











(b) injection at 180 sec (c)
(d) (e)
Figure 48: Results of IS from 7 day denervation group, stimulated at 3.2g/ml. (48a) F-t record of
3.2g/ml ACh stimulation (48b) HS of 3.2g/ml ACh stimulation (48c) HS of electrical stimulation












(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 49: Results of 7 day DS stimulated at 3.2g/ml. (49a) F-t record of 3.2g/ml ACh stimula-
tion (49b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (49c) HS of 3.2g/ml ACh stimulation (49d) HS of electrical
stimulation post ACh administration (49e) MHS of 3.2g/ml ACh stimulation (49f) MHS of electrical











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 50: Results of IG from 7 day denervation group, stimulated at 3.2g/ml. (50a) F-t record
of 3.2g/ml ACh stimulation (50b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (50c) HS of 3.2g/ml ACh stimulation
(50d) HS of electrical stimulation post ACh administration (50e) MHS of 3.2g/ml ACh stimulation











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 51: Results of 7 day DG stimulated at 6.3g/ml. (51a) F-t record of 6.3g/ml ACh stimula-
tion (51b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (51c) HS of 6.3g/ml ACh stimulation (51d) HS of electrical
stimulation post ACh administration (51e) MHS of 6.3g/ml ACh stimulation (51f) MHS of electrical











energy contribution in a 0.13-0.25Hz frequency range (in addition to the low frequency contribu-
tion between 0.06-0.13Hz). The HS supports this, demonstrating well conned energy (very little
frequency 'scatter' occurred). Electrical stimulation produced small contractions post ACh admin-
istration. The HS of the electrical test demonstrates no clear locality, although clear components
are visible throughout the signal, again presumably a continuation of the eects of previous ACh
administration.
Alternate chemical and electrical stimulation of muscles denervated for a 14 day period
The F-t trace of the initial chemical stimulation of a 14 day DG by 4µg/ml (see Figure 54a)
displayed a steady increase in force post injection, which stabilised at around 750s on the graph
(corresponding to 9m30s after injection), uctuating about a 10g force. This steady uctuation
around a force value was considered unfused tetanus, as described in section 2.1.3 and illustrated
in Figure 5. (The HS of the chemical stimulation test displays a small increase in energy in the
low frequency range post injection, with frequency 'scatter' occurring in a 0-1Hz range). The
MHS pertaining to this chemical stimulation test displayed a large energy component within a
0.37-0.5Hz frequency range (peaking at 0.44Hz). Electrical stimulation after the application of
4µg/ml of ACh, resulted in a very weak response from the muscle, barely discernable from the high
frequency uctuations present in the signal. These could be due to continued action of the ACh on
the muscle. The MHS of the electrical stimulation test demonstrated that energy was only present
in low frequency components. This is consistent with literature reporting that the muscle can not
be further electrically stimulated by a signicant amount if it has already been exposed to a high
concentration (or dose) of ACh [Brown, 1937].
Stimulation of a 14 day DS by 4µg/ml of ACh, resulted in a steady increase in force with time,
which reached unfused tetanus by 800s, uctuating around 14g. The HS displays an increase in
energy post injection, concentrated in the low frequency range. The MHS displayed a larger than
usual amount of energy in the full frequency range, with increases occurring at the extremes of very
low frequencies and a high frequency range of 0.44-0.5Hz, the latter contributing the most energy.
Further electrical stimulation resulted in a clearer response than that of the DG under the same
conditions. This is further depicted more clearly in the F-t trace of Figure 55b. The HS depicting the
energy-frequency-time distribution of the electrical stimulation is displayed in Figure 55d, with clear
locality and some intrawave frequency modulation occurring in regions corresponding to stimulation
(compare to F-t trace of electrical test, Figure 55b). Further chemical stimulation was applied, the
HS of which is illustrated in Figure 56d. The low frequency components show a substantial increase
in energy after injection (at 30s). The signal was comprised of more localised energy components
(i.e., displaying less scatter) The MHS illustrates an increased energy contribution in the 0.18-
0.31Hz range and a higher than usual energy contribution between 0.31-0.44Hz. Further electrical











(c) injection at 180 sec
(d) (e)
Figure 52: Results of 7 day DS stimulated at 6.3g/ml. (52a) F-t record of 6.3g/ml ACh stimula-
tion (52b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (52c) HS of 6.3g/ml ACh stimulation (52d) MHS of 6.3g/ml











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 53: Results of IS from 7 day denervation group, stimulated at 6.3g/ml. (53a) F-t record
of 6.3g/ml ACh stimulation (53b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (53c) HS of 6.3g/ml ACh stimulation
(53d) HS of electrical stimulation post ACh administration (53e) MHS of 6.3g/ml ACh stimulation











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 54: Results of 14 day DG stimulated at 4µg/ml. (54a) F-t record of 4µg/ml ACh stimu-
lation (54b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (54c) HS of 4µg/ml ACh stimulation (54d) HS of electrical
stimulation post ACh administration (54e) MHS of 4µg/ml ACh stimulation (54f) MHS of electrical











An IS (control) from a 14 day denervated rat, stimulated with 4µg/ml of ACh, only displayed a
signicant increase in force 320s post injection (post 500s on the F-t graph in Figure 57a). Unfused
tetanus was reached by 800s but the muscle displayed signs of fatigue after 1100s. Localised energy
was observed and conned to low frequency components, as illustrated in its HS (Figure 57c). The
MHS demonstrated high energy contributions in a 0.18-0.31Hz frequency range. Post injection
activity was observed in the HS to occur in a slightly higher frequency range than pre injection
activity, this is supported by the observations made from the MHS. Electrical stimulation displayed
no clearly discernable contractions, despite some larger than usual energy contributions from the
low frequency range (presumably due to continued ACh eects) and a slight increase in energy in
the 0.44-0.5Hz range.
The DS and IS stimulated at the same concentration diered in a number of observations. The
IS exhibited a delay in rate of rise of force not observed in the DS. Both reached a state of unfused
tetanus, but the IS displayed later signs of fatigue, indicated by a decrease in force. Electrical
stimulation failed to produce contractile activity in the IS, whereas a clear response was visible
in the DS, even after additional ACh stimulation. This further attested to increased sensitivity
of denervated muscles in comparison to their innervated contralaterals. The frequency ranges of
energy contribution diered between muscles, the DS displaying full frequency range sensitivity and
low and high frequency extreme energy contribution, and the IS maintaining a localised contribution
between 0.18-0.31Hz.
Administration of 96µg/ml of ACh to a 14 day DG resulted in large force variation (peak-to-
peak uctuation), a gradual increase in force over time, unfused tetanus and eventual muscle fatigue
(see Figure 58a). The HS shows activity very localised in frequency, with more 'scatter' across a
larger frequency range post ACh administration. The MHS illustrates a considerably high energy
contribution in the 0.25-0.37Hz range (note the large frequency range in comparison to ranges
of other tests) with a peak at 0.31Hz. This energy contribution is higher than that of the low
frequency energy contribution. Electrical stimulation resulted in small, but discernable twitches, a
clearer response than that achieved by electrical stimulation after chemical stimulation by 4µg/ml
of ACh. No clear localised activity is visible in the HS corresponding to the electrical test, but
continued eects of previous ACh administration are evident throughout the signal.
Figure 59 and 60 illustrate the response of an IG to multiple stimulation. The F-t trace in
Figure 60a does not display much change in force post injection of 96µg/ml. Large force uctuation
was observed up until 600s, after which the force variations were smaller. Moreover, no gradual
increase was visible. The HS of this test is illustrated in Figure 59c, which demonstrates very little
frequency scatter, the energy being conned to low frequency components. This is conrmed by the
MHS which indicates high concentrations of energy in frequency ranges of 0.06-0.18Hz and 0.25-
0.37Hz. Electrical stimulation produced a weak contractile response, weaker than that observed











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 55: Results of 14 day DS stimulated at 4µg/ml. (55a) F-t record of 4µg/ml ACh stimu-
lation (55b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (55c) HS of 4µg/ml ACh stimulation (55f) HS of electrical
stimulation post ACh administration (55e) MHS of 4µg/ml ACh stimulation (55f) MHS of electrical











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 56: Results of further chemical and electrical stimulation of 14 day DS, initially stimulated
at 4µg/ml (see Figure 55). (56a) F-t record of stimulation by large dose of ACh (56d) F-t record
(top) and amplitude (A)-t indication of stimulation (bottom) for electrical stimulation post ACh
administration (56c) HS of large dose ACh stimulation (56d) HS of electrical stimulation post ACh












(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 57: Results of IS from 14 day denervation group, stimulated at 4µg/ml. (57a) F-t record
of 4µg/ml ACh stimulation (57b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (57c) HS of 4µg/ml ACh stimulation
(57d) HS of electrical stimulation post ACh administration (57e) MHS of 4µg/ml ACh stimulation











frequency range. Further chemical stimulation produced an increase in the low energy components
of the signal post injection in the HS, although no change was observed in the F-t trace (shown
in Figure 60a). The MHS displays energy mostly concentrated in the low frequency range, with
small contributions from the 0.25-0.37Hz range. Further electrical stimulation resulted in small
contractions of low energy (hence no localisation on the HS) and no notable energy contributions
observed from the MHS outside of the usual low frequency energy contribution.
The DG and IG were similar in their response in that they both exhibited large force uctuations
post ACh administration (although this lasted only a short time in the IG). The DG displayed more
energy scatter across frequencies than the IG which displayed a more localised energy distribution
in frequencies. As mentioned, the electrical response evoked in the IG was smaller than that of the
DG.
A 14 day DS tested at 96µg/ml (Figure 61) displayed a steady yet gradual increase in force
which does not appear to reach a tetanic state of any mode. No large uctuations in force were
observed. The HS demonstrates a large amount of energy 'scatter' throughout a large frequency
range over time. The MHS is supportive of this observation, showing energy contributions in the
signal to exist over all frequencies, the majority of the energy being in the low frequency range.
Electrical stimulation resulted in visible contractile activity, with higher energy components visible
in the HS at the corresponding stimulation time. The MHS shows the main energy contribution of
the signal to be from the 0.06-0.25Hz frequency range.
An IS stimulated with 96µg/ml of ACh resulted in a very small and gradual rise in force over
time (see Figure 62a). This increase is a lot more gradual than that observed in the DS and reaches
a state of unfused tetanus, at less than 5g. No large force uctuations occurred, as in the case of the
DS. A slight increase in energy occurred at the injection point, as illustrated in the HS in Figure
62c. The energy was a lot more scattered in frequency in the HS of the DS (stimulated at the
same concentration) than that of the HS for the IS, whose energy was more localised in frequency.
Electrical stimulation of this muscle after the initial chemical stimulation resulted in a localised
region of energy-frequency-time, as illustrated in Figure 62d,similar to that of the DS. Further
chemical stimulation resulted in a scattered energy-frequency-time plot (Figure 63b), whose MHS
indicates an increased energy contribution in the 0.25-0.37Hz frequency range. Further electrical
stimulation no longer showed a region of high locality, maintaining the scattered HS plot, with
the MHS supporting this observation by indicating that most of the signals' energy occurred in the
low 0.06-0.25Hz range.
Refer to Figure 64. Stimulation of a DS with 550µg/ml of ACh resulted in a gradual increase
in force, but only low forces were obtained (less than 5g) upon reaching unfused tetanus. The HS
shows an increase in energy after injection (visible from 180-300s) at the lowest frequency. The HS
displays a large amount of energy scatter across the frequencies present in the signal throughout











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 58: Results of 14 day DG stimulated at 96µg/ml. (58a) F-t record of 96µg/ml ACh
stimulation (58b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for
electrical stimulation post ACh administration (58c) HS of 96µg/ml ACh stimulation (58d) HS of
electrical stimulation post ACh administration (58e) MHS of 96µg/ml ACh stimulation (58f) MHS











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 59: Results of IG from 14 day denervation group, stimulated at 96µg/ml. (59a) F-t record
of 96µg/ml ACh stimulation (59b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (59c) HS of 96µg/ml ACh stimulation
(59d) HS of electrical stimulation post ACh administration (59e) MHS of 96µg/ml ACh stimulation











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 60: Results of further chemical and electrical stimulation of IG from 14 day denervation
period group, initially stimulated at 96µg/ml (see Figure 59). (60a) F-t record of stimulation by
large dose of ACh (60b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom)
for electrical stimulation post ACh administration (60c) HS of large dose ACh stimulation (60d) HS
of electrical stimulation post ACh administration (60e) MHS of large dose ACh stimulation (60f)











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 61: Results of 14 day DS stimulated at 96µg/ml. (61a) F-t record of 96µg/ml ACh stimu-
lation (61b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (61c) HS of 96µg/ml ACh stimulation (61d) HS of electri-
cal stimulation post ACh administration (61e) MHS of 96µg/ml ACh stimulation (61f) MHS of











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 62: Results of IS from 14 day denervation group, stimulated at 96µg/ml. (62a) F-t record
of 96µg/ml ACh stimulation (62b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (62c) HS of 96µg/ml ACh stimulation
(62d) HS of electrical stimulation post ACh administration (62e) MHS of 96µg/ml ACh stimulation











(b) injection at 180 sec (c)
(d) (e)
Figure 63: Results of further chemical and electrical stimulation of 14 day IS, initially stimulated
at 96µg/ml (see Figure 62). (63a) F-t record of stimulation by large dose of ACh (63b) HS of large
dose ACh stimulation (63c) HS of electrical stimulation post ACh administration (63d) MHS of











energy in the signal. Low energy was contributed from all frequencies, higher energy components
occurred between 0.06-0.18Hz and 0.31-0.44Hz. Electrical stimulation post contraction resulted in
large contractions, visible in the HS as a localised, high energy signal (the energy was localised in
frequency and in time).
The F-t trace of an IS stimulated by 550µg/ml exhibited a steady increase post injection, with
unfused tetanus reached after 720s of exposure to ACh, uctuating around 10g. The trend is thus
similar to that of the DS. The muscle appears to exhibit signs of fatigue towards the end of the
test whereas no signs of fatigue were noted in the DS. The MHS indicates that the main energy
components of the signal occurred within the low frequency range as well as between 0.13-0.25Hz.
The DS frequency range of energy contribution was higher at 0.31-0.44Hz. The electrical stimulation
post ACh administration displayed high energy components and reduced 'scatter' in the HS during
the period of stimulation. The MHS of the electrical signal shows only a signicant contribution of
energy from the low frequency range, with a small energy increase in the 0.37-0.44Hz. In addition,
another, low energy component, exists within the signal (seen in the HS), its activity uctuating
within a 0.5-2.2Hz range. The lowest energy components contain the highest energy in the signal.
An IG from a 14 day post-denervation group did not reach tetanus when stimulated with
550µg/ml of ACh. An increase in force occurred after about 300s post injection, followed by a
decrease which reestablished stability around 5g from around 800s. The HS of this test indicates
that activity fell within a 0-0.5Hz range with a small energy increase spike upon injection at
180s. The MHS of the chemical test shows the main energy component was contributed from the
0.06-0.18Hz frequency range, with a peak at 0.13Hz. The HS of an electrical test conducted after
the chemical stimulation is displayed in Figure 66d. No clear localisation corresponding to the
period of stimulation was observed. Clear low energy components may be indicative of muscle
bre recruitment. The MHS indicates that the highest contribution of energy occurs between 0.06-
0.25Hz. Further chemical stimulation caused an increase in the activity frequency band (mostly
between 0-2Hz) with the most energy wielding components being the lowest frequency components.
An energy increase was visibl post ACh administration, although a large amount of energy scatter
across frequency bands is visible. The MHS displays high energy contributions from a 0.13-0.25Hz
range. The HS of a second electrical test is void of locality with activity ranging in a frequency
band of 0-3Hz. The MHS shows high energy contributions from 0.06-0.25Hz.
The F-t trace of a 14 day DG stimulated by 550µg/ml of ACh, displayed a gradual increase
in force over time, with no notable uctuations within the signal and stabilised (reached unfused
tetanus) at 1200s on the F-t graph (Figure 68a). The gradual increase in force was similar to
that of the IG, although no drop in force occurred as with the IG. The highest energy (seen in
the HS) lies between 400-500s, which can be seen from the F-t trace to represent a stepped up
increase in force (less gradual than the overall force increase). The main energy contributing











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 64: Results of 14 day DS stimulated at 550µg/ml. (64a) F-t record of 550µg/ml ACh
stimulation (64b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for
electrical stimulation post ACh administration (64c) HS of 550µg/ml ACh stimulation (64d) HS
of electrical stimulation post ACh administration (64e) MHS of 550µg/ml ACh stimulation (64f)











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 65: Results of IS from 14 day denervation group, stimulated at 550µg/ml. (65a) F-t record
of 550µg/ml ACh stimulation (65b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (65c) HS of 550µg/ml ACh stimulation
(65d) HS of electrical stimulation post ACh administration (65e) MHS of 550µg/ml ACh stimulation











test showed clear frequency components within the signal which additionally displayed intrawave
frequency modulation. No locality for contractile activity was evident. The MHS displayed low
frequency energy contributions (0.06-0.25Hz). Further administration of ACh, this time of a large
concentration, displayed an increase in energy for some 50s post injection in the low frequency range
(refer to HS Figure 69c) and then decreased in energy again thereafter. The MHS indicated most
of the signal energy occurred in a 0.31-0.44Hz range. High energy and less frequency 'scatter' were
evident upon further electrical stimulation. Clear components visible in the HS displayed increases
in energy over time.
Stimulation of a 14 day DG with 1.6g/ml of ACh (Figure 70) resulted in an increase in force over
time, with no clear display of unfused tetanus. The HS indicated that the signals energy was slightly
scattered within a frequency range of 0-1Hz, with the MHS indicating a large energy component
within the 0.13-0.25Hz range (peaking at 0.18Hz). The HS of the electrical check displayed no high
energy components at the time of stimulation, although clear intrawave frequency modulation and
low energy components are evident during this period. This was supported by the MHS of the
electrical stimulation test which indicated that most of the signals energy was contributed by a
0.06-0.25Hz (i.e. low) frequency range.
Stimulation of an IG with 1.6g/ml of ACh (Figure 71) caused the F-t signal to display larger
uctuations in force (albeit at low forces). No slow increase in force over time was observed as
in the case of the DG. The HS displayed little spread in spectral energy (more energy is conned
to fewer frequency bands) compared to the more scattered energy representation of the DG. The
MHS supported this, displaying a large amount of cumulative energy in the 0.25-0.37Hz frequency
range. The HS of the electrical stimulation test did not provide any clear indication of contraction
(although an increase in energy in the low frequency band is noted during the stimulation period),
neither were any indications visible in the force trace of the electrical stimulation signal. The MHS
displayed a large high energy low frequency component, corresponding to the observation made
from the HS.
The F-t trace of a DS stimulated at 1.6g/ml displayed multiple uctuating peaks within the
signal post injection, not seen in other, lower concentration tests. An increase in energy was ob-
served in the HS post injection in the low frequency range. A pertinent observation was made
from the MHS, in which a large energy component existed within the 0.25-0.37Hz frequency range,
higher than the previously noted frequency ranges of cumulative energy contribution in lower con-
centration tests for the same denervation period. This indicates the presence of higher frequencies
of contraction upon the administration of higher concentrations of ACh. This energy contribution
frequency range was noted for gastrocnemii and for IS at high ACh concentrations following pre-
vious electrical stimulation. Administration of high concentrations of ACh thus indicates greater
activity or contribution of fast twitch bres. The HS of the muscles' response to electrical stimula-











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 66: Results of IG from 14 day denervation group, stimulated at 550µg/ml. (67a) F-t record
of 550µg/ml ACh stimulation (66b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (66c) HS of 550µg/ml ACh stimulation
(66d) HS of electrical stimulation post ACh administration (66e) MHS of 550µg/ml ACh stimulation











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 67: Results of further chemical and electrical stimulation of an IG from a 14 day denervation
group, initially stimulated at 550µg/ml (see Figure 66). (67a) F-t record of stimulation by large
dose of ACh (67b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for
electrical stimulation post ACh administration (67c) HS of large dose ACh stimulation (67d) HS
of electrical stimulation post ACh administration (67e) MHS of large dose ACh stimulation (67f)











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 68: Results of 14 day DG stimulated at 550µg/ml. (68a) F-t record of 550µg/ml ACh
stimulation (68b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for
electrical stimulation post ACh administration (68c) HS of 550µg/ml ACh stimulation (68d) HS
of electrical stimulation post ACh administration (68e) MHS of 550µg/ml ACh stimulation (68f)











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 69: Results of further chemical and electrical stimulation of 14 day DG, initially stimulated
at 550µg/ml (see Figure 68). (69a) F-t record of stimulation by large dose of ACh (69b) F-t record
(top) and amplitude (A)-t indication of stimulation (bottom) for electrical stimulation post ACh
administration (69c) HS of large dose ACh stimulation (69d) HS of electrical stimulation post ACh












(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 70: Results of 14 day DG stimulated at 1.6g/ml. (70a) F-t record of 1.6g/ml ACh stimu-
lation (70b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (70c) HS of 1.6g/ml ACh stimulation (70d) HS of electrical
stimulation post ACh administration (70e) MHS of 1.6g/ml ACh stimulation (70f) MHS of electrical











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 71: Results of IG from 14 day denervation group, stimulated at 1.6g/ml. (71a) F-t record
of 1.6g/ml ACh stimulation (71b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (71c) HS of 1.6g/ml ACh stimulation
(71d) HS of electrical stimulation post ACh administration (71e) MHS of 1.6g/ml ACh stimulation











frequency modulation between 8-11sec (corresponding to the stimulation period). This shows a
clear muscular response which is not immediately evident in the corresponding F-t trace.
An IS, stimulated at 1.6g/ml (Figure 73), demonstrated greater uctuation of force per unit time
post ACh administration, which is indicative of a higher frequency existing within the signal. This
was supported by the MHS of this test which displayed high energy components within a frequency
range of 0.31-0.44Hz, higher than the frequency range of the IG and DS under the same conditions.
The electrical stimulation check indicated higher energy components (as with the locality in the
DS) between 10-13 seconds, although it still displayed energy spread in all frequency ranges over
time.
A DS stimulated at 3.2g/ml (Figure 74) displayed an increase in frequency which was apparent
after injection, and supported by the MHS which indicated the largest amount of cumulative energy
was within a 0.37-0.5Hz range. The HS of the muscles' response to electrical stimulation indicated
a clear region of increased energy corresponding to the period of electrical stimulation. Further
chemical stimulation indicated that the main energy components of the signal existed within a 0.31-
0.44Hz range (Figure 75e). The electrical stimulation appeared to have reduced the signal energy
(and hence muscle energy) as well as causing a reduction in the frequency band in which the energy
components were present. This resulted in the muscle contracting at lower frequency and outputting
less energy. Further electrical stimulation indicated no changes in energy or frequency with time
in the HS plot. The cumulative energy within a 0.44-0.5Hz range in the MHS is indicative of a
response of the muscle to electrical stimulation, although large amounts of 'scatter' in the HS and
low energy contribution point to a small response of the muscle to the further electrical stimulation.
The IS stimulated at 3.2g/ml (Figure 76a) displayed a higher frequency of force uctuation (as
with the DS) but little increase in force. The signals' energy components were mainly present in
a 0.37-0.5Hz range (also the same as that of the DS), higher than the range of the IS stimulated
at a lower concentration of 1.6g/ml. The HS of the electrical stimulation check illustrates high
energy components during the stimulation period, as well as a reduction in frequency 'scatter'. The
MHS displayed a concentration of energy in the 0.44-0.5Hz range, supporting the observation of
contractile activity in response to electrical stimulation (which was clearly visible in the force trace;
clearer than that of the DS). The range of frequency in which energy is mainly distributed may be
indicative of a gradual recruitment of bres (corresponding to the low end of the frequency range)
with a peak occurring at the maximum force of contraction (corresponding to the high end of the
frequency range).
A DG stimulated at 6.3g/ml was seen to follow the same trend as other high concentration range
tests on the DG, that is, a notable increase in force variation post stimulation, uctuating around
a low force. The MHS showed a cumulative energy contribution in the 0.37-0.5Hz range (peak
at +-0.44Hz). The HS showed hardly any scatter (hence little energy spread across frequencies,











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 72: Results of 14 day DS stimulated at 1.6g/ml. (72a) F-t record of 1.6g/ml ACh stimu-
lation (72b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (72c) HS of 1.6g/ml ACh stimulation (72d) HS of electrical
stimulation post ACh administration (72e) MHS of 1.6g/ml ACh stimulation (72f) MHS of electrical











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 73: Results of IS from 14 day denervation group, stimulated at 1.6g/ml. (73a) F-t record
of 1.6g/ml ACh stimulation (73b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (73c) HS of 1.6g/ml ACh stimulation
(73d) HS of electrical stimulation post ACh administration (73e) MHS of 1.6g/ml ACh stimulation











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 74: Results of 14 day DS stimulated at 3.2g/ml. (74a) F-t record of 3.2g/ml ACh stimu-
lation (74b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (74c) HS of 3.2g/ml ACh stimulation (74d) HS of electrical
stimulation post ACh administration (74e) MHS of 3.2g/ml ACh stimulation (74f) MHS of electrical











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 75: Results of further chemical and electrical stimulation of 14 day DS, initially stimulated
at 3.2g/ml (see Figure 74). (75a) F-t record of stimulation by large dose of ACh (75b) F-t record
(top) and amplitude (A)-t indication of stimulation (bottom) for electrical stimulation post ACh
administration (75c) HS of large dose ACh stimulation (75d) HS of electrical stimulation post ACh












(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 76: Results of IS from 14 day denervation group, stimulated at 3.2g/ml. (76a) F-t record
of 3.2g/ml ACh stimulation (76b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (76c) HS of 3.2g/ml ACh stimulation
(76d) HS of electrical stimulation post ACh administration (76e) MHS of 3.2g/ml ACh stimulation










energy, more localised frequency contribution. The MHS showed a small contribution of energy
from the 0.44-0.5Hz range, indicating a small/weak response to electrical stimulation post ACh
administration. Figure 77 illustrates the results of these tests.
Chemical stimulation at 6.3g/ml of the IG demonstrated the same trend as that of the DS for
the same denervation period and concentration. A notable dierence between the two is that the IG
displayed an increase in force almost immediately post ACh administration (in comparison to the
DS in which a delay in force increase was noted). Further, the muscle (IG) appears to reach unfused
tetanus at around 700s on the F-t graph (Figure 78a). No clear gradual increase in force or tetanus
was apparent in the DG stimulated at the same concentration. No large frequency scatter was noted,
as was the case with the DS. High energy contributions in the signal occurred between 0.18-0.31Hz
(peak at about 0.25Hz), as indicated by the MHS. (An increase in gradual force generation seemed
to occur pari passu with a lower frequency range of energy contribution). Note however, that the
energy contribution in the 0.18-0.31Hz frequency range was large (higher than that of the initial
lowest frequency contributions). The HS of the electrical check test indicates frequency localised,
high energy activity corresponding to the stimulation period of 4-7sec. No energy spreading was
visible, but high energy components were noted to appear in the low frequency range. A small
energy contribution from the 0.44-0.5Hz range was noted from the MHS.
The DS diers from the lower concentrations in the high concentration range in that it displays
an additional increase in force post administration. This force increase was only noted to occur
about 620s after injection of 6.3g/ml of ACh (800s on graph, Figure 79a) and does not appear to
reach tetanus of any mode. The MHS displayed a relatively high energy distribution between the
low frequency components of 0.13-0.25Hz (peak at +-0.18Hz). This energy distribution occurred
in a lower frequency range than the lower chemical stimulation concentrations of the same muscle
type for the same denervation period (but the energy contribution is comparatively substantial).
The HS of the electrical test displayed no locality, nor did the MHS display any signicant energy
contribution in the 0.44-0.5Hz f equency range of the signal. This may be indicative of either
undetectable (and hence negligible) reaction, or no reaction of the muscle to electrical stimulation.
A consideration of the force trace of the electrical stimulation test conrms this hypothesis, as a
barely discernable response to electrical stimulation was noted (see Figure 79b).
The IS stimulated by 6.3g/ml displayed an increase in uctuation (around the same pretensioned
force value). This was supported by the MHS displaying an energy contribution lying within the
0.06-0.18Hz frequency range (which is the same as baseline noise range) but the contribution was
notably higher and peaked at 0.13Hz. This may be indicative of a combined energy contribution
from both inherent noise contribution as well as the muscles' generated energy contribution. The HS
of the electrical test showed neither clear locality in frequency, nor any higher energy contributions.
The MHS of the electrical test displayed an increased energy contribution in 0.44-0.5Hz range as











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 77: Results of 14 day DG stimulated at 6.3g/ml. (77a) F-t record of 6.3g/ml ACh stimu-
lation (77b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (77c) HS of 6.3g/ml ACh stimulation (77d) HS of electrical
stimulation post ACh administration (77e) MHS of 6.3g/ml ACh stimulation (77f) MHS of electrical











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 78: Results of IG from 14 day denervation group, stimulated at 6.3g/ml. (78a) F-t record
of 6.3g/ml ACh stimulation (78b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (78c) HS of 6.3g/ml ACh stimulation
(78d) HS of electrical stimulation post ACh administration (78e) MHS of 6.3g/ml ACh stimulation










resulted in a large increase in force with time (see F-t graph in Figure 81), with possible occurrence
of unfused tetanus after 1020sec (1200s on graph) post injection. The MHS of this test illustrated
a large energy contribution in the 0.25-0.37Hz range.
In general, frequency bands of energy contribution were higher for innervated solei than den-
ervated solei at 7 days post-denervation for concentrations up to 550µg/ml and vice versa for the
high concentration range up to 6.3g/ml, with the most notable dierence in energy contribution ob-
served between IS and DS at 6.3g/ml. The opposite trend was observed for 14 days post-denervation
where the range was greater for DS in the low concentration range (except at 96µg/ml, but this
was accounted for by energy spread through the full range of frequencies) and less than or equal
to that of the IS in the high concentration range. The frequency bands of energy contribution for
the DG were always greater for DG than IG, for both denervation periods and all concentrations.
Additionally, low frequency energy contributions were always present, representing preferential al-
tered bre recruitment (in this case slow twitch), followed by recruitment of original bres (in this
case fast twitch bres).
4.3 Histology
The results of the ATPase staining for fast twitch muscle bres are presented. Muscles from each
denervation period were stained and are compared here to their innervated controls. One example
of each group is depicted in Table 7 which are representative of the overall features characteristic











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 79: Results of 14 day DS stimulated at 6.3g/ml. (79a) F-t record of 6.3g/ml ACh stimu-
lation (79b) F-t record (top) and amplitude (A)-t indication of stimulation (bottom) for electrical
stimulation post ACh administration (79c) HS of 6.3g/ml ACh stimulation (79d) HS of electrical
stimulation post ACh administration (79e) MHS of 6.3g/ml ACh stimulation (79f) MHS of electrical











(c) injection at 180 sec (d) stimulation as in (b)
(e) (f)
Figure 80: Results of IS from 14 day denervation group, stimulated at 6.3g/ml. (80a) F-t record
of 6.3g/ml ACh stimulation (80b) F-t record (top) and amplitude (A)-t indication of stimulation
(bottom) for electrical stimulation post ACh administration (80c) HS of 6.3g/ml ACh stimulation
(80d) HS of electrical stimulation post ACh administration (80e) MHS of 6.3g/ml ACh stimulation










(a) (b) injection at 180 sec
(c)
Figure 81: Results of further chemical stimulation of IS from a 14 day denervation period group,
initially stimulated at 6.3g/ml (see Figure 80). (81a) F-t record of stimulation by large dose of ACh










Table 7: Histological sections of fast twitch bres as demonstrated by ATPase staining for various























The labels in Table 7 are indicative of the following:
A and C - slow twitch bres present in the IG
B - fast twitch bres present in the IS
D - slow twitch bres from a 14 day DG
E - fast twitch bres from a 14 day DG
F - fast twitch bres from a 14 day DS
G - freezing artefact (not to be mistaken for fast twitch bres)
H - fast twitch bres from a 22 day DG
I - slow twitch bres from a 22 day DG
J - freezing artefact
K - slow twitch bres present in a 204 day DG
ATPase staining for fast twitch bres in both gastrocnemii as well as solei produced results
consistent with literature [Bakou et al., 1996]. The denervated gastrocnemii muscles demonstrated
an increase in slow twitch bres with an increase in denervation period and the denervated soleus
demonstrated an increase in the number of fast twitch bres 14 days post-denervation. For reasons










periods to demonstrate that the observed changes comply with literature, although further histo-
logical ATPase bre staining would be ideal for the denervation periods not included here. The
bre type changes as observed here are supportive of the muscle responses (as previously discussed










5 Overview of Results/Summary
This section presents a brief overview of the results presented and discussed in section 4 and serves
as a comprehensive summary before conclusions are drawn in section 6.
A consideration of F-t traces of all muscles as functions of denervation periods and concentra-
tion, demonstrated that 7 day DG showed greater slow contracture responses than IG. The IG
and 7 day DS displayed the same pattern in slow contracture response as 7 day DG with an in-
crease in concentration, but these patterns initiated at higher concentrations than 7 day DG. This
phenomenon was termed a `concentration lag' (as dened in the Glossary of Terms, page xix).
Larger slow contractures were noted in 14 day DG than 7 day DG in response to low concen-
trations (4-550µg/ml) of ACh. This observation was not made when these groups were tested with
high (1.6-6.3g/ml) concentrations of ACh. IG displayed increased force variation for all concentra-
tions of ACh used in this study at 14 days post-denervation compared to 7 days post-denervation.
In general, a reduced response in both force variation as well as in the development of slow con-
tracture, was observed for the two long term denervation periods of 50-55 days and 204-208 days
in comparison to the short term denervation periods of 7 and 14 days for gastrocnemii.
DS displayed greater force variation than IS at 7 days probably due to an increase in the number
of fast twitch bres (compared to its pre denervation state). Such bre type changes were observed
post-denervation by histological ATPase staining. At 14 days post-denervation, slow contractures
occurred at lower concentrations but the increase in force was observed to be more gradual and has
been attributed to bre type changes, (increased type II bres), demonstrated to have occurred by
histological ATPase staining. No slow contractures were noted for DS from long term denervation
periods of 50-55 days and 204-208 days, compared to IS which did display slow contractures.
A consideration of peak forces produced by all tested muscles illustrated that denervated muscles
were more sensitive to developing peak forces than their innervated counterparts for all investigated
periods of denervation as well as for all concentrations. Greater peak forces were outputted by inner-
vated muscles compared to their denervated contralaterals only as an exception to this observation;
and occurred at a combination of high concentrations (1.6-6.3g/ml) and short denervation peri-
ods (7 and 14 days) for the gastrocnemii. This was supported by literature reporting a depressed
response from muscles at high dosages of ACh.
The highest percentage dierences in peak force occurred at 14 days post-denervation for solei
(supportive of the high sensitivity to ACh for this period) and increased with increasing periods of
denervation (7, 50-55 and 204-208 days) thereafter.
The data indicate that physiological changes either occur, or peak later (i.e. develop at a slower
rate and with higher sensitivity to ACh) for the DS than the DG muscles. This was explained by
timing in receptor proliferation (noted in literature to occur sooner in gastrocnemii than solei post-










to initiate from 3 days for gastrocnemii and 1 week post-denervation for solei [Bakou et al., 1996,
Dhoot and Perry, 1982]) as well as later sensitivity in gastrocnemii for later denervation periods due
to an impeded mitochondrial ability to manufacture ATP. The DS displayed the highest sensitivity
(generated the largest forces) at 14 days post-denervation, consistent with literature on nAChR
proliferation of mammalian slow twitch skeletal bres [Hartzell and Fambrough, 1972].
In order of decreasing sensitivity to ACh, muscles ranked as follows: DS, IS, DG, IG. In terms of
this ranking, a consideration of the bre types and receptor proliferation suggest that the greatest
output force response is obtained from muscles with a combination of slow and fast twitch bres
(although predominantly slow) and most likely a large number of receptors, as occurs in DS. Whilst
DG exhibit changes from fast to slow twitch bres, the possible lack of ATP production may render
receptor proliferation inconsequential, thus reducing bre type inuence. The lowest peak forces
were produced by IG muscles, containing the least amount of slow twitch bres and no receptor
proliferation since they were not denervated.
An increase in concentration within the low concentration range (4-550µg/ml) was observed
with a simultaneous decrease in output force for both solei and gastrocnemii for denervation periods
longer than 7 days. This may be due to potential neuromuscular blocking eects similar to those
reported by Brown [1950]. The DS however, appeared to demonstrate a threshold concentration
such that stimulation with concentrations beyond it were able to cause the reappearance of slow
contractures and a consequent increase in force with further increase in concentration. Further
testing would be required to establish whether this trend exists for muscles denervated for periods
longer than 7 days. Gastrocnemii showed no signs of such a concentration threshold. It may well
be that such a trend would be visible in muscles denervated for periods shorter than 7 days, given
the time dierences in physiological changes between solei and gastrocnemii (with gastrocnemii
reacting more quickly to denervation than solei).
An observance of the time to peak force responses of all muscles tested as functions of concentra-
tion and denervation period demonstrated that IG reached peak forces faster than IS. This would
be expected since IG are comprised primarily of fast twitch bres and IS are comprised primarily
of slow twitch bres. DG were slower to reach peak force than IG for all denervation periods. This
was also expected since DG have been reported, and were observed in this study, by histological
ATPase staining, to develop an increased number of slow twitch bres. All DG follow the same
time to peak force response trend as IG from a 7 day denervation period group, but they did so at
a time lag. DS followed the opposite trend to DG in terms of time to peak force response. That is,
the DS reached peak forces sooner than their innervated contralaterals. This too, is supported by
literature as well as by histological ATPase staining conducted in this study, showing an increase
in the number of fast twitch bres in DS post-denervation. DS thus contained more type II bres
than IS, as well as a larger number of nAChR's due to receptor proliferation post-denervation and










There were however, similarities in time to peak force responses of DG and DS which were
noted by denervation period grouping, where the respective responses (although dierent for solei
and gastrocnemii), were similar for 7 and 14 day groups and followed the trends of their respective
innervated contralaterals from the 7 day denervation period. Long term denervation periods of
50-55 days and 204-208 days too, each followed the same trend. The highest forces for the DS
occurred at (the most sensitive) 14 day post-denervation period, for which the longest time to peak
force was recorded.
The time to peak force measurements demonstrated the possibility that dierent concentration
thresholds exist for dierent denervation periods at which DS would be more likely to respond faster
than IS. The highest concentration dependency was demonstrated at 14 days post-denervation
(also the period of highest force generation). Since DG were observed to take longer to reach peak
tension than IG, optimisation of shorter time dierences are important. Such small time dierences
occurred between DG and IG with administration of high concentrations (1.6-6.3g/ml) of ACh for
short denervation periods (7 and 14 days). It would thus be appropriate to note the eects of high
concentrations on the time to peak tension of longer term denervated muscles in potential future
studies. Further, DG contracted faster than IG at the lowest concentration (4µg/ml) for long term
denervation periods and at the highest concentration for short term denervation periods.
Fibre type is an important consideration of muscle response to ACh doses. The alteration of
bre type post-denervation, aects the muscle response to ACh, such that either slow contracture
responses or fast twitch responses can be obtained. The greatest (in terms of force) fast twitch
responses were obtained for gastrocnemii (predominantly comprised of type II bres) at high con-
centrations of ACh which allowed for saturation of the fast twitch bre receptors. Similarly, slow
contracture responses were obtained for solei (predominantly comprised of type I bres) at high
concentrations of ACh which allowed for saturation of the slow twitch bre receptors.
Alternate chemical and electrical stimulation provided further observations supportive of those
previously discussed in terms of post-denervation bre type changes and sensitivity to ACh (ob-
served by the relative degree of change in peak force with increase in concentration). Contractile
responses with high energy outputs within a relatively low frequency range were considered to be
indicative of slow contracture responses, and such observations were supported by muscle bre type
composition. Energy outputs within higher frequency ranges were considered to be contributions
from fast twitch bres and or from local high energy contractions of bre bundles. Large energy
contributions from frequency bands illustrated in the MHS were represented by little or no scatter
in the corresponding HS plots.
In general, visible contractions due to electrical stimulation (as observed by local increases in
force at the time of stimulation, or 'spikes' in the F-t traces) were larger and hence more evident in
denervated muscles in comparison to their innervated contralaterals. This could well be a further










unlikely to have been saturated by low concentrations, thus eliminating the known eect of high
concentrations of ACh blocking depolarisation and action potential conduction along the bre,
allowing for further electrical stimulation.
After stimulation at very high concentrations of ACh, contractions due to electrical stimula-
tion were more visible (larger and produced higher energy outputs) in the IS than the DS. The
energy output from the DS generally occurred across the full range of frequencies with additional
localisations, compared to the energy components of the IS which were more localised in frequency.
Frequency 'scatter' was more evident for denervated muscles in comparison to their innervated
counterparts, indicating large energy contributions from wider frequency ranges. This could be
indicative of localised contractions of bre bundles occurring at dierent rates (hence not as well
localised in frequency) as their innervated controls.
Muscles tested chemically with large doses of ACh after electrical stimulation demonstrated a
reduced energy response and a shift in frequency bands of energy contribution. For denervated
muscles, this meant that if the energy was spread throughout the frequency range before, they were
more localised in frequency in their response to large doses of ACh administration post electrical
stimulation. This suggests that fewer local contractions of bre bundles were likely to occur and
smaller contractures evolved. IG contributed energy from the same frequency range, but outputted
a reduced energy response. IS displayed an increased energy contribution from the full frequency
range but an overall reduction in energy and a shift to lower frequency band energy contribution,
reported in literature as an inhibition of conduction ability due to a block produced by large doses
of ACh [Brown, 1950].








[low]: low concentration range (4-550µg/ml)
[high]: high concentration range (1.6-6.3g/ml)










Table 8: Summary of experimental results pertaining to peak force and time to peak force for soleus
muscles
DP Peak Force (contractures) Time to peak force
[low ACh] [high ACh] Response [low ACh] [high ACh] Response





DS<IS DS<IS DS same trend as
IS; 14 days same
trend as 7 days;







50-55 DS=0, <IS - DS<IS - DS same trend as
IS

























Table 9: Summary of experimental results pertaining to peak force, time to peak force and force
variation for gastrocnemii muscles
















































































Table 10: Summary of results pertaining to alternate chemical and electrical stimulation for solei
and gastrocnemii denervated for 7 days















dg4,7d N Y N Y N
ds4,7d N Y Y Y Y
is4,7d Y (slight) Y (slight) Y >1/2 Y
dg96,7d Y (large) Y Y >1/2 Y
ds96,7d N Y Y >1/2 Y
is96,7d Y Y (slight) N N <1/2 N
dg550,7d Y (slight) Y Y Y Y
ig550,7d N Y Y Y Y
ds550,7d Y Y Y Y (w/in low energy range
but 10−3)
Y
is550,7d Y (large) Y (slight) Y Y (w/in low energy range
but 10−3)
Y
is1.6,7d Y (slight) Y (after
time)
Y Y Y
is3.2,7d Y (slight) Y (slight) na N <1/2 Y
ds3.2,7d Y (initially but decreases
after)
Y Y >1/2 Y
ig3.2,7d Y (after time) N Y Y Y
dg6.3,7d Y N Y Y (w/in low energy range
but 10−3)
Y
ds6.3,7d Y (large) Y (slight) Y (tiny) Y (w/in low energy range
but 10−3 + 2ranges)
na
is6.3,7d Y (initially but decreases
after)










Table 11: Summary of results pertaining to alternate chemical and electrical stimulation for solei


































dg4,14d Y Y (slight) N >1/2 N
ds4,14d Y Y Y Y Y Y Y >1/2 N
is4,14d Y (after
time)
Y (slight) N >1/2 Y
dg96,14d Y Y Y Y N
ig96,14d N Y
(initially)
N Y Y N N N N
ds96,14d Y N Y N N
is96,14d Y (slight) Y (slight) Y >1/2 N N na <1/2 N
ds550,14d Y Y (slight) Y N Y














dg550,14d Y N N N N N Y <1/2 N
dg1.614d Y N N >1/2 Y
ig1.6,14d Y (slight) Y N Y N
ds1.6,14d N Y N >1/2 N
is1.6,14d Y (after
time)
Y (slight) Y Y Y
ds3.2,14d Y (slight) Y Y Y Y N N <1/2 N
is3.2,14d Y (slight) Y Y >1/2 Y
dg6.3,14d Y (slight) N Y >1/2 Y
ig6.3,14d Y Y Y Y Y
ds6.3,14d Y (after
time)
Y Y (tiny) >1/2 N
is6.3,14d N Y N Y (w/in low
energy range
but 10−4)











This section draws conclusions following from the results, discussion and overview presented in
sections 4 and 5 and highlights the essential deductions relating to the three-fold objectives. The
conclusions presented are novel contributions deduced from this study, except where conformation
with the literature is explicitly stated.
The investigation involved examining two fundamental parameters (time taken to peak force and
maximum force of contraction) under a variation of three conditions (ACh concentration, muscle
type and denervation period), the combination of which has not been reported in literature. Forces
were examined both in terms of slow contracture or gradual force increase as well as local force
variation observed over the full time period of contraction. Data was further analysed by the novel
application and combined approach of EMD, HSA and MHS. This allowed for a more thorough
and detailed representation of information in terms of energy distribution resulting from muscle
stimulation by ACh application. Resultant analysis allowed for the following observations.
6.1 Deductions based on analysis of F-t traces
- Changes in bre composition post-denervation, for both fast twitch and slow twitch muscles,
occurred in a manner consistent with reports in the literature. It can thus be asserted that dener-
vated fast twitch muscles experience an increase in slow twitch bres post-denervation and similarly
denervated slow twitch muscles experience an increase in fast twitch bres post-denervation.
- Slow twitch muscles denervated for long time periods appear to lose all potential for slow
contracture (i.e. even if slow twitch bres still exist in the muscle, they are not sensitive enough
for low concentrations of ACh to initiate contraction).
Slow contractures were still visible in long term denervated muscles which were originally pre-
dominantly fast twitch. Additionally, the fast twitch bre response of originally predominantly fast
twitch muscles was still visible (noted by force variation) after long denervation periods (50-55 days
and 204-208 days) (note that fast twitch bres are known to be more sensitive in their contractile
response than slow twitch bres [Gaster et al., 2001, Ploug et al., 1984]).
This observation leads to a number of deductions: (1) either all the bres of originally slow
twitch muscles change to fast twitch bres, or to a combination of fast and slow twitch bres in
which the post-denervation slow twitch bres are less sensitive (or likely unable to produce ATP)
than the original slow twitch bres (literature supports the latter [Patterson et al., 2006] by noted
dierences in phenotypes) and (2) originally slow twitch bres either deteriorate at a faster rate or
are less sensitive than slow twitch bres which appear post-denervation in originally predominantly
fast twitch muscles. The deduction made in '(2)' is supported by Tomanek and Lund [1973] who
reported that slow twitch bres of predominantly fast twitch muscles were less aected than those










degrees of neural dependence despite similar histochemical conguration.
- Although beyond the scope of this study, the results indicate that it would be worthwhile to
investigate if a preferential change in fast twitch bre type occurs post-denervation (such that a
certain fast twitch bre type is more likely to convert to a slow twitch bre).
- Low ACh concentrations produce large contractures (slow/gradual contractions) in slow twitch
bres. Higher concentrations are needed to produce the same eects in the presence of predomi-
nantly fast twitch bre muscles.
- The slow contracture response (and thus greater presentation of force summation) is more
prominent in originally fast twitch muscles at 7 days post-denervation compared to the slow con-
tracture response of originally slow twitch muscles of the same denervation period. The slow
contracture response of originally predominantly slow twitch muscles is most prominent at 14 days
post-denervation compared to other denervation periods as well as to originally predominantly fast
twitch muscles of the same denervation period. This is not attributed to receptor proliferation,
but rather due to phenotype dierences between slow twitch bres developed post-denervation in
originally fast twitch bres and those from originally slow twitch muscles. Fibre type changes oc-
curred sooner in fast twitch muscles than slow twitch muscles once denervated, as supported by
histological evidence.
- Innervated fast twitch muscles appear to display an increase in force variation for short periods
of denervation (7 and 14 days), which is taken to indicate an increase in fast twitch bre activity.
This may be due to the increased movement and eort required from the innervated limb to support
the animal due to the impaired function of the denervated contralateral.
- For fast twitch muscles: Longer term denervation periods (50-55 days and 204-208 days)
displayed a decrease in slow contracture as well as force variation in comparison to short term
denervation periods. This demonstrates a reduced response to stimulation with an increase in
denervation period, as is consistant with literature.
6.2 Deduction based on analysis of peak force recordings
- High concentrations of ACh cause high peak force fast twitch responses in fast twitch muscles and
high peak force contractures in slow twitch muscles, as is to be expected based on theory.
- In general, denervated muscles produced greater peak forces than their innervated contralat-
erals. This was true for all periods of denervation and all concentrations reported in this study.
The only exceptions to occur were related to the concentration of ACh, such that innervated fast
twitch muscles produced greater peak forces than short term denervated muscles (7 and 14 days)
when stimulated with high concentrations of ACh. Receptor proliferation is considered the primary
underlying cause for this observation. It is suggested that the concentration threshold which results










to the increased sensitivity by way of receptor proliferation after short periods of denervation. It
is further suggested that this eect is more prominant in originally fast twitch muscles since, once
denervated, fast twitch bres tend to alter in preference to slow twitch bres [Gauthier and Dunn,
1973, Tomanek and Lund, 1973]. It is postulated that this eect was not observed for longer den-
ervation periods due to a reduction in receptor proliferation which occurs after the initial increase
post-denervation. As a result, bre type becomes a predominant factor in the contractile response
of long term denervated muscle. The signicantly larger ratio of slow to fast twitch bres after long
denervation periods in comparison to the innervated contralaterals (fast twitch muscles), surpasses
the fast twitch bre peak force capacity even at high concentrations. The gradual force increase
due to contraction of slow twitch bres is taken to govern the value of the peak force.
- The largest percentage dierence in peak force between denervated and innervated slow twitch
muscles was observed at 14 days post-denervation, thus further conrming the receptor proliferation
peak and conforming to literature.
- In order of decreasing sensitivity, muscles were ranked as follows: denervated slow twitch,
innervated slow twitch, denervated fast twitch, innervated fast twitch. This indicates a rank by
original predominant bre type (slow twitch more responsive than fast twitch) and a sub-split by
denervation such that denervated muscles are more responsive than their innervated contralaterals,
as is supported by literature. It is worth mentioning that the peak response measured was a
combined contribution of both slow contracture as well as localised (in time) contractions. Over
the testing time of 19 minutes, the slow contracture force is thus the primary contributor to the
measured output, explaining why slow twitch bres were found to outrank fast twitch bres in
their force output. Had only contractions been considered, fast twitch muscles would outrank slow
twitch bres in their measurable contractile ability. Moreover, bre type inuence is reduced due to
inhibition of ATP production and the consequent reduction in the eect of proliferated receptors.
- An increase in concentration within the low concentration range of 4-550µg/ml resulted in a
simultaneous decrease in output force for all muscles denervated for periods longer than 7 days,
suggesting a potential neuromuscular block, as supported by literature. Results suggest that a
threshold condition in denervation period in slow twitch muscles exists, such that a subsequent
increase in concentration results in an increase in force beyond the suggested threshold denervation
period. It is suggested that this is likely due to timing of, and changes in, receptor proliferation.
Further testing would be required to conrm this.
Additional testing at shorter denervation periods for a wide concentration range (as used in
this study) would allow for further clarication of the threshold denervation period. It could
be hypothesised that such an observation (of a threshold denervation period) can be made with
denervated fast twitch muscles as well, for shorter time periods of denervation (less than 7 days,










6.3 Deductions based on analysis of time to peak force responses
- Innervated fast twitch muscles were found to respond faster than innervated slow twitch muscles,
which is to be expected and complies with theory and literature.
- Denervated fast twitch muscles were slower to reach peak force than innervated fast twitch
muscles for all denervation periods considered. This is likely due to a reduction in the fast to slow
twitch bre ratio.
- All denervated fast twitch muscles followed the same time response trend as innervated fast
twitch muscles from a 7 day denervation period group. This time frame suggests a point of dener-
vation stability beyond the peak of receptor proliferation.
- Denervated slow twitch muscles reached peak tension sooner than their innervated contralat-
erals. This is likely due to a combination of increased sensitivity and an increase in fast to slow
twitch bre ratio (as supported by histological ATPase staining and existing theory).
- Denervated muscles followed the same trend in time to contraction for varying concentrations
of ACh as their innervated contralaterals for both fast and slow twitch muscles (although dierent
between twitch types). Further grouping was noted according to denervation period, where short
term denervation groups (7 and 14 days) displayed the same trend and simarlarly long term den-
ervation groups (50-55 and 204-208 days) displayed the same trend. This indicates that both fast
and slow twitch muscles can be grouped into denervation period categories such that the properties
change accordingly with an increase in denervation period. This information can be implemented
in later applications of ACh administration where time to contraction can be estimated by the
investigator when stimulating muscles of known denervation period and muscle type with a given
concentration or concentration range.
- For slow twitch muscles, dierent concentration dependencies exist for dierent denervation
periods such that denervated muscles tend to react faster than their innervated contralaterals. The
highest concentration dependency appears to occur at the height of the receptor proliferation phase
(observed at 14 days).
- Small dierences in time to contraction occur between innervated and denervated fast twitch
muscles denervated for short periods when stimulated with high concentrations of ACh. Further
testing is required to determine high concentration eects on long term denervated fast twitch
muscles.
- For long term denervation periods and low concentrations, denervated fast twitch muscles
were found to contract sooner than their innervated contralaterals. The same was found true in










6.4 Deductions based on alternate chemical and electrical stimulation
and novel application of signal analysis methods
This thesis made use of EMD and HSA as a novel approach in determining dierences in muscle
contraction dynamics under various parameters (muscle type, denervation period and concentration
strength). Application of ACh to denervated muscles in vivo produced raw force-time data which
is considered non-stationary and non-linear, thus appropriating the use of these techniques. To
the best of my knowledge, no literature has hitherto approached the analysis of muscle contraction
dynamics as described in the context of this thesis. Results were analysed in terms of energy
distributions in varying frequency ranges of bre contractions. This approach allowed for a more in
depth determination of bre activity whilst maintaining the perspective of whole muscle contraction.
Based on this approach, the following deductions could be made:
- Direct electrical stimulation of the muscle was used post ACh administration in order to deter-
mine the eects of ACh on muscle contractility and measure the response against a known stimulus
(electrical). The general result indicated that denervated muscles produced a larger contractions
than their innervated contralaterals, suggesting receptor proliferation to account for supersenstivity
of denervated muscle.
- The eect of electrical stimulation was more prominant in innervated slow twitch muscles
than their denervated contralaterals when stimulated at high concentrations of ACh. This may be
due to the saturation of innervated muscle receptors and the known 'priming' eect of electrical
stimulation prior to chemical stimulation [Bach-y Rita and Ito, 1966] for contraction, although
further experimentation would be required to conrm this hypothesis.
- Large energy contributions from a wider frequency range were noted for denervated mus-
cles compared to their innervated contralaterals. It is suggested that this is due to bre bundles
contracting at dierent frequencies due to varying bre type composition of the muscle (where
denervated muscle composition is more varied due to physiological post-denervation changes).
- A reduced energy response and change in frequency bands of energy contribution was noted in
denervated muscles tested with large doses of ACh post-electrical stimulation. This may indicate a
specic bre type reaction, inferring that some bre type receptors become saturated in preference
to others and/or that fast twitch bres present in the denervated muscles were easily fatigued - a
known property of fast twitch bres and a likelihood when considering the reduced ability for ATP
production in denervated bres.
- The reduced energy output whilst remaining in the same frequency range from innervated fast
twitch muscles stimulated by high doses of ACh post-electrical stimulation, indicates that a number
of the fast twitch bres may have been fatigued.
- The reduced energy output and contractions occurring within a lower frequency range produced










further indicates slow bre predominance, fatigue of any existing fast twitch bres and potential
block of conduction ability.
6.5 Overall conclusion
Based on these deductions, it can be surmised that application of ACh in a manner consistent with
the methods reported here would be less ecient than the use of electrical stimulation. Times
taken to reach peak force were signicantly longer than those caused by electrical stimulation as
reported in literature. Nevertheless, the breadth of the parameters investigated (large denervation
period ranges, large concentration ranges and various muscle types) provide a comparitive basis and
valuable documentation of the varying responses of innervated and denervated muscles of various
types (type I and II) to application of ACh. These ndings can be applied to possible further
studies involving i.a. ACh administration, leading up to the eventual administration of ACh by
potential implementation of implantable microuidic devices. In addition, the novel application of
the analytical approach presented herein to stochastic F-t signals, allowed for the energy-frequency-










7 Recommendations for future studies
This sections provides recommendations for further research pertaining to this topic.
1. The rst improvement relates to administration of ACh in the explanted preparation. In vivo
experiments or alternatively, experiments which involve explantation of the muscle with an
artery, could be conducted. This would allow for the ACh to be administered i.a. as done by
Sanghvi and Smith [1969], presumably resulting in shorter lag and rise times and increased
responses due to improved localisation.
2. In this study it has been demonstrated that slow twitch soleus bres convert to fast twitch
bres post-denervation, it is hypothesized that intermediate stimulation would result in a
reversion of the altered bres to their original state, dependent on denervation time periods.
Consequently, the preparation could be stimulated at a set rate for a set time period (AChE
will be required to relax muscle in between stimulations). Subsequently perform an ATPase
stain on the tested muscle to determine any change in bre composition.
3. To further explore physiological compensation for denervated limbs, conduct histological AT-
Pase stains of innervated contralaterals to note bre typ changes which may occur.
4. Conduct tests at shorter denervation periods (1-2 days) before receptors have proliferated.
The aim of this would be to test if the physiological changes known to occur after muscle
denervation can be intercepted and the muscle made to contract as though it still maintained
full functionality. This would most likely work best with tests conducted with i.a. injection
where whole muscle contractions will be more visible and easily distinguishable than slow
contractures, hence paving the way for more practical device implantation which could release
ACh at set periods to cause contraction. The overall picture to keep in mind is (a) fast
acting treatment for patients paralysed 1-2 days earlier, (b) rehabilitation for patients in the
intermediate stages of denervation and (c) treatment to combat muscle atrophy for patients
who have been paralysed for long periods of time.
5. Dierences in force trends between low and high concentration ranges of ACh should be further
investigated to establish threshold periods for changes in trends. Further, longer denervation
periods could be tested at higher concentrations, as data pertaining to these parameters were
not recorded in this study.
6. Larger groups of test subjects should be used to attest to statistical signicance. Exceptions
to trends should be further investigated with larger sample sizes.
7. In order to fully inform device design for furthering the idea of eective stimulation in range










between fast and slow twitch muscles for various denervation periods should be conducted.
This would allow for a better understanding of the force generation with respect to muscle
sensitivity based on nAChR proliferation. More often than not, the literature leans towards
investigations based on mixed bre types, or predominantly fast twitch muscles, leaving a
gap in the knowledge of slow twitch muscles. In terms of future implementations in practical
applications, these gaps need to be lled for device design to eventually eectively simulate
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Prof Graham Anatomy lllgally responsible for Veterinarian SAVC No 
louw. Human Bldg. 4.05 prescribing and dilllcting 7611324 
Biology ext. 6302 tl» administration of the 
controlllld Scheelule 3-6 
medicinal substances 
Simon Anatomy Foodina and monitoma of UCTtrained NlA Yes 
Oingalibaba. Bldg. 1.01 animals daily and over the 
Human Biology ext. 6277 
wllllkend 
-Dr. Nicholas Anatomy Will perform aninal surgeries 4 years experience NlA No 
Sachs. l ee!. Bldg. 7.17 and drug administration as with small animal 
Human Biology ext. 7613 well as supervise muscle surgery. induding sti11ulation experiments and PhD and postdoc 
0725796900 prcwide surgical trailing. training 
Available alter hours. 
Or. lester Anatomy W~I consult on and assist 7 years experience in NlA No 
John. leel Bldg. 7.05 with muscle stimulation bioinstrumentation 
Human Biology 
ext. 6548 
procedures. and neurallmuscular 
interfacing 
AlProf laurie Anatomy Will consult on and assist >25 years OXperi90C9 NlA No 
Kellaway. HOD Bldg. 5.14 with animal surgery and with small animal 
Human Biology ext. 6271 muscle stimulation surgery and muscle procedures. physiology studies 
-Ghabiba Anatomy Will perform muscle BS in M9ch. Eng. NlA No 
Modak. MSc Bldg. 7.07 stinulation experiments Current MSc (MOO) Student 0732810926 
(chemical) and reeeive 
Biomedical Eng. Human Biology supervised training in animal Student surgery . 
-Nlelen Anatomy Will perform muscle BS in M9Chatronics NlA No 
Ventner. MSc Bldg. 7.12 sti11ulation experiments Current MSc (MOO) Student 
0835567889 
(electrical) and reeeiv9 Biomedical Eng. 
Human Biology supervised training in animal Student surgery. 
I 
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• the A EC accreditation course wi l be completed bv the resoective participants 
8. STUDY INFORMATION: Background 
Provide a brief introductory statement in ~teehnical terms that explains what problems. questions. needs. 
obseIvations. or new ideas have led to the planning of this experiment. (Note: Must be understandable to those 
outside of the fMlld) 
Certain types of injuries and diseases (such as spinal cord injury, stroke, and multiple sclerosis) result in 
damagD to tho nervous systOm. H such damago affocts motor neurons. which synapse with musclGs and 
signal thom to contract it will often lead to paralysis. Deponding on tho typO of injury, tho motor neuron 
itsoH may still be alivo and functiona~ but just disconllOCtIId from tho brain. In such casos, tho uso of 
applied eloctrical currents (similar to those provided by a pacemaker), has allowed resoarchors and 
clinicians to artificially stimulate thoso nerves and causo tho muscles thoy innorv31ll to contract This has 
bllen an efioctive rnoans of restoring simple movlllTlent and primitive function to paralyzed muscle and has 
bllen an active area of nlsoarch for tho past 50 )'liars. 
A more complicated problem occurs whon tho motor neurons actually die. as is tho caso in poriphoral 
nervo injuries. Whon this happons. tho muscle fibers they had synapsed with becorno denorvated. 
Denorvated muscle fibers can be dilllctly stimulated by oIGctrical currents, in much tho sarno way as motor 
neurons can be. how""er it is much mOIll difficult. Tho diflllnlnco is that a single nervo synapses with a 
very large number of muscle fibers. so stimulating a singlo small nerve can gDnerate a IargD contraction, 
whoreas oach denervated muscle fiber must be activated by tho injected oloctrical currents directly. 
Bocauso tho muscle itsoH occupies such a largo volume compared to tho nerve that innervateS it. much 
more curront is required to activ31ll tho entire clllnorv31lld muscle than to simply activate tho nerve that 
usod to illllllrvate that musclo. Injecting largD amounts of current will often cause unwanted side offects, 
most notably the activation of pain fibers in tho surrounding area that may still be collllllcted to tho brain. 
Thus, whilo technically possible, olectrically reactivating donorvated muscles in most cases turns out to be 
impractical 
It has bllen anocdotally reported that it takes less olectrical current to directly activ31ll a donorvated muscle 
fiber than to directly activate an innervated muscle fiber (not via its motor neuron). H this is indolld true, it 
means that something has happened to tho fiber's mIIITlbrano as a result of denorvation that has sensitized 
it to olGctrical currents. A thorough understanding of tho rnochanism of this sensitization would increase 
our understanding of musclG denervation and could potentially be exploited to improw oktctrical rnothods 
of reactivating denorvated muscle fibers. Othorwise it is cloar that pursuing altomative (such as chomical) 
methods of stimulating denervatlld muscle fibers is warranted. Once muscle fibers havo bllen denervated. 
changDs to tho mombranos occur which distinguish thom from tho rnombranes of illllllrvated muscle fibers. 
Tho topography of tho rocoptors which aid neurotransmitter function changDs and lack of stimulation 
results in muscle atrophy. It takos timlt for tho changDs which draw tho distinction botwOlln innervated and 
denervated musclo fibers to occur. Inwstigations involving denervation g_rally allow for a poriod of 1 to 
2 wOllks for thllSO changos to taka place. 
Tho normal rnothod of communication betwoon tho motor neuron and tho musele is via neurotransmitter, 
specifically acetylcholine (ACh). An alternative method of activating denervated musclG could be to 
anificially administer ACh directly to tho muscle f iber's rnombrane, activating tho ACh nlC4lPtors and 
causing contraction in much tho same way an incoming signal from tho motor neuron would. H this is 
offoctive. rocont advancos in technology (panicularty in tho fiold of microfluidies) could potentially enable a 
prosthotic device to be dIIVelopod that would chomically stimulate denervated muscle fibers for specific 
appliestions whore electrical stimulation may not be viable (such as reactivating tho muscles in tho e)'lliids 
to enablo e)'lliid closure following fac·ial paralysis). Not nearty onough is currently known about tho 
interaction botwOlln denorvated muscle fibers and extracellular ACh to cillsign such a devico, let alone 
confirm its feasibility, howewr. An investigation of tho dynamics of musclo contraction duo to controlled 
amounts of oxtracellularty cIIIlivered ACh is a logical first stop along this Path. 
O. MIS OF THE STUDY 
Please be brief and succmcl 
Tho aims of this study are 
to confinn tho anecdotally reportlld ektctrical sensitization of denorvated muscle fibers through 
controlled ox po riments 
to invostigate possible mechanisms of eloctrical sensitization of denervated muscle f ibers 
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to examine tho dynamies of muscle contraction elicitlld by administration of oxtracellular ACh, 
particularty in denervated muscle 
to investigate means of controlling musclo relaxation aftor extracollular ACh elicited contraction 
to histologically oxamine tho offocts of artificially administered ACh on denorv31lld muscle. 
10. HYPOTHESIS 
H a hypothesis is being tested (explanatory research) please state what it is. 
Tho following hypothosos are being tested: 
Donervation causos musclo fibers to become sonsitized to oloctrical stimulation. 
Extracollularty injected ACh is an offoctiw moans of eliciting artificial contraction of denervated 
muscle. 
11. POTENTIAL BENEFITS OF THE RESEARCH RNDINGS 
These are required to aid the reviewing committ90 in pertorming a hannstb9nefrt assessment of the 
researchileaching proposal. 
This resoarch would incroaso our understanding of denervated muscle physiology and could be a major 
first step toward tho dIIVeloprnont of a prosthetic dIIVico that could nlstOre muscle function in patients that 




13. FOCUS ON REPLACEMENT: JUSTIRCATION FOR THE USE OF SENTIENT ANIMALS 
Please provide justnication for the use of animals rather than an n.vitro model. Which alternatives to the use of 
animals have vou considered? Also prcwide justnication for the need to use the specified species. 
This study requires tho use of muscle fibers, which cannot be anificially gDnerated. Tho physiological 
changDs that occur as a rosult of denervation require a natural biological onvironrnont to dew lop, and are 
not wollenough understOOd to be adoqu31llly modelled. 
Rnile olernont modelling of tho oktctrical propertios of muscle fiber mIIITlbranos both before and aftor 
denervation has bllen considered to address tho electrical sensitivity issuo, however the sonsitization of 
denervated fibers contradicts what would naturally be eXPllCtlld baSlld on gross morphologiesl changes 
consistent with musele atrophy. Thorllfore, empirical evidence is noIIdIId to validate results of newly 
developod modols that might account for more subtle changes to tho rnombrane propenills. 
Ethically and legally this rosearch cannot be porformed on humans, as it requires tho denervation of 
Rats are tho most common modo! for muscle denervation studies and are used widely in tho literature. Tho, 
tricops SUral! muscles (soleus and gastrocnemius) in particular are common sites of denervation, with an 
easily accessible nerve supply (sciatic), simple and reliabIG way of tIIsting for porsistent denervation (drop 
induced toO splllad reflex), and limited adwlSO effects when paralyzed unilaterally (impaired mobility but 
no oth~r effects on gOMraI hoalth). ~
'"UiClo and iho harwstiiiy of tissuo. 
Tho use of tho Long Evans strain will provide easy diffl!lIIntiation from Wistar rats that are being hold in tho 
sarno facility and used by resoarchors for athor exporirnonts. 
114. FOCUS ON REDUCTION AND RERoIEMENT 
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Please provide justffication lor: 
(m the number of .nimals _ ired. 
An initial pilot study using 5 animals will be conductod to dovolop tho skills involvod with tho surgical 
tochniquo and to monitor tho behaviour of tho animals and idontify potential complications in tho post-
oporativo poriod. ospecially in torm of solf-mutilation of tho donorvated limb. This is ossontial to lOst the 
feasibilitY and productivo outcomo of tho stUdy. Upon succoss of tho pilot study. tho main stUdy will 
involvo 3 soparato groups of animals. oach of which will undorgo musclll donorvation for a diffonlnt 
duration of timo (1 weok, 4 woeks, 8 woeks). 30 animals will be usod in tho main stUdy. which providos for 
10 animals por group. a sufficiont numbor for statistical comparison. 35 animals will bo u90d in total 
(including tho pilot study). 
(b) _. if • sinalo _ is nlauinld. 
NlA 
15. OVERVIEW OF EXPERIMENTAl DESIGN 
In a llow diagram. summarise how the animals will be allocaled to expelWnentai and control groups. indicamg the 
schedule lor trealment. sarnoinQ and endpoint. 
Soe attach mont. 
16. DETAILS OF EXPERIMENTAL PROCEDURES AND STATEMENT OF COMPETENCE 
Provide a delailed descr1ltion 01 all procedll'es. treatments. tissue sarnoIina that the animals wiU underao. and 
the method of euthanasia. loolCate in 7 who will pertorm each procedure. and their appropriate competence lor 
the tasks. 
Briefly oudine parameters to be measuredlfinal tissue analysis to be pertormed in order to achieve the aims of the 
study. 
DelMlrv ation Procedu nI : 
Each animal will bo placed in a chamber with halothano (4%) to induOll alMlstllesia. OnOll tho animal is 
unconscious, a mask will bo affixed to the animal through which vaporized halothano (1.5%) will be 
continuously admlnlmnld for tho duration of the procedunl In ordllr to maintain anosthosla. 10mgrkg of 
moloxicam will bo adminimred subcutalMlOusly fNery 24 hours for thnle days following an initial dose. 
which will be adminisaonld OIMI hour pre-operatively in order to provido p~mPtive analgesia. 
Tho right hindlimb will bo shaved. A saorile drapo will bo used to isolalO tho limb. Tho hindlimb will bo 
saorilized with iodino, applied thnle times using steri le gauze and a hemoStat from tho OIInter of the surgical 
site outward. Body temporatUnI will bo maintainod using a temporatUnI controlled ba90 plate. 
Using aseptic lOchnique a 2-cm skin incision will be mado along tho hindlimb, moving diStally from the hip. 
Tho sciatic IMIrve will bo identified visually and through the U90 of an elllctrical stimulator I norw locator. A 
1·cm SOction of tho sciatic norw will bo nlmoved above tho klMle. The nlmaining IMIrve stump will bo 
ligated and fixed to the quadricops muscles using 6-0 silk sutunl. Complete donorvation of tho Iowor 
hindlimb will bo confirmod using olllctrical stimulation. Tho skin will be sutunld clo90d in a single layor 
using 4-0 silk sutur~s. 
PostoporatiVII Caro: 
Tho animal will be monitonld until it wakes from alMlstllosia. at which timo it will be nlturnod to tho animal 
facility and kopt in isolation until tho surgical wound has hoallld. Moloxicam (10mg1kg) will be adminisaored 
ovory 24 hours for 3 days in order to maintain analgosia. Animal monitoring shoots (as shown on pago 13) 
will bo filled in daily for the romainder of the exporirnont. Antibiotic ackninistration will includo a onOll' off 
intramuscular injection of 0.1mllkg of Lentrax containing procaine ponicillin (1~ml) and bonzathino 
ponicillin (112.Smglml) which is effective for a fiVII day interval After tho wound has hoallld. each animal 
will bo hold in the air and lowenld at a rapid rate to test for the existenOll of tho toe sproad roflex (lack of 
tho toe sproad roflllx on tho pnlviously donorvated side will confirm paralysis). 
Muscle Fiber Harvesting I Euthanasia: 
At the end of tho animaf s group-dependent delMlrvat.ion period (1 week, 4 weoks, or 8 weoks post surgory) . 
tho nlflllx test will bo ropeaaod to confirm paralysis. The animal will then bo plaOlld in a chambor with 
halothano (4%) to induOll anosthosia. On<» tho animal is unconscious. a mask will bo affilClld to the animal 
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through which vaporized halothalMl (1.5%) will be continuously administenld for the duration of tho 
procedure in ordor to maintain alMlstllesia. A skin incision will bo mado along the length of tho hindlimb to 
exposo the undorlying muscllls. An electrical stimulator I norve locator will bo used to confirm dolMlrvation 
of tho tricops surae (soleus and gaStrocnomius) muscles on tho pnlviously operated sido. While under 
anosthosia. a lethal intraporitonoal doso of sodium pontobarbital (2OOmgrkg) will bo administerod to 
outhanizo tho animal Tho Iowor hindlimb will bo dotachod on both sidos and tho soleus and ga.strocnomius 
muscles will bo harvosted for furthor stUdy. 
17. END-POINT FOR EXPERIMENTS THAT. BY NECESSITY OR UNAVOJDABL Y, INDUCE 
ILLNESSIDlSTRESSlDEA TH 
H the experimental procedlJresltreatrnents will inevitably cause. illness. loss of weight. and/or increasing pain or 
distress to the animals. dearly indicate at what endpoint the objectives of the studv will be reached. and provide 
adequate justilication for this endpOOl ll death is the erqx,r,t. provide adcfrtional justification lor this requirement. 
Tho donorvation proooduro will cause discomfort to tho animal due to impainld movement. Anaesthosia 
will bo ackninistered during tho surgory and analgosia will bo adminisaorod pro- and post·oporatiVIIIy to 
avoid tho animal from exporienc ing any pain. Some weight loss is expocted but will bo monitored - a 20% 
weight loss is considenld significant and will rosult in euthanasia. For details on distlllss factors nlsulting 
in euthanasia. pleaso rofllr to 9Oction 21.6. Further than the distross factors. thore ani 3 explicit endpoints 
to tho stUdy at 1 weok, 4 weeks and 8 weeks post-donorvation. at which times tho animals will be 
euthanized doponding on thoir nlspoctiVII groups. It would be inhumano to keop tho animals alive whon 
thoir moVllmont is impaired by a paralyzed limb. 
18. STATISTICAL ANALYSIS 
Ooscme brieflY how data obtained from this studvwil be analysed statisticallY. and by whom. 
Rhoobaso valuos will bo rocordod and chronaxie values will be calculated for all elllctrical stimulation 
exporiments. Thoso will be compared among groups using a t·test and ANOVA by Nielen Ventnor. 
Onsot times and maximum forOll outputs of muscle contraction for varied concentrations of ACh dIIlivery 
will bo rocorded and compared among groups using a t·test and ANOVA by Ghabiba Modak. 
Tho hoalthy cont.ralateral musclo will be u90d as a control for all exporiments. 
111. RECEPTION 
Is this study a repetition of previous work performed b( vourseH or others? 
~. explain why it is being repeated. 
If no. is it pan of ongoing research being conducted by your group. 
No. this study is not a ropoat of pnlvious work. It is tho first study in a dovoloping rosoarch dinlction for 
our group, but is informed by pnlvious work that has boon dono on olllctrical stimulation of delMlrvatod 
muscle (spocifically in tho rabbit eyelid). 
20. PUBLICATIONS 
Highlight any publications stemming from your research molving the use 01 animals thus far. 
N. A. Sachs. E. L Chang, N. Vyas. B. N. Soronsen. and J . D. Woiland, "Electrical stimulation of tho 
paraJyzod orbiaJlaris oculi in rabbi~ " IEEE Trans. Neur. Sys. Rehab. Eng.. vol. 15, pp. 67·75, 2007. 
N. A. Sachs. E. l. Chang, V. Pradoop and J. D. Woiland. " Restoration of blink symmotry foUowing unilateral 
facial paralysis, " in Proc. 12th Ann Conf. IFESS. Philadolphia. PA. Nov. 1()'14. 2007. 
N. A. Sachs, E. L Chang. and J. D. Weiland, " Contralateral EMG-triggenld electrical stimulation of the 
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eyelid;"-inProc. HIIlAnn. COnCIFESS,-Miyag~Zao, Japan, Sept 12=-15;-2006. 
N. A. Sachs, E. L. Chang, and J. D. Weiland, -Kinematics of ei9ctrically elicited eyelid movement," in Proc. 
28th Ann. Inti. Conf. IEEE-EMBS, New Yoril, NY, Aug. 3c)'SePt. 3, 2OOS. 
N. A. Sachs, E. L. Chang, N. Vyas, and J. D. Weiland, - Electrical stimulation of the paralyzed orbicularis 
oculi; ' in Proc. 10th Ann. Conf. IFE5$, Mont.real, Canada, July !>-10, 2005. 
21. ANIMAL CARE AND HOUSING 
21.1 location 
Where win the animals be housed (specify pr&- and post-treatment if different)? 
Where will the experiments be performed? 
(For both of the above. if not at the Animal Unil. explain why not) 
Animals will be housed in the Department of Human Biology's Animal Satellite Facility. 
Experiments will be perlorrned in the Anatomy Building on the UCT Faculty of Health Sciences, room 4.13. 
21.2 Gaging and social requiJlIfnentS 
Describe how the animals will be caged and what provisions have been made for their physical and psychological 
wel~beiM i.e. comfort. socialisation. behavioural needs and enrichment of their caQe environment. 
Animals will be housed in plastic cages with wire grids and a built in food hopper. Food and water will be 
provided ad lb. Wood shavings will be used as bedding mat9rial The animals will be housed in groups of 
three per cage. This I9quires 10 cages and allows for them to maintain the ir social environment 
Animals will be isolated during the recovery period following surgery in order to ensure proper wound 
healing and to avoid cannibalism from other rats before being retUrned to Standard caging conditions. If 
however, the pilot Study indicates that it would be mOI9 i9asible to k&ep the animals in isolation to prevent 
inflicting hann on one another then they will be kept in isolation for the remainder of the study until 
euthanized. 
21.3 Measures to be tabn to minimise painldistress caused by the experimental proc»dures 
What negatNe effeas will the experimental procedure!'Jlreatments have on study animal weI-being (e.g. fear. 
deprivation. pain and dislress). Give detais 01 preventative measures taken pr&-. inlra- and post-
procedurellreatment. as wei as during transportation and restraint 01 the animals. that may minimize these effects. 
Indicate in 7 who wil implement these measures. and their appropriate competence for the tasks. 
A single dose of pre.qmPlive analgesia will be provided via intramuscular injection of 10rrlWkg of 
meloxicam 1 hour prior to surgery. 
21 .4 Expected/unavoidable effects of the proc»dures on animal well-being 
Describe how the experimental procedures may unavoidably impact on the animals' wellare. irrespective of the 
measures taken as indicated in 21.3 (e.g. paralysis due to nerve transection; poSl-op social deprivation 01 
animals if ·ustilied). 
Animals will undergo unilateral nerve transection, I9sulting in paralysis of the right hindlimb. This is an 
unavoidablel9sult corl9sponding to the muscle denervation that is the focus of this study. 
21.5. Potential adverse effects of the QXperirnental procedures 
State what specific signs (physical and behavioural e.g. not eatilg) will be monitored for as an indication 01 
unexpected but potential adlerse events (e.g. septicaemia) caused by the procedureltreatmenl 
2S N"""",ber2l108 Page 7 0114 FHSOOl 
The condition of the surgical wound wm be monitored as an indication of localized infection following 
surgery. Additionally, animals will be monitored for i9thargy, hyperactivity, isolation from the social group 
(after the wound has healed), signs of setf.mutilation when in isolation, limb injury dua to movement 
restriction induced by paralysis and weight loss (animals will be weighed ewry three days) as indications 
of poor health and/or distl9SS (see Animal Monitoring Sheet on page 13). Further observ,ation of communal 
inl9raction will be made when the rats are placed back in groups of 3 again after wound healing. 
Cannibal'ism from other rats in communal cages will result in animal separation or, if severe, in euthanasia. 
21 .S Euthanasia 
Under what conditions will euthanasia be performed prior to the determined experimental end-point delined in 
is above? 
Animals will be euthanized if they are observed to be in distl9ss (see Animal Monitoring Sheet on page 113). 
A 20% weight loss will serve as the limit which, if 19ached, will I9sult in the respective animal being 
euthanized. Sevel9 seH~mutilation or mutilation by cannibalism will be an indication for immediate 
euthanasia. 
22. DISTRESS AND DISCOMFORT SEVERITY (Please tick where appropri .. ) 
I 
Category A 8cDeriments involving non-livino materials. plants. bacteria. 
or non-sentient species 01 animals. 
Category B Experiments on sentient animal species expected to produce 
(mild) little or no discomfort. e.g. blood samping. injections. or procedures on anaesthetised animals Ihal do not reoain 
consciousness. 
CategoryC Experiments that involve some olSCOITIfort to sentient 
(moderatO) anmals. 9.g. surgical procedure under anaesthesia and some postoperative discomfort. 
Category D Experiments that involve signifJCallt but unavoidable distress X 
(sewre) or discomfort to sentient aninals. 
23. ANIMAL MONITORING AND STATEMENT OF ANIMAL CARE COMPETENCE 
I-Iow often wil the animal subjects in this study be monttored (pr&-. inlra· and pos~procedurellreatment) to ensure 
their comlort, health and humane Ireatment? Indicate in 7 who will do this for each stage. and their appropriate 
competence for !he task. 
NOTE: Alklvia1ion of pain: POSTOPERATIVE CARE MONITORING 
As a manilestation of pain in animals is not always easily recognised the internationally accepted principle is thai 
any procedure which is liable to cause pain in humans will cause alleast a similar level 01 pain in animals. A 
reasoned scientDlC justiftcation for the decision to withhold the use of anaes!hetics and analgesics will be required. ij 
any invasive procedure is to be performed. 
Animals will be monitored daily and weighed every 3 days. Fl9quancy of monitoring may be incl9ased to 
twice daily at any time in cases of animal discomfort or st19SS. Animal monitoring sheets will be completed 
(see page 13). 
24. FATIE OF THE ANIMALS AND METHOD OF DISPOSAL 
Will !he animals be kil ed at the end of the experiment? If so. please explain why, il it is not obvious Irom the 
experimental design. 
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Animals will be euthanized immediately prior to muscl9 fiber hal'\ll9sting. This is necessary because they 
will be paralyzed during the surgical prOOlldures and muscl9s from both hindlimbs will be hal'\ll9Sted for 
analysis. It would be inhumane to keep them alive following such prOOlldures. 
25. METHOD OF KllUNG (PIe_ tick category, and give details in 16) 
Inhalation Exsanguination under anaesthesia 
(speciy B9!'111 aOO '¥stem used in 26 below) (spedfy whowilionsure dealh in 16 abave) 
Fatal dose of anaesthetic agent X Lethal injection whilst under 
(speciy 89!'111 BOO dose in 26 below) anaesthesia 
(spedfy agert and da6e in 26 below) 
Other 
(speciy here and in 26 as re<Jrired. and jus::ily in 16 
abore) 
26: DRUGS AND SUBSTANCES TO BE ADMINISTERED 
list all substances administered to the animals. Indicate the route of admilistration and dosage per 
body mass for each substance. Include anaesthetics. analgesics and kiling agents. 
Note: It is inperalive that you state in 7 abovewho is ~ authorised to prescribe. and direct the 
administration of Schedule 3-6 medicilal substances. 
Item Route/Site Dose Frequency Name and Signature of 
person administering the 
substance 
Halothane Inhalation 4.0% To induce anesthesia Nicholas Sachs 
Halothane Inhalation 1.5% Throughout surgery Nicholas Sachs 
in order to maintain 
anesthesia 
Meloxicam SUbcutaneous 1Om~g Once one hour prior Nicholas Sachs 
to surgery, fNery 24 
hours for 3 days 
following the first 
administration (4 total 
doses) 
Sodium Intraperitoneal 200mgkg Once for euthanasia Nicholas Sachs 
pentobarbital 
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PIIrson taking IIIgal responsllility for the schedukl3-6 drugs litn&d above: 
Name I Dr. Graham louw 
Signature I I Date I 
'0. BIOHAZARD STATEMENT 
Is this a requirement for this project? If yes, please append prool of approval 
No 
28. REFERENCES 
Give a briellist 01 releroooos to support the information in 8, 13 and 14. 
Note: Provide relerGllC9Slsources to sUllOOrt the manner in which vou will pooorm the procedures. treatments and 
monitoring of the study animals. 
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Give a brief rlSt of references to supper! the information 11 8. 13 and 14. 
~: Provide references/sources to supper! the manner 11 which you will perfoon the procedures. trea/mOOs and 
monitoring 01 the study animals. 
A. Rlitz and A. Malian, "An analysis of Acetylcholine responses of junctional and extrajunctional receptors 
of frog muscle fibres," J. PhysioL vol. 219, pp. 8>100, 1071. 
D.B. Drachman, E.F. Stanley, A. P9$1ronk, J.W. Griffin and D.L Price, " Neurotrophic regulation of two 
properties of skeletal muscle by impulse.dependent and spontanllOUs Acetylcholine transmission," Thli 
Journal of Neuroscience, vol. 2, no. 2, pp. 232·243, 1082. 
G. Bazakova, l Rabben, l Sefland, G. Fumagalfi and T. lome, " Neural agrin controls Acetylcholine receptor 
stability in skeletal muscle fibres, " Neurobiology, Vol. 09, no.17, pp. 0024-0020, 2001. 
H.C Hartzell and D.N. Fambrough, "Acetylcholine receptors - Distribution and extrajunctional density in rat 
diaphragm after denervation correlatlld with acetylcholine sensitivity," The Journal of General Physiology, 
vol.6O, pp. 248-262, 1072. 
J.C. Jay and K.F. Barald, "Denervated single myofibers: neurite interactions and synaptic molecules,' 
Muscle and Nerw, voL 12, pp. 081.002, 1080. 
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PlIlNCTPTES 
Animal We/fan! 
Ethical review of proposed experiments on sentient animals is necessary because such aninals have moral 
standing. Accordingly. there are resbictioflS on how such arimals may be treated. Atthough there is 
disagrooment on whether aninals may be used at aN in experiments that cause deprivation. fear. discomfort 
distress. pUt or death. there is now widespread agreement that arWnais used in scientifIC experiments: 
• May not be used in studies that are methodologicaly unSOlM, frivolous, trivial, or which unnecessanly duplicate 
eaJ1ier studies. 
• May not be subjected to unnecessary hunger. thiS!. disease. parasitism. ir1ury, discomfort. pain fear. or social 
deprivation. 
Therefore. arWnais hetd for, and used iI. scientific experiments: 
• Must be kept comfortable tn:Ier cond~ioflS thai are suitable to their species, enabli~ them to express normal 
behaviour. These include adequate space, company of corJSp9clflCS. and adequate stinu ation. 
• Must be monitored for il~health and distress. and, where necessary. eniov rapid diaanosis and either trealment 
or other alleviation 01 thei" condition. 
• Must be handled and treated 11 wavs that either avoid or at least milimize distress. pain and sufferi1Q. 
TheThnlll 'R's 
Proposals tor research on sentient animal subjects must salisly tll"oo princ~es : 
Reolacemenl: Sentient animals may not be used if they can be replaced by non-sentient subjects or systems. 
Reduction: The number of animals used must be reduced 10 the mllimum that will allow the objectives of the study 
lobealtained, 
Reflll9lTlenl: Experimental methodology and procedures should be reflled in a way that mininizes the causation of 
pain, discomforl. fear and social deprivation to the experimental animal. 
Responsibility 
Everyone using animals. whether for experimentation. testflg or provision of tissues or body lkJids is responsible in 
ther personal caoacitv for assurillll thai they are afforded the hiQhes\ lovels of welfare and proteclion from abuse. 
Responsibilities of the Priqlal lnvestigator: 
a To read and comply with the University's "Code of Ethics and Procedures for the Use of Animals in Teaching 
and Research". 
b. To maintain records of all procedures performed on the animals. 
c. To ensure that all animals used are deartv idOOifled with the allocated authorisation rumber bv mearlS of labels 
on cages. peflS or rooms. 
d. To ensure that all the designated associate and assistant personnel are quaified and compelent to perform the 
allocated procedures and that no other persoMel will be allowed to perform any procedures without written 
authorisation from the Aninal Ethics Committoo. 
e. To ensure that there will be no deviation from J!m: of the procedures as specified in the application without the 
prior written approval of the Aninal Ethics Committoo. 
To 911Sure that 11 the ovent 01 a situation arisillll durilQ the course of the experiment wherel7( an animal is 
found to be sufferllg from severe pain or distress, a veterinarian wil be cofISUhed for advice. In the event that 
the pain or distress cannel be alleviated. the experiment will be lerminated. the aninal immediately euthanased 
and the Animal Ethics Commirtoo IlI00ned. 
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1. I, •.... ............. .. .. as Principal Investigator in this application hereby 
declare that I am fami iar with tho ideas. principles and responsibilfiies outlined in Section L and will 
personal", undertake to see that these are upheld in the conduct of this study, should H be apprO/ed. 
2. I understand that I am legally responsible for all aspects of the study. 
3. In my opinion. all persons named and working under my supervision have the appropriate training and sk~ls 
nlquirod to carry out their responsibiilios as indicated. 
4. I undertake not to deviate from tho approved protocol without first obtainirlg apprO/al for such amendments 
from the UCT Health Sciences Faculty Animal Ethics Committee. 
5. I undertake 10 !llpon to the Animal Ethics Committoo on the outcome of the study at fis condusion, and to 
fumWlthe AEC oIfice with copies of all publications thai resutt flom this study 
6. Should the stud'{ lake lonQer than t vear, I uooertake to submit an annual prog!llSS nIPOI't to the AEC. This 
win be submitted 12 monthly from the month 01 tho initial approval by tho Commfitoo. 
7. If a biohazard declaration is necessary. this has boon submfited 10 the Faculty Bio safety Committee. and 
proof of their approval of the safelY practices stipulated in this apoi'lCalion aopended. 
I have read aoo accGjll the declaralion. 
...... .... 1 .. 
DatIl 
.. .. 1 .......... . 
SijjiiatUro·Of.PPlicant 'Print' Ran. 
Support from Head of Depanlllllnt 
NotiI: Your attention is drawn to the responsibiilies 01 the Head 01 Department as specified in the University's 
"Code of Ethics and Procedures fOf the Use of Animals in Teaching and Research". 
In my opinion. the researcher is competent to perform the experiment and I supporlthis applcalion 
SignatUre of Printnalllll 
o;n.; ..... i... ........... .I. 
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16 August 2010 
University of Cape Town 
Animal Ethics Committee 
UNIVERSITY OF CAPE TOWN 
Faculty of Health Sciences 




Tel: +'ll 21 4066235 
Fax: +27 21 448 7?26 
Re: Changes to HSFAEC proposal 010/002 entitled "Response of denenated muscle to electrical and 
chemical stilllUlation" 
Dear Committee 
Unfortunately, the group of animals that we have used (originally allocated as five rats) was inadequate to refine 
our data collection procedures. One of these rats died during surgery and of the four remaining, only one gave 
useful data. In order to properly develop our data collection procedure we will require the use of more rats. We 
will begin by drawing these from tlle remaining allocation for the study, but in order to maintain appropriate 
munbers for statstical significance within our study groups we may need to draw additional rats beyond tlle 
original study allocation of 35. TIus additional cohort will be capped at 10, giving a new total allocation of 45 
allinws. Please advise if this change is acceptable. 
Kind regards 
Nicholas A Sachs, PhD 
Lecturer 
Department of Hmnan Biology 
University of Cape Town 
e-mail: llicholas.sachs@uct.ac.za 










30 "\ngns 2010 
ulli -ersitr of Cape To -n 
.-\nimal E hics Conunittee 
UNIVERSITY OF CAPE TOWN 
Faculty of Health Sciences 
Depanment of Human Biology 
AnzioRoad 
Obse!TIItorr - 9_5 
South_llic"a 
Tel: +T 21 ~ 62J5 
Fa."C +_- 21-HS - 226 
Re: Changes to HSFAEC proposal 010/ 002 entitled "Response of denen-ated muscle to electrical and 
chemical stimulation" 
Dear Conunittee 
TIle original application detailed a muscle explanta '01 procedure wluc was to be dOL e 'hils the rats -ere 
anaesthetised -it 1 lalothane. \,'e la -e s lbsequentlr found that the use of llalothane affects III lscle 
COL rractility. TIle muscle response to stimulation decreased substantially owards the end of the explantation 
procedure (ie e longer le rats reI 1M ed on halothane, the greater le effect on e muscle contractili j. \\'e 
therefore propose tilat decapitation be used instead. 
TIle n uscle fibre halyesting procedure ~-ill thus be as follo ~'s : 
_\t he end of le alumal's gro lp-dependent denen-ation period, the reflex test ~-ill be repeated to confinn 
paralysis. TIle aiumal ~ill then be decapita ed. _\ skin U cision ~ill be made at the base of the leg along the 
length of the lundlimb to expose the l1lderlrulg mnscles. The denelyated muscles ~-ill be remo oed and the 
procedure repeated 01 the uUlelTated hindlimb. 
Please ad\-ise if tius change is acceptable. 
hind regards 
Nicholas A Sachs, PhD 
Lec lrer 
Department of Hnman Biology 
-IU -ersity of Cape T OWL 
e-mail: nicholas.sachs@uct.ac.za 









A.3 Ethics reports and accreditation course certicate
Two reports based on the addenda were submitted to the AEC, one presenting the dierences in
results between rats which were euthanised with halothane and those which were decapitated and
one which detailed animal numbers at various periods throughout the duration of the study. (In
addition to these reports, annual reports were submitted but are not included in the appendices
as they would serve only as repetitive summaries of what has been presented in the body of the
dissertation).
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INTRODUCTION 
Tm IOpotI dolails the oflecls of halolhane vorsus decapiIalIOn as a means of euthanasia of 
Long Evans ralS with the po.rpose of subsequont use of sk .. lotal muscle fues lot in vit o 
stirrulation. The skolelal muscIo Rlres ate Slinulaled bolh chomicafly (by moans of the 
nourollanslr'lllOl AcolI'lctIofine (ACIl)) as wei as oleclricafly. 
1.1 Subject of Rlport 
Two molhods of euthanasia wi be discussod wilh direcl appIicaIion 10 Ihoir effec:ls on 
skeletal muscle con:racIion dynamics. 
1.2 Background to report 
An original application was submil!ed for rNO 51Ldos wtOch delailed the in vi~o oleclricaf 
and chemocal slint.Ca:ion of denerval&d and I1OONa:ed (as a ccnlrOf) sl<elelal rruscle Rlres 
wIII:h wt!(e 10 bo ""planted from Long Evans ralS. This appficatiln stipUalOd the use of 
halothane as a means of anaoslhelJ: during the explanwion prccedure. Muscle fibres Wt!fO 
acplanl&d and IeSIOd on whist the I8l was under &naOSlhelic. This was a vafJdaI&d melhod 
III filora .... e and was thus deom&d acceptable althe timo of the appIca:Jon. h stbsequoolly 
bocamo oviden. IhaI haIo!hane had a substantial &!loa on the skeIotal muscIo conIraCIifily . 
l.iIerann ciI&d shonor lino perods of halothane usage. As llis was cornproniUlg the 
'lUdy. it was decided !hal an amendment 10 the ~inaf proloc:d wotAd be SlJbmin&d for 
elhicaf approval whore docapiIatiln would be used as a moans of ouIhanasia ilstead of 
halothane. This appf'lCStiln was approv&d and a repon of lhe IOsufls (as requeslOd by the 
AEC) is as follows. 
1.3 Objectives of report 
The objocIM!s of the repon are lhe<&fore 10: 
0Jt1ne Iho offec:ls of halolhano on sk .. lotal rrusde conlrllCtlity OYer line 
Demonslrate Iho daleronces bow oon halocI1ane and decapitation on skoletal 
muscle comrac:dity 
1.4 Scope and limitations of IlIport 
Tm IOpotI wil fOQJS on Iho skefolal musc:Io el!planlalion procedure of !he firs! fivo 
docapilalod rals. as roqt.eSIed by the AEC upon awrovaJ of lhe IIfTIC!fdner4 for 
docapilation. 




1.5 Plan of dewlopmant 
This roporl rolatos to the oflec1s of IIalothane rNef line on skeb:al muscto concractiity. Tho 
ccmparalivo e.~octs of docapitation are presentod. The pIiIn fOf the most viabfo option for 
the resLCts 01 this study is thoo pcovidod. 
2 METHODOLOGY 
Both innelVa:OO and derorvated muscfo fibres wll<e IIlSIOd. Fast and sbN typO fibres '-" 
used. from the soleus and gasttoa1Omius muscles respectively. 
The informallOn fOf halothane and dOC8jXtation tosts was ga:hered in tho following wgy: 
2. 1 Musd9s explanted under halothane anaesthesia 
IAJscIos were oxpianled from the rats whist undor anaosthesia One muscle at 8 tino was 
acpfanted inlO 8 speaaf chambor oontaining Krebs Rnge< IUfor solution and separatod into 
fhe boodles before being teslOd. This proc:o<Ue 'HaS repeatod fOf each 01 the feu muscfes 
who:h WIl<O tostod C!m&fVatod soleus. denervated sobus, ",neova:ed gastIOCnomius and 
denervated gastr'OCnelnuS). For c:t1omical stinula\i)n, the muscle fboe tuldfes '-., 
stimulated willi 8 number of difforent concentrations of ACh rNor 8 line poriod of 20 
mi1utes pel tost. 
2.2 Musd9s explanted alter decapitation 
Rats wore rapi<Iy decapitatod using 8 spocif'lC smal animal QIiIlotine and aI fOUl muscfes 
'"""",ed immediatoly and placed in a Kreb& Rfooe< buffer solution. As pmviously doscrilod. 
stimulation tests wero conducted inmecf .. lely afle< the acpfanta60n prococisro. Tests were 
done successively and the musdos _re kepi in solution 814 'C LI1IiI testod on. 
Alf proc:o<Uos adhered 10 prCIOCCIs appruved by the AEC for appicaIion OOtlOO4. 




3 COMPARISON OF THE EFFECTS OF HALOTHANE AND 
DECAPITATION ON SKELATAL MUSCLE CONTRACTION OYER 
TIME 
Habthane is a vo!a:iIo anaeslilt>tic and has been shcMIn to af.ecl skeletal mus<*l 
COI\uaClion dynamic:s in both CSSI>S 01 ditec1 as wei as ildirec1 stimulation by depre~ 
lilt> po6Hynaptic respoose 10 lilt> neuro1ransmittef. ACII [l ~ lieIB1Ure cites dependencies 
on ecposure dlMalion (of skelela1 mus<*l to haklthane). haIodIane oonoenuation and 
lempe<81Ure oon1to/. Comple1e block has been SOONn to occur al with admilistta1ion of 
haIo1hane SI 4% and 5.6'Ifo tn:Ier VSJYilg oon<itions (1 ~ The tosts peltaWng to lhis repon 
_re 000Iducted tn:Ier the following oondilioRS: 
Con:roIIed ~ and lesting lempelBlure oI3TC. 
Concentration maimailed al 1.S%.. 
All ecposure d Ilations ecceeded 40 mirll1eS. 
3.1 Stimulation by means of ACh 
Tlvee concoottations 0/ ACh wero used to stirraJlate conuac:tions. These were 4pg'mI. 
96~mI and 55tW'rrI. 
3. t. t D9Capita/lon ana HalOthane Btf9CtS on contraction /l11I9S 
Figlxes 1 depCIs the tine 10 oonttacli:ln and time 10 peak tension cPn for clecapilatod ISIS 
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FIgUre 1: lime 10 connctlon and lime lO"n 10""'" peale tMSIon tor InnotV .... a_. 
muse .. from (I) C10capltaIeCI moC1ol and (Ill hatornane moC1o l 
Fo< lilt> decapitati::>n model. an increase il oonoenua1ion is SOONn 10 cause a decrease il 
lilt> time to oontracti:>n as wei as time to pea!< toRSion. The halothane model does noT 
display lhis Trend. This oouId be anrbJr.ed to the d.ration 0/ exposu-e of the muscle to 
halolhane. Tho solEvs muscle stimWle<l with 4pg'ml 01 ACh was exposed to halothane for 
45 minu1es betore the leSl was <Xlncb:1od. The soleus musde stimula1ed wih 55Ol.\;lImi of 
ACh was ""posed to haIo1hane for 25 minutes beIoro the lesl was oonduc:tod. 
Figures 2 alSplays a more Meet comparison be('NOOn 00capiIa1ion and haIo1hane models 
tor lime 10 oontracti:>n and time to peale toRSion. 
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FIgUre 2: DIreCt coqIaMson oelM!en ....... 1On and n_ ... ne _IS lOr (I) dme 10 
COIItI1IC1lonancl (13 dme ..... n 10 .. lOb peak_I\. 
Time taken 110 conltaClioo is siln~icanlly highel for haIochane than decaPtatioo models 
(F;gtn 2(a)) at sUooIation concentrations of ~jJi1ml and ~mI and sliglnly less for 
961l11m1. The soleus musde tested stimulated al 96JJ11ml was oxposod 10 halolt>ane 10< less 
lI1an 5 nWwIeS wheleas thoso tested at 4JJi1m1 and 55OjJII'ml wore exposed for 45 minutes 
and 25 minutes respoctilely. 
Figml 2(b) indicates lI1at halothane a~ed tests roach peak tension faster than 
decapitation models. The lower concentration of ACh. II1e greater the e~ 01 hafothane 
(shoner time 10 peak tension). 






FIgUre 3: Wluenoe on PT 01 elp05U" time 10 ... _ on ..,,.,"'ated gasttOCR!lIWS 
IIIU1CIe. stnulHd ""111 41Q'mI ACh. 
A sigrWicam decrease in force with an incroase in exposure time is dePCled in Fogure 3. 
Resuhs display ACh stinwialioo concentration of ~~mI (th& "'Nest used concentration). 
Aher haK an hour 01 expos..-e lime 10 halochane. !he OOooNated gastrocoomius was unable 
10 be stiTlllated 'Nih lI1e "'Nest .. ",c""uation. 
3.1.2 DecapitatiOn ana HalOthaf1(J effectS on torce genfJfIJtlon 
Figure ~ i lusueres II1e diffe<ences in peak tensiln obtained aI lI1e three Slim~ 









FIgUre 4: DIIte .. nces WI PT betWeen ~ ... ne and ..,~ est _IS at 3 ",'oed 
concemmlons. Ao...-s ffom Wlnervated soleus mu""'" 
7 




From FIQUIll ~ • is eYidenl dlat halothane i>croases pea!< tension iI comparison III no 
anaesthetic use. This conIonns to litoouuro [II. 
3.2 Electrical stimulation 
The purpose 01 the eloarical stirrulatioo pcoject is III model the speciic pararnetefS 01 
skolelal rnJSCles by observ~ the muscle's overal response III electrical stimulation. II any 
01 the exparimental conditions ater the SIale 01 the measured parame:ers. the results wiD be 
!utile. 
Habthane has been fOUld III aI1ect merrtxane ",ents, excaation-contnlCtion couplilg 
steps, time to peak tension as well as paak tension i1 isolated muscles (21. 
The method 01 eudlanasa that loaves the muscle in as nauaJ a state as possele is 
decapitation. This procedure is clearly best suited III the experimenlal condi1ions. 
3.2.1 ~SUIS from C1eca{1tBtfOn eXP«'lmerws 
The stmngtlHbatioo curves 0/ soleus rruscles (expanted anor docapitatDn) !rom tNO 
seperato rats are shaNn bobN in Fog. 5 (other results are similar). In those graphs red 
represeJ1ls the threshold VaAles lor denerva:od soleus and blue mpresents the threshold 
VablS lor ilnervated soleus. 
~ ) u 
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FIgure 5: SUOngdl dlllllion CUM'S of soleus muscles 
While thess graphs could beneftt lrom irnp"",ed cu,,'s littiIg techniques .• this i1itiaJ 
comparison suggests conIitmation 01 the iteralUm, in thi!; case the Iaa that the denervated 
musde contracts at a loNor \'Clage level (due to the ~hel resting membrane potential after 
dener.'Stion (3)). 
4 CONCLUSION 
The data presented indica:.es that halothane alIects rruscle contractili1\t over time. Whilst 
l'!lWre cites Irequem use 01 habdlane as an anaesthetic, long test durations make i 
unleasible lor the purposes 01 this SbIy. Test results from docapCa:ed rats conlonn to 
9IlIlIJr9 and tIvJs add Uthor vaJidatioo to results shaNn hele and tM warrant IImI>Odmem 
to the original procedure. 
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B Equipment Design and Specications
This Appendix includes the workshop drawings for the tissue bath used in the chemical stimulation
procedure. All drawings were done in ProEngineer Wildre 5.0. Drawings are presented as com-
ponent parts and an additional nal exploded assembly. All component parts were manufactured
from acrylic with the exception of the central heating tubes which were made of glass.
The experimental set-up was designed for practicality and ease of use. Descriptions of such
design implementation are given for further clarication.
The bath was designed to be horizontal to ensure ease of access to the muscle, for both chemical
as well as electrical stimulation. The bath was xed into a cupboard with all necessary pipes and
leads passed through side connections. A sliding glass front enabled the cupboard to be closed
during testing. The fan and temperature probe were thus able to operate at maximum eciency
and fewer disturbances were introduced from external factors.
In the bath itself, the two glass tubes were tted into tapered brass connectors and the connec-
tion sealed with non-reactive sealant. The ends of the brass connectors attached to the tissue bath
were threaded for a secure interference t into the endcaps of the tissue bath. The opposite ends
of the connectors were tapered, allowing for ease of use of exible pipes, the ends of which were
attached to the heating circulator, thus forming a closed circulation loop.
The entry point for the bubbled carbogen gas was placed at the lowest possible position in one
of the endcaps. A thin perspex sheet was slightly distended into the bathing solution during testing
at the entry point of the gases to detract from the formation of large bubbles which might burst
against the strain gauge attachment and cause spurious results. These features also allowed for
minimum disturbance of the muscle by movement of the bathing solution due to bubbling.
Prior to the commencement of recording, a small circulator was placed in the bath to circulate
the carbogen gas and ensure homogeneity in the pH of the solution. The circulator was made from
a simple round rubber stopper attached to the connecting shaft of a small motor, and was powered
by a 2V battery. The circulator was removed before AChCl administration to prevent circulating
the chemical stimulant away from the muscle.
A suction pump was used to remove bathing and ushing solutions between tests.
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Tissue Bath Base 
All dimesions in mm. Scale: 0,850 
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Tissue Bath Stand 
Quantity: 2 
All dimensions in mm. Scale: 1,000 
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Tissue Bath Stopper1 
Scale: 1,000 





·AII holes 21 .2° 







All chamfers R5. 
~t-IIlC== I[~ 
l-I. 76 • -, 
[1-1][-J 
I 20 I I 
~




Tissue Bath Stopper2 
Scale: 1,000 
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C Chemical Dose Calculations and Specications
C.1 Calculations of AChCl doses to be administered
This study implemented the use of 6 dierent concentrations of AChCl which were injected onto
skeletal muscle held within a tissue bath containing Krebs Ringer buer solution. The 6 concen-
trations were known, predetermined values. In order to ensure that the muscle was exposed to the
proper concentration, the dilution principle was employed. The method undertaken is presented as
follows.
The concentrations used could be separated into a low concentration range and a high concen-
tration range. The rst step in the process was to mix stock solutions from which the necessary
doses could be obtained. Two stock solutions were thus prepared, namely that of 1mM and 0.56M
concentrations. The former was chosen based on similar concentration use reported in literature
and the latter was chosen based on the solubility of AChCl (as provided by Sigma-Aldrich). Fur-
ther information on the chemical specications is presented later in this Appendix. The molecular
weight of AChCl, as provided by Sigma-Aldrich is 181.66g/mol.
Given that
(stock solution concentration) (molecular weight) = mass per unit volume
and the known molecular weight of AChCl, the amount (in g/L) of AChCl which is required to
obtain a stock solution of given concentration can thus be determined.






















Measured on a scale sensitive to 4 decimal units, the following amounts of AChCl were dissolved
in the specied volume to obtain the two stock solutions (based on equations C.1 and C.2):
0.1mM stock solution: 0.1817g dissolved in 1000ml of double distilled water
0.56M stock solution: 40.6918g dissolved in 400ml of double distilled water (calculated by ratio)
Once the stock solutions were mixed, it was necessary to determine the volumes of stock solution
which needed to be added to the 63ml tissue bath (the detailed design of which is presented in
Appendix B) to obtain the concentrations given in section 3.3, Table 2. The dilution principle,
given by equation 3.1 in section 3.3 was thus applied here as follows











Table 12: Application of the dilution principle in determination of stock solution volumes (Vstart)
to be added to tissue bath solution
Cstart Vstart [µl] = Cnal Vnal [ml]
1 [mM] 1.39 4 [µg/ml] 63
1 [mM] 33.3 96 [µg/ml] 63
1 [mM] 190.7 550 [µg/ml] 63
0.56 [M] 100 1.6 [g/ml] 63
0.56 [M] 200 3.2 [g/ml] 63
0.56 [M] 400 6.3 [g/ml] 63
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Material safety Data sheet 
Date printed: 01/AlJG/2010 
Date updated: 14/FEB/2006 
version 1.2 
Regulation (EC) NO 1907/2006 




Technical Phone Ii 
Fax 
2 - Hazards Identification 
KREBS-RINGER BICARBONATE BUPFER, WITH 
1800 Ma/L GLUCOSE, WITHOUT CALCIUM 
CHLORIDE AND SODIUM BICARBONATE. CELL 
CULTURE TESTED 
K4002 
Sigma-Aldrich (Pty . ) Ltd. 
Aviation Park, Unit 4 
1619 Kempton Park 
South Africa 
27 11 979 1188 
27 11 979 1119 
SPECIAL INDICATION OF HAZARDS TO HUMANS AND THE ENVIRONMENT 
Not hazardous according to Directive 67/S48/EEC. 
3 - Composition/Information on Ingredients 
product Name 
KREBS-RINGER BICARBONATE 
BUFFERW/1800 MG GLUCOSE/L W/O 









If inhaled, remove to fresh air. If breathing becomes difficult, 
call a physician. 
AFTER SKIN CONTACT 
In case of contact, immediately wash skin with soap and copious 
amounts of water. 
AFTER EY!! CONTACT 
In case of contact with eyes, flush with copious amounts of 
water for at least lS minutes. Assure adequate flushing by 
separating the eyelids with fingers. Call a physician. 
AFTER INGESTION 
If swallo,.·ed, wash out mouth 'olith water provided person is 
conscious. Call a physician . 
5 - Fire Fighting Measures 
EXTINGUISHING MEDIA 
SUitable: Water spray. Carbon dioxide, dry chemical powder, or 
appropriate foam. 
SPECIAL RISKS 
Specific Hazard(s): Emits toxic fumes under fire conditions. 
SPECIAL PROTECTIVE EQUlPMENT FOR FIREFIGHTERS 
wear self-contained breathing apparatus and protective clothing 
to prevent contact with skin and eyes. 
6 - Accidental Release Measures 
PROCEDURE (S) OF PERSONAL PRECAUTION (S) 
EXercise appropriate precautions to minimize direct contact with 
skin or eyes and prevent inhalation of dust. 
METHODS FOR CLEANING UP 
sweep up, place in a bag and hold for waste disposal. Avoid 
raising dust. vent1late area and wash sp1ll site after material 
pickup is complete. 
7 - Handling and storage 
HANDLING 
Directions for Safe Handling: Avoid inhalation. Avoid contact 
with eyes, skin, and clothing. Avoid prolonged or repeated 
exposure. 
STORAGE 
Conditions of storage: Keep tightly closed. 
Store at 2-8°C 
8 - Exposure Controls / Personal Protection 
ENGINEERING CONTROLS 
Safety shower and eye bath. Mechanical exhaust required . 
GENERAL HYGIENE MEASURES 
wash thoroughly after handling . 
PERSONAL PROTECTIVE EQUI PMENT 
Respiratory protection: use respirators and components tested and 
approved under appropriate government standards such as NIOSH (US) 
or CEN (EU). Respiratory protection is not required. where 
protection from nuisance levels of dusts are desired, use type N9S 
(US) or type Pl (EN 143) dust masks. 
Hand Protection: Protective gloves. 
Eye Protection: chemical safety goggles . 
9 - Physical and Chemical properties 
~ ~A 
BP/BP Range N/A 
MP/MP Range N/A 
Flash point N/l\. 
Flammab1lity N/l\. 
Autoignition Temp N/l\. 
OXid1zing Properties N/l\. 
Explosive Properties N/l\. 
Explosion Limits N/l\. 
vapor Pressure N/l\. 
Partition Coefficient N/l\. 
Viscosity N/l\. 
vapor Density N/l\. 
Saturated vapor Conc. N/l\. 
SIGMA - K4002 www.sigma - aldrich.com page 






















10 - stability and Reactiv1ty 
STABILITY 
Stable: Stable. 
Mater1als to Av01d: Strong oxid1z1ng agents. 
HAZARDOUS DECOMPOSITION PRODUCTS 
Hazardous DQcompos1tion Products: Carbon monoxide. Carbon dioxide. 
HAZARDOUS POLYMERIZATION 
Hazardous Polymerization: W1ll not occur 
11 - TOx1cological Information 
SIGNS AND SYMPTOMS OF EXPOSURE 
TO the best of our knowledge, the chem1cal, physical, and 
tox1cological properties have not been thoroughly investigated. 
ROUTE OF EXPOSURE 
Skin contact: May cause sk1n irritation. 
sk1n Absorption: May be harmful if absorbed through the skin. 
Eye contact: May cause eye 1rr1tation . 
Inhalation: Mater1al may be 1rritating to mucous membranes and 
upper respiratory tract. May be harmful if inhaled. 
Ingestion: May be harmful if swallo .... ed. 
12 - Ecological Information 
No data available. 
13 - D1sposal Cons1derations 
SUBSTANCB DISPOSAL 
Contact a licensed professional waste disposal service to dispose 
of th1s material. Dissolve or mix the material with a cOll'.bustible 
solvent and burn in a chemical incinerator equ1pped 'Nith an 
afterburner and scrubber. Observe all federal, state, and local 
environmental regulations. 
14 - Transport Information 
RID/ADR 
Non-hazardous for rO<ld tr<lOsport. 
lMOG 
Non-hazardous for se<l transport. 
lATA 
Non-hazardous for air transport. 
15 - Regulatory Information 
SIGMA - K4002 W'IIW. s1gma-aldrich. com Page 
Not hazardous accord1ng to Directive 67/548/EEC. 
Caut10n: Substance not yet fully tested (EU). 




16 - Other Information 
WARRANTY 
The above informat10n 1s bel1eved to be correct but does not 
purport to be all 1nclusive and shall be used only as a gu1de. The 
1nformation in th1s document is based on the present state of our 
kno .... ledge and 1s applicable to the product with regard to 
appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. S1gma-Aldrich Inc . • 
shall not be held l1able for any damage resulting from handl1ng or 
from contact .... ith the above product. see reverse side of 1nvoice 
or pack1ng sl1p for addit10nal terms and cond1tions of sale. 
copyright 2010 Sigma-Aldrich Co. L1cense granted to make 
unlimitedpaper cop1es for internal use only. 
DISCLAIMER 
For R&D use only. Not for drug. household or other uses. 















l Reference (file sequence): 
l http://::>atlab. Vlle 13. coIt/WU:l/FAO'HolLcaFLL;;>roceSS_<Lsequence_of_flles. 3F 
c: ear a:: 
c l ose all 
c: c 
date.Jlov = c l ocle : 
date.Jlov = strcat (num2str (date_now(1», '_' , num2str(da~e_no-. (2», '_' , 
nu.-:>2str(date.Jlo-, (3» , num2str (date_no-. (4» , num2str (date_no~' ( 5» ) : 
d1ary (streat ( ' log' , date_no~, ' .10g' ) ) ; 
dlary on 
oyFolder = 'G:\lab results\mat illes' : 
fl l ePattern = !u l l!lle (myFolder, ".mat' ) : 
oatF1 l es = dlr(!llepattern) : 
for k = : : length (ma,tF1les) 
s = :80: 
try ltry-catch: ailolls for code to JW::P to next loop (le ~es~) if error OCC:.lrs 
baseF11eKan:e = matFlles (k) . name : 
fu l lF1leKaa:e = !ull!lle (myFolder, baseFlleName) : 
fprintf (1, 'NO" readlng ~s\n' , !ullFlleName) : 
l:.oad lndlv1dual data sets lnto >lor):s;;>ace to dOll!lsa:nple 
l oad (baseFl l eName) 
l covns3::ple data 
tlcktlmel;...block:Lds = do-.nsaple (t1ckt1mes_block2, 20) : 
clear t1ckt!mes_block2 
7 = t1cktla:es_block:Lds: 
clear t1ckt 1mes_block:Lds 
dataJ>10ck2_ds = do-.nsaa:ple (dat<Lblock2 (1 , : ) , 20) : 
c l ear dat<Lblock2 
F = (dat<Lbl ock:Lds/(-0.1 - 10'-6» - 0 .551: ~Conver~s mV ~o rorce -> -2.5'10'-
6 for t.ests be:ore 29Nov2010, -0.1-10"-6 :or a:ter 
c l ear dat<Lblock:Lds 
l FO = (F - (FIl)-0.551»'-1 + 0.551: 'tBrlng;; prete:1s10::ed 
(start va:ue) to FO ::: O.551g, no In'lerslon needed 
FO = F - F(:) + 0. 551: 
at 30sec 
c: ear r-
con = conv (,0, ones (1 , 1000) ' (1/1000» : 
CCC = (con - con(l) + 0. 551): 
c : ear con 
l PL075 
lnJT = mln(round«(s/maX (T))) - length(T)) , leng~h(T)- 501) : 'tfl::cs l:lJecUo:: Ume 
t~orE: catn:ent out lnjT2 1: only one ln~ectl0:". 
l lnj!2 = ::>1n (round«(238/max(T) 1)'length(T», leng~h(T)-51l1): lfl::ds seco::d 
!nject.!on tl::4e if a,ppilcable 
lflnd index 0: =x and .. in polnts: 
1E"OaX = find (ma x (CCC (lnJT+ 500: length (T») = CCC (lnJT+500: leng:h (T») +lnjT+500-1 : 
lfnln = f1nd(m1n(CCC(ln;r : length(T)) = CCC(lnJT : leng~h(T)))+lnlT-1 ; 
lflnds e:ax and mln ar.pl1tudes 
d.-:>ax = «FO(lFmax»-FO(l)) : 
<i::l1n = «(FO(lFm1n»-FO(l)) : 
clear lFoax lFmln 
l Detere:lne by means of ar.plltude if graph should be 1nver~ed or root 
if abs (cim.a x ) <abs (dmin) 
lrma X = flnd(ma x (CCC(lnJT+500:length(T») = 
CCC (lnF,500 : length (T») HnJT+ 500-l ; 
else 
lm.1n = !lnd(m1n(CCC(lnJT:length(T))) = CCC(lnJT: lenq:h(T»)+lnlT-1; 
p = plot(T, CCC(l : length(CCC)-999)) : 
lF1na X = :lnd(max(-l-CCC(lnJT+SOO:length(T») = -
: ' CCC (lnF-500 : length(T») HnjT+ 500-l: 
plot 
end 
lrmln = :lnd(m1n(-l ' CCC(lnjT:length(T») = -l -CCC(lnJT : leng~h(T»)+lnjT-l ; 
p = plot(T, CCC(1:length(CCC)-999) ' -1 +0 .551' 2) ; :t inver: da~a 
l ::> = (FO(length(FO)-lOO))-FO(l))/(T(iength(T)-T(l))); 'tqradle::~ be~. 
f!rst. and last. pOlnt 
l 
\Oeterolne by means of gradlent 1f graph should be l::verted or ::0: 
1: ~ >0 
\ 1F=x = !lnd(r.:ax(CCC(ln:T+500:length(!») = 
CCC (1nF-500: length (T»).lnjT.500-1; 
\ iF::>ln = flnd(m1n(CCC(ln:T:length(T)11 = CCC(l::JT:le::g:h(T»)+1::JT-l: 
p = plot(T, CCC(1:length(CCC)-999»; 
else 
l IF=X = f1ndcc:ax(-1'CCC(lnjT.500:length(T)ll == -
: 'CCC (1nF-500: length(T) I +1nJT+500-1: 
\ 1F::>ln = flnd(e:ln(-l-CCC(lnJT:length(T)) = -l"CCC(l::JT:leng~h(T»)+l::jT-l: 
p = plot(T, CCC(1:length(CCC)-999)'-1 .C.551'2) ; :t ir.ver~ da~a 
plot 
l end 
t!Ue (rege xprep(baseFlleName , 
e = rege xpl (base F lle Name , 'elec' ) ; 
if e > 0 ; 
else 
aX1s([0 1000 - 5 5J) 
~ Injection 11ne plot 
lyll::l=get (gca, 'yile:' ); 
y:uu=[-:2, 26J ; 
, ' » 
llne([T(lnjT) ; T(lnjT)J , yllm. ', 'llne>lldth' ,0 .5, 'color' , [1,O, OJ) ; 
~OOTE: cOl:llll!nt out next 11ne 1£ only 1 lnJec:1on 
llne('T(lnjT2);T(ln:r2)].yl1e:.', 'l1nellidth',O.5, 'color', [1,0,OJ); 
a Xl5([O 1400 -12 26J) ~[O 800 -12 26J for tests before 29Nov2010 
end 
a x is (ax is) 
xlabel ( ' 71e:e (seC)' ) 
y : abel( ',oroe (g)' ) 
x = get(p, 'XData' ) ; 
y = get(p, 'YData' ) ; 
\ loIln and 1'!ax iabe is 
text (x (lF1n1n) , y(lFm1n) , [ 'I'.1n = ' , num2str(X(lFm1n» , ' ; " nuln2Hr(y(1 .... 1n»] , 
tve:-t!Ca:A:lgnment' , • top' I t HorlzontalAllgnnent t , , le~:. I , . FontSlze t I 10) 
text (x (lrmax) , y(lFma x ), [ 'I'.3X = ' , num2str(x(lFmax» , ' : " nwn2s~r(y(l .... a x »] , 
'Vertl.ca:A:tgnment' , 'bottom' , 'Horl%OntalAllgnment' , 'lef't' , 'Fon:Sl,e' , 10) 
hold on 
p:ot{x (lFmln) , y(lFrc.1n) , 'r .. · , X(lFma'x ) , y(lFma x ) , 'r .. ' ) ; 
hold of: 





t out.put rt:.3Xlrcur:. force Frt.ax and tune to l:axlr:;.:c. force Tmax a:-:.d copy 
t !nt.o exce:' 
x:slI rlte( ' cel hl rlte .x ls ' , Y(lFIllaX) , ' statistics ' , ( ' G' num2str(i<) j ) ; 
t Alter ' fl:enar:e ' to save looped datasets: 
t Saves plot :ro~ each data set as .er:: to worklng dlcec:ory, 'gcf ' refers 
t t.o current. figure 
t s.J;\'eas (gef, t filename denervation perlod. ~pgf) 
sa\'eas (gcf, strcat (baseF11eName , I . elC.: 1 ) ) ; 
catch ME 
dlsp:ay (strcat (baseFlleNalll!!, ' FAILED ' )) ; 
dlsp:ay(~.r:essage); t ~ 15 a structure wlth 1nfo 0:-:' t!:e error 
end 
dlary off 




t Reference (Hie sequence): 
t hup://=t:ab. vtkla. coll:/"lkl/FAQ.ilo,,_caIl.-Lproc:ess_'l.-sequenc:e_of_flles. 3<' 
date-"ov = c:'ock ; 
date-"ov = strcat (num.2str (dat,,-no ... ( 1) ) , '_' , num.2str (da~e_no ... (2» , '_' , 
nuo2strcdate-"0 ... (3» , num.2str (dat,,-no ... ( 4» , num2str (date_no~' ( 5» ) ; 




c :' c 
oyFo:der = 'G:\lab results\n:.at flles' ; 
f! : ePattern = :u :' i : lie (myFolder, • ·.n:.at' ) j 
oatFl:es = dlr (: lie Pattern) ; 
t Va:ue of k based on tests to be conc3tenated 
for k = ' 90 ~:: length (c:atFlies) 
s = l80; ~tll,",S ""'rker ~or later determlnatlon of lnjec:1on ~1:ne 
try ttry-catch: aliovs ~or code to JUI!:P to next loop (le ~es~) if error occ::rs 
baseFlleName = matFlles(lq. name ; 
fu : lnleName = ~uilflle (myFolder, baseFlleName) ; 
fprlntf (1, 'No ... readlng \s\n' , : ullFlleName) ; 
~:'03d lndlvldual data sets lnto vorkspace to dOVl:sa:nple 
:oad (baseFl :eName) 
\ OOvns3::lple data 
tlcktlmes-b: ockLds = do ... nsample (tlcktlmes_blockl , 20) ; 
c:ear tlcktlmes_blockl 
7 = tlcktlmes_blockLds; 
clear tlcktlmes_blockLds 
dataJ>lock l_ds = do ... nsample(dat'l.-blockl(l , : ) , 20) ; 
c : ear dat'l.-blockl 
F = ldat'l.-b :ockLds/(-0 . 1 · 10'-6» ~0 .55 1 ; ~conver~5 mV ~o .orce -> -2.;>10'-
6 for tests before 29Nov2010, -0.1 ' 10'-6 for a~ter 
c:ear data.....block1_ds 
t FO = (F - (F(1)-0.551»--1 + 0.551; \llrl::gs pre~e::slor.ed 
(stan "3:00) to FO = 0 .551g, no lnverSlon needed 
FO = F - Fll) + 0. 551; 
at 30sec 
clear F 
con = conv (FO, ones(1, 1000) ' (1/1000» ; 
CCC = detrend(con - con(l) + 0. 551) ; 
c:ear con 
t PLO"IS 
!nlT = mln(round( «s/maX(T») ' length(T) , length(T)- 501) ; Hlr.ds lr.jec~lo" ~lme 
iN'OT£: ccc-~ent out lnJT2 1: only one lnJectl0:1. 
l 1n:72 = r::ln(round«(238/r.:.u(!) - length(T)),le::g:r.(T)-501); Hlnds 
second lnjeceon u::e 1: appl1cable 
lnjTt2 = length(T) ; ler.d of 
Elrst test and In:ectlon and hence start of ach check tes~ 
tflnd lndex 0: I!:ax and .Un pOlnts: 
lR:la x = flnd( .... x (CCC I lnjT+ 500: length (T») = CCC (lnjT+ 500 : leng~h (T) ) ) +lnjT+ 500-1 ; 
lFoln = flnd(lIUn(CCC(lnjT: length(T») = CCC(lnjT: length(T» )+lnjT-l ; 
tfinds max and mtn aJr.pl1tudes 
d:,ax = «FO (lFma x ) )-FO(l» ; 
d:'ln = (IFOltFmln»-FO(l» ; 
clear lFaax lFmln 
t teterm1ne by means of ampl1tude if graph should be lnverted or ::o~ 
lf aoax<dmtn 
IF!na X = ~lnd(max {CCC(lnjT+ 500 : length{T») = 
CCC (ln17-500 : :ength (T») +1njT+500-1 ; 
e:se 
iFIIUn = :lnd (IIUn (CCC (lnjT : length (T») = CCC (lnjT : leng~h (T» ) +lnjT-l ; 
p = plot(T, CCC(l: length(CCC)-999» ; 
IF!na X = :lnd (ma x (-l'CCC (lnjT+ 500 : length (T ) » = -
: ' CCC (ln17-500: length(T») +1njT+500-1 ; 
plot 
end 
IFIIUn = !lnd (lIUn(-l - CCC(lnjT : length(T») = - 1'CCC(lnjT: l ength(T»)+lnjT- 1; 
p = plot(T, CCC(l: iength(CCC)-999) - -1 .0. 55 1- 2) ; ~ l::ver: da~a 
'" = «FO (length (FO) -100) )-FO (1»/ (T (length (T) -T (1»); 
19rad!ent bet. ~ lrst and last pOlnt 
t 
~ teterclne by means of grad lent 1f graph shodd be lr.verted or ::ot 
H '" >0 
l lFr.:ax = flnd(max(ccc (lnjT+500 : length (T») = 
CCC (ln17.500: :ength In» HnjT+500-1; 
t IFlI:ln = flnd("..ln(CCC(lnj7 :length(T») == CCC(l::jT:le::gth(T»)+l::j"I-
p = plot(T, ccc(l:length(CCC)-999»; 
else 
t IFmax = flndlmax(-1 ' CCCllnjT+500:1e::gthIT») = -
l'CCC(lnF*500: length(T») +lnjT+500-1; 
l IFr.;.tn = flnd(r::ln(-l ' CCC(tnjT:ler.gth(T») = -
: -ccc(ln17:length(7») +In;T-l; 
\ ? = plotlT, CCC(l:length(CCC)-999) ' -1 +0.551 ' 2) 
!nvert dat.a p:'ot 
l end 
tltle{regexprep(baseFlleName , 
e = rege xpl (baseFlleName, 'elec' ) ; 
if e > 0 ; 
else 
a x ls ([0 50 - 5 5]) 
l Injection llne plot 
il'il::>=get Igca, • ylll1:' I; 
Y:lm=[-:2, 26] ; 
, ' » 
:lne ([T 11njT) ; T (lnjTl] , y l1m. " 'l1nevldth' , 0 .;, 'color' , [1,0, 0] ) ; 
:lne ([T (lnjTt2) ; T (lnjTt2) ] , y l1l1: . • , ' l1nevldth' , 0.5, 'color' , [1,0,0] ) ; 
lNOTE: coc:cent out next llne lf only 1 lnjec~lo:: 
t l1ne ( [T (In::iT2); T (In::iT2) j, ylln: . " . ilne'A'ld'tr.' # 0.5, 
'co:'o:r', ':,O,Oj); 
tax1S([O :000 -12 26j) \[0 800 -12 26] for tests before 29NOv2e10 
end 
taxls (aX1S) 
x:abe : ( '71a:e (sec)' ) 
y:abe: (. Foroe (g)' ) 
x = get(p, 'xoata' ) ; 
y = get (p, 'YOata' ) ; 
t )o\1n and !-!ax labe 15 




text (x(1Fl!Un), y(1FllUn), ( 'tUn = ' ,num2str(x(lFllUn», ' ; " m:.m2s~r(y(1.-m1n»j, 
'Vert!.ca:Allgrurent I , . top' , 'HorlzontaiAilgnment I , , left.' ~ . FontSlze t ,10) 
text (X(1FmaX), y(1FmaX), ( '''..1X = ' ,num2str(X(lFmaX», ' : " num2str(y(1.-max»j, 
'Vert:.ca:A:lgnment I , I bottom' , • HorlzontalAilgnment I I I Ie:,: I I • Fon-:Slze' ,10) 
end 
ho:d on 
p:'ot{x(lFmln), y(lFmln), ' r .' , x(lFmax), y(lFn:ax), ' r.' ); 
~ho~d off 
c:ear p 
1: out.put rr..axlrr.~ force Fr::.ax and tlroo to rt..axlrc-:.!~ force Tmax a~d copy 
1: int.o exce ' 
x:'slir:.te(' cell.."rlte.xls' , y(lFmax), 'test' , [ 'G' num2st.r(ic)]); 
t Alt.er ' :l:enarne ' to S3\,"e looped datasets: 
t Saves plot. :ro::. each data set as .er:.: to work,l::.g dlrec:.ory, ·qcf ' refers 
t t.o current. figure 
't 
s3veas(gc:, strcat (ooseFlieName, '.emf' »; 
cat.ch :-'.!E 
disp:ay (strcat (basel'lleNan:e, ' FAILED' »: 
d!sp:'ay (ME. ~ssage); ~ ~ 1s .a structure with 1n:0 0:: the error 
end 
'tU E:'EC:R:CA:' CH£CK ttt 
for k = 48 2 't: : Length (c:atf1Les) 
try nry-catch: allolls :or code to ~ump to nex~ loop (le ~es~) if error occurs 
baseFlleName = matF1ies(lq. name: 
fu:LFlleName = :ulLf1ie (myFoLder, baseF1ieName): 
fpr1nt: (1, 'Noli reading ts\n' , :ulLFlleName): 
~:'CNd 1nd1vlduaL data sets 1nto lIorksp3ce to do-.rnsa:lIple 
:oad (basef1 :eNan:e) 
~ oovnsa::zole datz 
tlcktlme.Lb:ockLds = downsampLe (ticktimes_blockl, 20) : 
clear ticktllll!!s_blocki 
:e = tickti<:es_blockLds; 
c:ear ticktlmes_blockLds 
dataJ>lockl_ds = dOllnsample (dat<Lblockl (1, : ), 20): 
c:ear data.....blockl 
Fe = (dat<LblockLds/ (-0.1 - 10"-6» - 0 . 551: lCo::ver~s mV ~o .orce -> -
2 . 5- :0"-6 for tests be:ore 29Nov2010, -0.1 " :0"-6 :or a:ter 
c:ear data.....blockLds 
~ FO = (F - (F(1)-O. 551» "-1 • 0.551: lBrl::qs prete::510::ed 
(start ,'alue) to FO = 0.551g, no 1nvers10n needed 
FOe = Fe - Fe(l) + 0. 551: t • FO(length(!); 
c:'ear Fe 
con = conv(FOe, onesO, 1000) " 0/1000»: 
ecce = con - con 0) + 0. 551: 
c:'ear con 
~p:.o:s 
lFt:laxe = flnd(max(CCcell:length(Te») = CCce(l:length(Te»)+l+500-1; 
1~1ne = f1nd(lIl1n(CCce(1:length(Te») = CCce(l:leng~h(Te»)+I-I; 
d..axe = (FOe (1 Fmaxe ) -FOe 11»: tampi1 tude bet. fir5: and la5: poln: 
d..lne = (FOe(1Fm1ne)-FOeIl»: 
c:'ear lFr:axe lFn:.lne 
, ce~ermlne by means 0: grad1ent 1: graph shol:ld be inverted or not 
H cL",axe < dlll1ne 
e:'se 
!Fma7.e = :1nd(max(CCce(1:Length(Te») = CCce(1:length(Te»)+l+500-1: 
lFllline = :1nd(m1n(CCce(1:length(Te») = CCce(l:leng:h(Te»)+I-I: 
p = piot(T(iength (T) )+Te, ccce (1: iength(CCce)-999»: 
iFma7.e = :lnd(max(-l"CCce 0+500: Length(Te») = -
: 'CCCe (:-500: :ength (Te» ) +1+ 500-1 ; 
lFlll1ne = :lnd(1II1n(-1"CCce(l:Length(Te») = -1 "CCce(l:length(Te»)+1-1: 
p = piot(T(length(T»+Te, ccceO:length(Ccce)-999)'-1 +'0(leng~h(T»·2) 
't !nvert data plot 
end 
xe = get (P, • xData' ): 
ye = get (P, ',(D3ta' ): 
lol1n and !-!ax labels 
text (7.e (ll'lIIine) , ye(ll'lIUne), ( '1'.1n = ' ,num2str(xe(1.-m1ne» , ' ; " 
nu."d2str eye (lFolne» 1, I vertlcalAllgnment I ~ I top' , I Hor1 zon~alAllqn."nent· # • lef:. I , 
'FontS!ze t ,10) 
text (>:e (!Fmaxe), ye(1FmaXe), ( 'I0(3X = ' , nUm2str( xe(1.-maxe», ' ; " 




p:ot (>:e (lFmlne), ye(1Fmine), 'r.' , xe(1FmaXe), ye(lrmaXe), 'r+' ): 
'thold off 
catch t~E 
dlSp:ay (strcat (base FlieName, ' FAILED' »: 
dlSp:ay (l-lE . r!l'!ssage): ~ !!E 1s a structure lI1th 1n:o oe. U.e error 
end 
u't CHElol:CAL CHECK 'tU 
for k = 489 ,:: length (IIl3tF1ies) 
try ttry-catch : alLolls :or code to jump to ::ex: loop (ie test) if error occ<.:rs 
basenleName = matFlles(k).name: 
fu:lnleName = :ulL:1le (lIIyFolder, baseFlleName): 
fpr1ntf (:, 'Noli read1ng ts\n' , :ulLFlleNan:e): 
't:'oad 1nd1vlduaL data sets 1nto workspace to dOll::5a:lIple 
:oad (baseFi:eName) 
~ OOllnsa::>ple data 
tlcktimelLb:ockLds = downsample (ticktlmes_blockl, 20): 
c:ear tickt!JDes_blockl 
:2 = tlckti<:e lLblocl: Lds: 
c:ear t1ckt!mes_blockLds 
data_blockl_ds = do-..nsample (dat<Lblock1 (1, :), 20): 
c:ear dat<Lblock 1 
F2 = (dat<LblockLds/ (-0. 1"10"-6» - 0 . 551; lCo:wer:s mV :0 Force -> -
2 . 5":0" -6 for tests before 29Nov2010, -0.1 "10"-6 for after 
c:ear dat<LblockLds 




FO = (F - (F(1)-0.551» - -1 • 0.551; ~Brlr.q3 pre:en31o".ed 
(start va:ue) to FO = 0 . 551g, no 1nvers1on needed 
F02 = F2 - F2(1) + 0 .551; \ • FO(length(T)); 
c:ear F2 
con = conv(F02, ones(l, 1000) ' (i/l000)); 
=2 = con - con(l) + 0. 55 1; 
c:ear con 
~p:.o:s 
IFOax2 = :1nd(max (CCC2(l:length(T2))) = CCC2(l:lenq:h(T2)))+1+ 500-1; 
IFt:1ln2 = :1nd(m.J.n(CCC2(l:length(T2))) = CCC2(l:lenq:h(T2)))+1-1 ; 
<i::lax2 = (F02 (lFma x2)-F02 (1» ; \qradlen: be:. f1r3: 3::d last pOl::: 
<i::lln2 = (F02 (lFm.J.n2)-F02 (l» ; 
c:ear lFoax2 lFrc.ln2 
~ lJeterlt!ne by means 0: grad1ent 1: graph sho:!ld be Inver:ed or no: 
If cbax2 > dnlln2 
e:se 
!Fmax.2 = :1nd(n:.ax (CCC2(l:length(T2))) = CCC2(1:lenqth(T2)))+1+ 500-1 ; 
H101n2 = :1nd(m1n(CCC2(1:length(T2))) = CCC2(1:length(T2)))+1-1 ; 
p = plot(T(ienqth(T)) +Te+T2, CCC2(1: length(CCC2)-999), 'r' ) ; 
IFmax2 = :lnd (ma x (-1 ' CCC2 (1+ 500 : length (T2) )) = -
l -CCC2 (1-5 00: :enqth (T2)) ) +1+ 500-1 ; 
!Fm.J.n2 = :1nd(m1n(-1 ' CCC2(1:length(T2))) = -1 ' CCC2(1:leng:n(T2)))+1-1 ; 
p = plot(T(lenqth(T»HeH2, CCC2(1:lenqth(CCC2)-999) - -1 +'0(lenql:h(T)) - 2 , 
• r' ) ; :t invert data plot 
end 
x 2 = get (P, 'xData' ) ; 
y2 = get (p, ''(Data' ) ; 
l' ~ln and lo!ax iabe is 
text(x2(!Fllan2) , y2(lFm.J.n2), [ 'rUn = ' , num2str( x2(U'mln2)) , ' ; " 
nuo2str (y2 (1Ft:1ln2)) J, 'VertlcaiAl1gnment' , ' top' , 'Horlzon:alAllgrunen:' , 'lef:' , 
'Fonts:ze' , 10) 
text (x2 (lFmax2), y2 (lFmax2), [ ' l-!3x = ' , num2str ( x2 (1 .... a x2»), ' ; " 
nuo2str (y2 (lFOaX2)) J, 'vertlcaiAl1gnment' , ' bottom' , 'Hortzon:alAl1grunen:' , ' lef"::' • 
'FontS!ze' , 10) 
end 
ho:d on 
p:ot (x2 (lFnan2), y2 (lFm1n2) , 'r.' I x2 (iFmax 2) , y2 (lFma x2), t r+ t ) ; 
~hoid o:f 
~ OUtput r::.axl1t= :orce Fr.:ax and time to =xl1t'Jn: force Tmax a::d copy 
l' !nt.o exce: 
x :slI I'!te(' celblrlte.xls' , y2(lFrc.ax ) , 'test' , [ 'HI nwn2st.r(:<)]); 
~ JU.ter ' :l:ename ' to save looped datasets: 
, Saves piot fror:. each data set .as .er:: to )lorking dlrec::ory, 'gef' refers 
l' t.o current :lgure 
saveas (gc:, strcat (baseFlleName, •. emf' » ; 
catch ME 
dlsp:ay (strcat (base F lle Name , ' FAILED' ») ; 
d!sp:ay (ME . r.l!ssage) ; ~ ~ 1s a structure '11th 1n:o 0:: tte error 
end 
dlary off 




date.-now = e:ock: 
date.-now = streat(num2str(date_noll (1ll, '_' , num2str(cate_no .. ' (2», 
nuro2str(date.-now (3)) , num2str (date_noli (4)), num2str (date_no .. ' (5))) : 





royFo:der = 'G:\transfer to m1k1s iaptop\hht' ; 
fl:ePattern = fu:lflle (myFolder, '-mat' ); 
catn:es = dlr(fllePattern) ; 
for k = 1 : length (matFlles) 
end 
cry 
basenleName = matFlles(k). name ; 
fu:1FlleName = fullf11e (myFolder, baseFlleName); 
fpr1ntf(: , 'So ... readLng ts\n' , fuilFlleName) ; 
~ scr:pt 1:0 run hhspecuum.c:, 1:o~c:age.m and d~sp_~hs . c: 
~Run hhspectrum. m 
load (hasen :eName) 
dataJ>lockl_ds = do ... nsample (dat<Lblock1, 20) ; 
c:ear dat<Lblock1 
x = dataJ>lockLds(1 : 124 : length (dat<LblockLds) ) ; 
clear data.....blockLds 
l"f = emd(x); 
jA,f,tt] = hhspectrum(Lmf(l :end-1,:)) ; 
c:'ear x 
~Run toL:oage. m 
t = l : length(:)i 
'l sp:'x = length(t) ; 
~ sp:y = length(t) ; 
'l [1:0, tt J = tOlmage (A, f, t ); 
10, n, ff] = tOlmage (A. f. t) ; 
'lRun dlSlLhhs 
tlck time !Lb:ock Lds = do" nsaClple (t lcktlme s_block!, 20) ; 
clear tickt:.mes_block1 
dlspJlhs (1m, t1cktlmes_blockLds) 
~ dl slLhhs (!n:, t) 
co:'orbar 
sa''eas(gc:. streat (baseFlleName, '.em:' )); 
cateh )o!£ 
dlsp:ay(streat (baseFlleName, 'FAILED' )) ; 
dlsp:ay(l£.nessage); l:t-a: ls a sructure lI1th 1nfo on the error 
end 
dlary off 
date_nO~1 = clock; 
oate_no .. · = strcat (num2s"r (Oa:e_nOW(1)) , '_' , num2str (Oat<Lnoll (2) ) , 
num2s:r(Oa:e.-nov (3)), num2Sl:r(Oate.-noll (4) I , num2sl:r(Oate...nOll (~))); 





myFolC1er = 'F:\transfer :'0 mlk.l.s :aptop\hht' ; 
:11epa~'tern = fUll:11e(myFolder, ''''mat' ) j 
matF1les = 01r (fllepattern); 
for l< = 1 : lengtn (matF 1les) 
try 
baseFHeName = ma"Flles (In.name ; 
fUllFlleName = fUllflle(r:lyFolaer. t>aseFlleNa::e) ; 
fpr!ntf (: , 'SO'" rea01ng Is\n' , fUllFlleName) ; 
~ scr1pt. to run !:!:5pectru.~.it .. mrts . r: 
~Rt:n nnSpectrulll. m 
10aO (baseFLleNan>e) 
Oa:aJ>lOCl<LOS = 00 ... nsa::ple(Oata.....b10ci<l. 20); 
clear oat<Lblocltl 
x = OataJ>10el<Los(1::2':lengtn(Oat<Lbloel<1_Os)); 
clear oat<Lblocltl_Os 
lmf = e:OO (x): 
[A, f , tl) = nnspec:rum(1r:lf(: : enO-1, i )) ; 
clear x 
~Rt:n ::ns.r. 
HS = A'; 
freq = f ; 
flag = 0 ; 
fres = O. O ~ ; 
fs = 20; ~(20000/20)/12~; 
[a F ) = r-..hs (HS, freg, flag , fres , fs); 
plot (F , a) 
saveas (gc:, strcat. (baseFlleName , I .emfl »; 
eatcn ME 
01splay{streat (baseFlleNat::e, • FAILED' )); 
01splay(t-a:.messaqe); i~': lS a sructt:re wl~n lnfo on tne error 
oLary off 




tHHSP£C7RID! cO!r.pute HUbert-Huang spectru!r. 
t 
~ i A, f,tt. ) = HHSPEC1"RUM:(X, t, 1, a::) co~?utes the Hl1bert-n:.:ang spectrt.::'n 
t 
~ !nputs: 
t - x :oatr!x vlth one slgnal per ro" 
- t. t!.a! 1nst3nts 
. estl:o;;tlon parameter for Instfreq (lnt.eger >=1 (l:c!efal:l~» 
- aft lf 1, dlsplays the cO!r.putatlon evolutlon 
t- output.s: 
t - A instantaneous an::olltudes 
t - f : !nstantaneoU5 :requenCles 
- tt : truncated time lnstants 
t ca::'s: 
t - hllbert : co::putes the analytlc s1gnal 
- !nstfreq : co::putes the 1nstantaneous frequency 
- d!sp:rog : d1splays the cor.:.putatlon evolution 
t£xa:::ples: 
t 
ls = :randn(l,512); 
t!:of = e:xi(s); 
l jA, f , tt j = hhspectrur::.( lito (i :end-i, : »; 
t 
ts = randn (10, 512); 
t iA, f, ttj = hhspect::UJ::(s , 1: 512,2,1); 
l 
t :re:o: need the :l.!r.e-frequency Toolbox (http://t:tb. nong:::.:. org) 
t 
t See a:50 
l e:xi, tOlmage, dlSp_hhs 
l 
t R£f£R£I>C£: G. RlE1ng, last Jt.Od1:1cat1on 3.2001 
t gab:r!e:.:rl:l1ng~ns-lyon.:r 
function 11., f,ttl = hhspectrum(x, t, 1, af:) 
error (nargchk (1, (, narg1n»; 
if nargln < 2 
t=1:slZe{x,2); 
end 
if nargln < 3 
:=1; 
end 
if nargln < ( 
aff = 0 ; 
end 
If :Oln(SlZe(X)) = : 
if SlZe(x,2) = 1 
x = x';, 
lf nargln < 2 
t = l:sne(x,2); 
end 
end 
~"::Iodes = l. 
else 
!>-""odes = slze(x,l); 
end 
:t=:ength (t) ; 
tt=t ((:-1): (:t-l»; 
for 1=1 : ~"::Iodes 
an(l, :)=h1:bert(x(l, :)')'; 
f (1,: )=lnstfreq(an(l, :)', tt, 1)'; 
A=abs (an{:,:+1 :end-l»; 
if aft 
dlsprog(l,Nmodes, ma x (:o/moc!es, 100» 
end 
end 




~70:Y.AG£ transfon:s a spectrun:. r:.ade 0: lD :unctlons in a:: 2:l image 
\ 
~ ,!::J., tt~ ffi = TOI~..AGE(A, f, t, splx, sply) trans:orr:.s a spect.r~"tl made 




al::plltudes of n:odes (1 r::ode per row of A) 
lnstantaneous frequencles 
- t 
- splx : 
- sply : 
time Instants 
nun:ber of col\ll!:lls of the output In: (time resoh:t1on). 






nw-.ber of rovs of the output In: (frecr"ency resoh::lon). 
20 lr::age of the spectruc 
Hoe Instants In the lr::age 
\ - ff centers of the frequency blns 
t 
\ £xa;::ples: i ie,n,ff] = tOla:..age(A,f);[1I::,ttj = tOia:age(A,f,t);[l:n,:::,ff] 
to!::age(A, f, sply); 
~ ilr:,tt,::; = tolcage(A,:,splx,sply);[lr:,:.t,ffj = :olmage(A,f,:',5plx,.;.ply); 
\ 
~ See a:so 
i e::xl, hhspectruc, dlSp_hhs 
l 
t RE.£R£N::£: G. Rll:1ng, last n:odlflcatlon 3.2007 
t gabrlel.rlll1ng~ens-lyon .fr 
funct!on 11m, n, ff] = tOlmage (A, f, varargln) 
O£.SPL = ( 00 ; 
error (nargchlt 12, 5, nargln) ); 
sWitch nargln 
case 2 
t = ::slze(A, 2) ; 
sp:y = O£.SP:'; 
sp:x = length(tl; 
case 3 
!f lsscalar(varargln(ll) 
t = ::slZe(A,2); 
sp:x = :ength(t); 
sp:y = varargln(ll; 
e:se 
t = varargln{lH 
sp:x = :ength (t); 
sp:y = OE.SPL; 
end 
case ( 
!f lssca:a.r(varargln(l I) 
t = ::slZe(A,2); 
sp:y = varargln (1 t; 
sp:x = \rarargln {2H 
e:se 
t = varargln(:t; 
sp:y = varargln(2t; 
spix = :ength (t); 
end 
case 5 
t = vararglnl11; 
sp:x = vararglnl21; 
sply = vararglnl31; 
end 
:f lsvector(AI 
1. = 1.1:1 '; 
f = f(:1 '; 
end 
:f l SSparse(AI I -lSreal(A) II length(SlZe(A)) > 2 
errOr( ·A argurcent must be a reallll3trlX' ) 
end 
if !ssparse(fl I -lSreal(f) II length(SlZe(f)) > 2 
error ( ' f argument rr.ust be a real n:.a.tr1x' ) 
end 
lf any(s!ze(fl-=slZe(A» 
error( 'A and: lC.ltrlces rcust have the same slze' ) 
end 
:f lssparse(tl I -lSreal(t) II -lsvector(t) II length(tl-=slZe(A,2) 
error ( ' t argmcent rcust be a vector and its length rr..lst be :he number of columns In A 
and f :nputs' I 
end 
!f -lsscalar(splx) I -lSreal(splx) II splx -= floor(splx) II splx <= 0 
error ( ' spix argurcent rcust be a pOSltiVe Integer' ) 
end 
if -lssca:ar (sply) I -lsreal (sply) II sply -= fIoor(sply) II sply <= 0 
error ( ' splx argurcent rcust be a positlve Integer' ) 
end 
if any(d!ff(d!ff(t))) && splx -= iength(t) 
varnlng( 'to:mage: nonuniforrctll".,lnsants' , '\'!ben splx differs fro:n leng:h(:), the functlon 
on:y works for equa:ly spaced Hme Instants. YOU may conSIder reformaung your da:a 
(us!ng e.g. !nterpo:atl0n) before USing tOlmage.' ) 
end 
f = '''In(f, O. 51; 
f = ::ax(f, 0); 
lndf = round(2·f·(sply-1)+1); 
lndt = repoat (round (l1nspace 0, length (t), splx) ), slze (A, 1), 1); 
10 = accucarray(!lndf(:),lndt(:)],A(:), [sply,splx]); 
lndt = Indt(l,:); 
tt = t (!ndt); 
ff = (O:sply-:) -0. 5/sply+1/ (4·sply); 
end 




\O:SP_HHS display Hilbert-Huang spectrum 
~ 
t D: SP_HHS (i::>, t , 1nf) 
~ d!.sp: ays 1n a ne v figure the spectrur:. contained 1n matrix· Lm-
t (a::lplltudes 1n dB). 
~ 
t !nputs: - !.r:.: lrc.age E:atrlx (e . g. , output 0: - tolr:.age - ) 
~ - t (o?t1onal) : tir.>e instants (e . g ., output of " tolmage" ) 
- 1n: (optional) : -dynamLc range in dB ( liet <:aX) 
default : In! = -20 
- fs : sa::pl1ng f requency 
~ use: d!spjlhsllm) ; dlS?_hhs(ln:, t) ; dLSP_hhs(lr., l:: f ) 
~ d!sp_hhs(lm, t,lnf) ; dLsp_hhsI1m, Lnf, fs) ; dlSp_hhs(l1::, [I , fs) 
d!sp_hhs(lm, t, [j, is) ; dLsp_hhs(lm, t , lnf, fs) 
~ See also 
~ eod, hhspectrun:, tOlmage 
t 
t RE,ER£N::E: G. Rll : lng, last mod iflcation 3. 2007 
t gabrle:. r1:' : lngl!ens-lyon.fr 
function d1spjlhs (varargln) 
error (nargchk (1,3, nargln) ); 
fs = 20 ; 
lnf = -20; 
10 = varargl n ill ; 






lnf = varargln{2H 
e:se 




t = varargln{21 ; 
lnf = varargln{3l; 
e:se 
lnf = varargln{21; 




t = varargln!21; 
lnf = varargln{ 31: 
fs = varargln{ 4 ) ; 
!f lSeopty(1nf) 
lnf = -20; 
end 
If lnf > 0 
lnf = -lnf ; 
e:seH lnf == 0 
errorc ·!n! cust be nonzero' ) 
end 
l-l=::Iax (oax (1m» ; 
warnlng off 
10 = 10 - log10 (lm/!!); 
varnlng on 
figure 
if fs = 0 
loagesc (t, [0,0 .5J, ln:, [In:, OJ); 
tco:'o!nap( coio:rcu be ) 
y:abe: ( 'nor=l!zed frequency' ) 
e:se 
loagesc(t, 10,0.5·fsJ,1n:, [In:,OJ); 
~colo=ap(coiorcube ) 
y:abe: ( ' frequency' ) 
end 
set (gC3, I Y01r' , , nor::lal' ) 
xlabe: ( ' t!rn>' ) 
tit:e ( ' Hl:bert-Huang spectrum' ) 




i f!nd the r::ag1nal Htlbert Spectrur.:. 
functlon la FJ = MS(HS, :req, flag, :res, :s) 
i---------------------------.;DSA- - - - - - - - -------------------------------
l: ' a ' :.s t.he SUIt. 0: the contribution 0: each :requency compone::=. 1:-. t.::e freq 
l: vect.or for all tl::e pOints. 
i 
\: F ,!S the vector lI!th the ,:requency axis, use it as x axis =.0 plot. t:~e m~s 
i 
i HS !s the Hllbert spectrur:: ar::plttudes, one 1",: per coulmn 
i 
l freq 15 the lnstantaneous:requency, one 1nstantaneous freque::cy per 
-\ co:'u.::ln 
i 
i F:ag (: or 0) flaq=l 1s used to quant1ze the values 0: ~he 1ns~a::~a::eo"s 
i frequency, then values 1ns1de a untt of the resolutlon ar co::::~ed as as 
-\ the sa.-;;e :requency. ,:or 1nstance 1: you have 2 :req..!enCles 10., 34 a::d 
\: :0 , tS and t.he resolution is .25, those 2 :requencles are cou::.t.ed eac::' or.e 
i as :0 , 5 and the "'hs sur:: the ar::plttude related to each freq::e::cy as If 
l they belong to the same frequency value, th1s produces slOOothed graphs 
l fs !s the sar.:.p:e rate of the or1g1nal s1gnal. 
l Eag = 0 dont quantlZe the vectors of 1nstantaneous freque::cy 
l!(07E : 7AKE 0); COL':oIT THAT THE FRE()VE)lCY AXIS IS )lOT ECOALLY i:SPACi::l . ,ROM 
l7HE ]!(S7M"TAlU:OtiS FRE()(lE)lCY SOIo(E VAL:JES 0, F ARE )lEVi:R Ri:ACilE:l, Tili: I, CAN 
tCHAN:;E FOR I);ST;"'1CE FR()!o( 12.5 TO H.5 ;"'1D 13 A.'1D 13.5 DO )lOT Ai'?i:AR AS 
iHAVl);:; 0 (ZERO) CO!."TRIB;)TIC)I 
l REFERE!(CE: Ja 1::e ce 19ado Saa 
HS = reshape (HS, 1, [J)'; 




if (fres > 1 II Eres <= 0) 
end 
d!sp ( 'The value of resol utlon should be > 0 and <= 1HZ ' ) 
return 
fract!on = log(1/:res)/log(2); 
vord:ength = nearest (log « (f 51 2- :ract10nl' 2A (frac~lon) ) +1) Ilog (2) ) ; 
q = quantizer( ' u:lxed' I 'nearest ' , 'saturate' , ['liordlengt.h fract.lon]); 
freq = quan tlze (q, :req); 
vhl : e !se::tpty(:req) =0 
end 
lndx = f~nd(fre~:req(l»; 
fte::tp(1)= freq(:); 
Ate::q> U) =sum{HS (lndx»; 
freq(lndx)=O; 
HS (l.ndx) =0; 
freq = freq (freqo-=O); 
HS=HS (HS~=O) ; 
1 = 1 • 1; 
iF lndx ; = sort (fte::p); 












This Appendix presents the raw data obtained from the experimental procedures. Additional data
may be obtained in soft copy from the disc accompanying this submission.
Muscle Conc Denervation Fmax Mass Length CSA F(csa) Time to F(csa)
[ug/ml] [g/ml] [days] [g] [g] [mm] [mm^2] [g] [s]
ds 96 50 2.64 0.072 15 4.53 0.58 1025.09
is 96 50 7.01 0.301 19 14.95 0.47 1140.54
ds 4 53 1.04 0.175 19 8.69 0.12 217.66
ig 4 53 2.12 2.105 20 99.29 0.02 850.04
is 4 53 0.23 0.309 20 14.58 0.02 921.60
dg 25 50 1.99 0.742 25 28.00 0.07 1267.40
ds 25 50 61.72 0.190 20 8.96 6.89 1106.40
ig 2.5 50 3.67 0.789 25 29.77 0.12 912.98
ig 25 50 3.67 0.789 25 29.77 0.12 912.98
is 25 50 6.14 0.362 18 18.97 0.32 1284.55
dg 4 54 4.79 1.006 20 47.45 0.10 1005.53
ds 4 54 3.10 0.129 16 7.61 0.41 1379.00
ig 4 54 13.50 2.183 22 93.61 0.14 1099.69
is 4 54 7.86 0.386 19 19.17 0.41 1314.90
dg 550 55 1.63 0.657 19 32.62 0.05 933.80
ds 550 55 1.23 0.144 25 5.43 0.23 1321.60
ig 550 55 1.84 2.377 22 101.93 0.02 246.65
is 550 55 3.67 0.503 17 27.91 0.13 1330.50
dg 96 51 16.44 0.988 24 38.84 0.42 1313.30
ds 96 51 6.54 0.152 20 7.17 0.91 489.45
ig 96 51 9.90 2.562 25 96.68 0.10 600.58











Muscle Conc Denervation Fmax Mass Length CSA F(csa) Time to F(csa)
is na 29 0.32 0.252 12 19.81 0.02 47.85
dg 150 50 2.69 0.620 26 22.50 0.12 1388.02
ds 150 50 1.74 0.076 19 3.77 0.46 908.47
is 150 50 3.66 0.245 19 12.16 0.30 839.22
dg 550 104 1.03 0.815 27 28.48 0.04 186.80
ds 550 104 1.77 0.085 10 8.02 0.22 354.05
ig 550 104 8.07 2.492 25 94.04 0.09 1301.76
is 550 104 8.91 0.424 13 30.77 0.29 1307.90
dg 550 104 3.25 0.817 25 30.83 0.11 574.39
ds 550 104 2.01 0.090 9 9.43 0.21 354.01
ig 550 104 7.64 2.522 26 91.51 0.08 1299.70
is 550 104 8.35 0.418 11 35.85 0.23 1306.40
dg 96 105 1.85 0.627 23 25.72 0.07 1314.40
ds 96 105 4.34 0.133 15 8.36 0.52 684.82
ig 96 105 6.89 2.924 22 125.39 0.05 625.82
is 96 105 6.45 0.340 13 24.67 0.26 1321.00
dg 96 105 1.84 0.633 22 27.14 0.07 1313.10
ds 96 105 4.20 0.140 15 8.81 0.48 686.31
ig 96 105 8.17 3.010 21 135.22 0.06 623.71
is 96 105 5.46 0.340 13 24.67 0.22 1303.24
dg 4 104 3.20 0.812 29 26.42 0.12 826.72
ds 4 104 2.08 0.085 13 6.17 0.34 576.26
ig 4 104 3.78 2.194 25 82.79 0.05 1278.00
is 4 104 4.22 0.377 18 19.76 0.21 1271.38
dg 4 104 3.09 0.874 27 30.54 0.10 824.64











Muscle Conc Denervation Fmax Mass Length CSA F(csa) Time to F(csa)
ig 4 104 4.54 2.054 24 80.74 0.06 1281.12
is 4 104 4.49 0.387 16 22.82 0.20 1269.46
dg 550 105 11.67 0.876 25 33.06 0.35 917.93
ds 550 105 4.44 0.166 14 11.19 0.40 1257.48
ig 550 105 2.32 1.242 27 43.40 0.05 447.84
is 550 105 6.42 0.336 12 26.42 0.24 1212.67
dg 96 108 4.81 1.126 22 48.28 0.10 1014.16
ds 96 108 8.04 0.118 19 5.86 1.37 1296.04
ig 96 108 5.93 2.666 22 114.32 0.05 460.62
is 96 108 4.19 0.416 15 26.16 0.16 1261.99
dg 4 107 17.52 0.692 26 25.11 0.70 1229.00
ds 4 107 5.06 0.035 14 2.36 2.15 1212.08
is 4 107 1.52 0.216 20 10.19 0.15 1211.03
dg 3.2 7 12.28 1.470 17 81.58 0.15 1293.74
ds 3.2 7 12.26 0.238 15 14.97 0.82 1288.97
ig 3.2 7 6.95 2.031 18 106.45 0.07 1216.87
is 3.2 7 4.67 0.220 10 20.75 0.23 908.21
dg 3.2 7 21.70 1.899 15 119.43 0.18 1199.69
ds 3.2 7 5.28 0.170 19 8.44 0.63 191.11
ig 3.2 7 21.40 1.735 22 74.40 0.29 967.15
is 3.2 7 34.30 0.227 18 11.90 2.88 880.26
dg 3.2 7 22.88 1.954 15 122.89 0.19 1212.66
ds 3.2 7 4.74 0.164 18 8.60 0.55 190.72
ig 3.2 7 21.01 1.712 20 80.75 0.26 976.17
is 3.2 7 34.33 0.225 18 11.79 2.91 874.19











Muscle Conc Denervation Fmax Mass Length CSA F(csa) Time to F(csa)
ds 1.6 7 7.57 0.161 17 8.93 0.85 873.79
is elec 7 1.64 0.220 11 18.87 0.09 NA
ig 1.6 7 6.89 1.588 20 74.91 0.09 1028.32
is 1.6 7 2.88 0.220 11 18.87 0.15 1309.55
dg 3.2 7 2.11 1.917 20 90.42 0.02 1250.14
ds elec 7 1.89 0.177 14 11.93 0.16 NA
ds 3.2 7 10.52 0.177 14 11.93 0.88 580.90
ig elec 7 1.86 1.420 23 58.24 0.03 NA
ig 3.2 7 13.08 1.420 23 58.24 0.22 1001.12
is elec 7 1.42 0.257 19 12.76 0.11 NA
is 3.2 7 6.24 0.257 19 12.76 0.49 1164.58
dg 3.2 7 1.26 1.917 20 90.42 0.01 1250.14
dg elec 7 3.24 1.521 20 71.75 0.05 NA
dg 6.3 7 13.43 1.521 20 71.75 0.19 1248.11
ds elec 7 0.30 0.200 19 9.93 0.03 NA
ds 6.3 7 37.80 0.200 19 9.93 3.81 999.19
ig 6.3 7 11.24 1.746 25 65.89 0.17 207.36
ig elec 7 0.71 1.746 25 65.89 0.01 NA
ig 6.3 7 55.73 1.746 25 65.89 0.85 1288.63
is elec 7 2.73 0.202 13 14.66 0.19 NA
is 6.3 7 5.69 0.202 13 14.66 0.39 428.06
dg elec 7 3.89 1.929 20 90.99 0.04 NA
dg 550 7 7.21 1.929 20 90.99 0.08 984.33
ds elec 7 1.97 0.214 15 13.46 0.15 NA
ds 550 7 8.70 0.214 15 13.46 0.65 1082.05











Muscle Conc Denervation Fmax Mass Length CSA F(csa) Time to F(csa)
ig 550 7 4.44 1.958 25 73.89 0.06 643.30
is elec 7 0.50 0.288 22 12.35 0.04 NA
is 550 7 34.28 0.288 22 12.35 2.78 1322.00
ig high 14 5.31 1.594 25 60.15 0.09 149.45
dg 550 14 3.19 0.714 18 37.42 0.09 1004.92
ds elec 14 1.31 0.116 20 5.47 0.24 NA
ds 550 14 3.13 0.116 20 5.47 0.57 762.16
ig high 14 5.48 1.594 25 60.15 0.09 186.83
ig elec 14 1.30 1.594 25 60.15 0.02 NA
ig elec 14 0.53 1.594 25 60.15 0.01 NA
ig 550 14 10.63 1.594 25 60.15 0.18 738.25
is elec 14 1.20 0.155 17 8.60 0.14 NA
is 550 14 10.43 0.155 17 8.60 1.21 1166.62
dg elec 7 0.63 1.601 21 71.92 0.01 NA
dg 96 7 25.00 1.601 21 71.92 0.35 1185.25
ds elec 7 1.32 0.157 17 8.71 0.15 NA
ds 96 7 4.58 0.157 17 8.71 0.53 845.06
ig 96 7 6.68 1.509 22 64.71 0.10 922.76
is elec 7 1.44 0.219 15 13.77 0.10 NA
is 96 7 8.96 0.219 15 13.77 0.65 1273.93
dg 96 7 25.19 1.601 20 75.52 0.33 1180.01
ds elec 7 1.37 0.157 17 8.71 0.16 NA
ds 96 7 3.80 0.157 17 8.71 0.44 844.86
ig 96 7 6.63 1.509 22 64.71 0.10 919.83
is elec 7 0.31 0.219 16 12.91 0.02 NA











Muscle Conc Denervation Fmax Mass Length CSA F(csa) Time to F(csa)
dg 0.56 14 3.91 1.322 25 49.89 0.08 931.88
ds elec 14 1.49 0.134 19 6.65 0.22 NA
ds elec 14 1.09 0.134 19 6.65 0.16 NA
ds high 14 3.60 0.134 19 6.65 0.54 185.05
ds 0.56 14 6.17 0.134 19 6.65 0.93 997.41
ig 0.56 14 6.73 1.538 25 58.04 0.12 1178.42
is elec 14 1.51 0.234 22 10.03 0.15 NA
is 0.56 14 5.36 0.234 22 10.03 0.53 1324.50
dg elec 7 1.93 1.676 20 79.06 0.02 NA
dg 4 7 4.06 1.676 20 79.06 0.05 1260.40
ds elec 7 1.26 0.177 20 8.35 0.15 NA
ds 4 7 4.76 0.177 20 8.35 0.57 585.84
ig 4 7 16.74 1.934 23 79.33 0.21 1276.94
is elec 7 2.73 0.173 15 10.88 0.25 NA
is 4 7 4.55 0.173 15 10.88 0.42 1301.88
dg elec 14 0.64 1.305 25 49.25 0.01 NA
dg 6.3 14 5.91 1.305 25 49.25 0.12 1187.59
ds elec 14 1.28 0.114 17 6.33 0.20 NA
ds 6.3 14 10.11 0.114 17 6.33 1.60 1316.90
ig elec 14 -0.07 2.359 30 74.18 0.00 NA
ig 6.3 14 16.64 2.359 30 74.18 0.22 1268.45
is elec 14 0.27 0.297 20 14.01 0.02 NA
is high 14 21.10 0.297 20 14.01 1.51 1244.53
is 6.3 14 4.04 0.297 20 14.01 0.29 742.31
dg elec 7 0.88 1.670 21 75.02 0.01 NA











Muscle Conc Denervation Fmax Mass Length CSA F(csa) Time to F(csa)
ds 1.6 7 53.07 0.153 14 10.31 5.15 1317.30
ig 1.6 7 11.98 1.767 25 66.68 0.18 1205.78
is elec 7 1.28 0.239 20 11.27 0.11 NA
is 1.6 7 16.09 0.239 20 11.27 1.43 763.67
dg elec 14 1.18 1.498 25 56.53 0.02 NA
dg 1.6 14 18.37 1.498 25 56.53 0.32 1326.60
ds elec 14 0.37 0.112 20 5.28 0.07 NA
ds 1.6 14 5.67 0.112 20 5.28 1.07 1182.79
ig elec 14 0.53 1.142 25 43.09 0.01 NA
ig 1.6 14 6.77 1.142 25 43.09 0.16 1193.23
is elec 14 1.29 0.198 15 12.45 0.10 NA
is 1.6 14 8.61 0.198 15 12.45 0.69 1304.67
is elec 7 0.12 0.133 18 6.97 0.02 NA
dg elec 7 0.45 1.550 25 58.49 0.01 NA
dg 6.3 7 2.74 1.550 25 58.49 0.05 1224.51
ds elec 7 0.32 0.121 16 7.13 0.05 NA
ds 6.3 7 6.91 0.121 16 7.13 0.97 536.56
ig 6.3 7 47.34 1.326 22 56.86 0.83 1303.73
is high 7 3.61 0.133 18 6.97 0.52 60.80
is 6.3 7 28.45 0.133 18 6.97 4.08 1272.62
dg elec 14 1.32 1.456 23 59.72 0.02 NA
dg 96 14 15.97 1.456 23 59.72 0.27 1087.32
ds elec 14 1.14 0.070 13 5.08 0.22 NA
ds 96 14 20.36 0.070 13 5.08 4.01 461.22
ig elec 14 1.80 1.975 25 74.53 0.02 NA











Muscle Conc Denervation Fmax Mass Length CSA F(csa) Time to F(csa)
ig 96 14 9.14 1.975 25 74.53 0.12 413.28
ig high 14 0.12 1.975 25 74.53 0.00 122.55
is elec 14 2.62 0.224 21 10.06 0.26 NA
is 96 14 14.57 0.224 21 10.06 1.45 916.52
dg elec 14 1.07 0.937 25 35.36 0.03 NA
dg 4 14 11.74 0.937 25 35.36 0.33 971.53
ds elec 14 0.40 0.087 20 4.10 0.10 NA
ds elec 14 2.20 0.087 20 4.10 0.54 NA
ds high 14 6.23 0.087 20 4.10 1.52 261.66
ds 4 14 15.91 0.087 20 4.10 3.88 1032.25
ig 4 14 6.64 1.414 20 66.70 0.10 491.68
is elec 14 1.21 0.141 11 12.09 0.10 NA
is 4 14 11.37 0.141 11 12.09 0.94 1115.07
ds elec 14 0.98 0.090 17 4.99 0.20 NA
ds 96 14 12.41 0.090 17 4.99 2.49 1320.10
ig 96 14 25.12 1.777 28 59.87 0.42 1191.97
is elec 14 0.55 0.238 15 14.97 0.04 NA
is elec 14 0.28 0.238 15 14.97 0.02 NA
is high 14 1.60 0.238 15 14.97 0.11 294.28
is 96 14 4.57 0.238 15 14.97 0.31 1258.79
dg elec 14 1.10 1.368 25 51.62 0.02 NA
dg elec 14 0.31 1.368 25 51.62 0.01 NA
dg elec 14 1.30 1.368 25 51.62 0.03 NA
dg high 14 1.50 1.368 25 51.62 0.03 214.35
dg 550 14 6.75 1.368 25 51.62 0.13 1296.67











Muscle Conc Denervation Fmax Mass Length CSA F(csa) Time to F(csa)
ds 550 14 4.58 0.087 18 4.56 1.00 1271.81
ig elec 14 0.27 1.483 25 55.96 0.00 NA
ig 550 14 14.48 1.483 25 55.96 0.26 1319.40
is elec 14 0.08 0.224 20 10.57 0.01 NA
is 550 14 3.66 0.224 20 10.57 0.35 1172.85
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